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Abstract 
Campylobacter jejuni, a commensal in poultry members, causes acute gastroenteritis in 
humans. Understanding of Campylobacter jejuni pathogenesis lags far behind that of other 
gastrointestinal pathogens despite Campylobacter sp. being a leading cause of bacterial 
gastroenteritis in the developed world.  
In this study C. jejuni was shown to induce high levels of IL-10 from dendritic cells, a potent 
anti-inflammatory cytokine. IL-10 secretion was induced by the flagella of C. jejuni, a 
protein based filament structure that is modified by sialic-acid like structures. These sugar 
structures were shown to be critical in the induction of IL-10. C. jejuni lacking flagella 
induced lower levels of p38 activation, and inhibition of p38 reduced IL-10 secretion. 
Interestingly Myd88-dependant TLR signalling was shown to be critical for the induction of 
IL-10 despite the inability of C. jejuni flagellin to activate TLR5. We showed that C. jejuni can 
bind to Siglec-10, an interaction that was dependent on the glycosylation of the flagella. 
We speculate that the addition of glycan structures to C. jejuni flagellin proteins may be a 
host-subversion strategy via the induction of IL-10.  
C. jejuni strains isolated from infected humans can be sub-divided into two distinct 
phylogenetic clades. We sought to investigate whether the lipooligosaccharide (LOS) 
structure is distinct between the two clades. The structures of the LOS from 15 different 
strains were analysed. Variation in the oligosaccharide (OS) structure, amide linkages 
connecting the acyl chains to the lipid A backbone, and phosphorylation of the lipid A 
between the strains were observed. Phosphorylation of the lipid A and sialylation of the OS 
correlated with the induction of TNF-α from monocytes. Interestingly, the sialylation of the 
OS correlated with the phylogenetic clade.   
Collectively the data presented highlights the importance of glycosylated surface 
determinants on pathogenic bacteria to manipulate the host innate immune response.  
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1.1  Campylobacter jejuni 
Campylobacteriosis is the most frequent cause of food-borne gastroenteritis in the 
European Union with over 190,000 cases reported annually, although the actual number of  
cases are estimated at 9 million (European Food Safety Authority; EFSA). Campylobacter sp. 
are a major cause of bacterial-associated gastroenteritis in the UK with rates as high as 9.3 
cases per 1000 person-years for community acquired infections (Tam et al. 2012).  The 
economic cost of infection in the EU is estimated to be 2.4 billion Euros therefore not 
surprisingly considerable efforts are being made to limit infection. Campylobacter jejuni is 
the cause of ~90% cases of human Campylobacter enteritis. In the majority of cases, 
disease is self-limiting with acute gastroenteritis lasting less than 1 week; however in a 
small minority of cases post-infection immune pathologies develop. Despite the heavy 
disease and economic burden presented by C. jejuni, far less is known about its 
pathogenesis when compared to other enteropathogens such as Salmonella typhimurium, 
Shigella sp., and Escherichia coli.    
1.1.1 Taxonomy 
C. jejuni belongs to the genus Campylobacter, order Campylobacterales, which are 
members of the epsilon class of proteobacteria. The Campylobacter genus was first 
identified as separate from Vibrio in 1963 after Sebald and Véron noted the distinct 
biochemical properties of Vibrio fetus and Vibrio bubulus from other Vibrio species (Sebald 
and Veron. 1963). In 1973, further analyses of microaerobic/anaerobic bacteria in the 
Vibrio taxa resulted in the re-classification of these bacteria into the Campylobacter taxon 
(Veron and Chatelain R 1973). Pre-1973 Campylobacter sp. were primarily seen as 
veterinary pathogens, and a 1957 report on related Vibrio in human diarrhoeal disease was 
believed to be an anomaly (King 1957). Throughout the 1970’s the importance of 
Campylobacter sp. in human gastroenteritis became apparent as new techniques allowed 
the culturing of these micro-aerophillic bacteria from patients presenting with diarrhoea 
(Skirrow 1977). There are currently 25 known species of Campylobacter which have been 
isolated from a diverse array of hosts, both colonised without apparent symptoms and 
from those presenting with enteritis.  
Campylobacter jejuni was first described in 1931 by Jones and colleagues in cattle suffering 
from spontaneous diarrhoea (termed Vibrio jejuni) (Jones et al. 1931). There are two 
subspecies of Campylobacter jejuni: C. jejuni subsp. jejuni (referred to as C. jejuni) which is 
the major cause of human Campylobacter enteritis (campylobacteriosis), and C. jejuni 
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subsp. doylei. The two sub species differ considerably in their distribution and ecology. As 
yet no known animal host has been identified for subsp. doylei (Parker et al. 2007). C. jejuni 
subsp. doylei has been isolated from patients suffering from both gastritis and enteritis, 
and is more frequently associated with bacteraemia than subsp. jejuni. Interestingly, the 
genes encoding the cytolethal distending toxin (CDT) are absent in subsp. doylei and it is 
hypothesised that a suboptimal host pro-inflammatory response increases chances of 
systemic infection. Overall, subsp. doylei is the cause of very few cases of gastroenteritis in 
comparison to subsp. jejuni.   
The second most common cause of campylobacteriosis is C. coli, which is genetically the 
closest relative of C. jejuni.  C. coli accounts for <20% of human disease and often colonises 
pigs (Gurtler et al. 2005). Over the past decade the importance of other Campylobacter sp. 
in human disease has increasingly been appreciated (Man 2011). C. concisus was first 
isolated from a patient suffering from periodontal disease in the 1980’s, its role in disease 
however remains unclear as it has subsequently been isolated from healthy patients 
(Macuch and Tanner 2000). C. concisus and C. upsaliensis have been isolated from patients 
suffering from campylobacteriosis in Belgium, South Africa, Denmark, and Sweden. It has 
been hypothesised that the fastidious growth conditions of these Campylobacter sp. has 
resulted in an under representation of these organisms in clinical diagnosis (Man 2011).   
Helicobacter, Wolinella, Arcobacter, Sulfurospirillium and Campylobacter belong to the 
order Campylobacterales. Helicobacter pylori was originally termed Campylobacter pylori, 
however in 1989 Helicobacter was assigned to a new genus as increasing structural and 
biochemical differences between the two genus’s were identified; such as the sheath that 
encases the flagellum of Helicobacter sp. but is absent in the Campylobacter sp. (Goodwin 
et al. 1989). H. pylori colonises the human stomach and is the leading cause of gastritis and 
related complications. Wolinella succinogenes is a non-pathogenic commensal of cattle 
rumen; interestingly it retains many of the virulence factors associated with H. pylori and C. 
jejuni (Baar et al. 2003). Intricate crosstalk between host and bacterial factors most likely 
determines the potential outcome of host-microbe interactions which may include 
commensalism, long-term existence with potential pathology or acute infection with or 
without additional chronic clinical manifestations.  
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1.1.2 Clinical Manifestations 
1.1.2.1 Gastroenteritis 
Acute gastroenteritis is the major clinical manifestation in humans infected with C. jejuni; 
clinical symptoms include watery or bloody diarrhoea, often accompanied by abdominal 
cramps and fever (Blaser 1997). Symptoms often resolve within 1 week, although they may 
persist longer than this. Incubation times of between 24-72h generally occur but incubation 
periods of >1 week have been reported, the latter may be associated with low inoculum of 
infection.  In the majority of cases in the developed world campylobacteriosis induces 
inflammatory diarrhoea, with polymorphonuclear (PMN) cells and erythrocytes present in 
the stools (Blaser et al. 1982).  Symptoms are generally self-limiting, although 
immunocompromised patients, such as HIV sufferers, are more likely to have extended 
gastroenteritis and develop bacteraemia (Manfredi et al. 2002).   
Clinical manifestations in developing versus developed countries   
Clinical manifestations of C. jejuni infection differ in people from developing countries than 
those from developed countries, a fact which may aid in improving our understanding of its 
pathogenesis. Principally, people in developing countries are exposed to multiple C. jejuni 
strains far more frequently throughout their lifetimes which correlates with a decrease in 
the symptoms associated with infection (Blaser 1997). Gastroenteritis is more commonly 
seen in young children, and it is rare for adults to suffer from symptomatic disease (Blaser 
1997). Additionally, people from developing countries may asymptomatically shed C. jejuni, 
a phenomena often associated with a prior enteritis episode (Blaser et al. 1980; Pazzaglia et 
al. 1991). Symptomatic disease is often watery rather than bloody diarrhoea. This suggests 
repeated exposure to different C. jejuni strains in early childhood allows the development 
of protective immunity which limits symptomatic disease in older individuals (Havelaar et 
al. 2009). Interestingly, travellers from developed countries with no pre-existing C. jejuni 
immunity develop the more serious symptoms of bloody diarrhoea/abdominal cramps 
when infected with C. jejuni in developing countries (Walz et al. 2001). Additionally, the 
same isolates associated with watery diarrhoea in children in developing countries have 
been isolated from travellers presenting with bloody diarrhoea (Ketley and Konkel 2005). 
This suggests strain variation is not the major cause for the differences observed between 
developed and developing countries. In addition, no differences have been found between 
strains isolated from symptomatic and asymptomatic infection (Champion et al. 2005; 
Sjogren et al. 1989). In a human volunteer study however C. jejuni strains showed 
differential ability to induce pathology (Black et al. 1988). Taken together, strain variation 
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may account for some but not all of the differences in clinical manifestations observed 
around the world.  
The protective immunity acquired by repeated exposure to different C. jejuni strains 
protects only from symptomatic disease but not colonisation in developing countries 
(Havelaar et al 2009; Sjogren, Ruiz-Palacios, & Kaijser 1989; Taylor et al. 1988). C. jejuni has 
also been isolated from asymptomatic long-term abattoir workers (Cawthraw et al. 2000). 
Calculations based on multiple longitudinal cohort studies predicts that even in developed 
countries only 1:120 people who shed Campylobacter species actually present with clinical 
manifestations (Havelaar et al. 2009). Host immunity is therefore predicted to be critical in 
the outcome of exposure to C. jejuni in humans.   
Invasive disease 
Invasive disease and bacteraemia is very uncommon in C. jejuni infected individuals. HIV-
patients and the elderly are more likely to suffer from bacteraemia which suggests host 
immunity plays a major role in limiting systemic spread (Fernandez-Cruz et al. 2010). 
The spectrum of clinical manifestations associated with human C. jejuni infection allows a 
basic model of infection to be predicted which is largely dependent on the host immune 
status. In an immune naïve individual a sufficient C. jejuni inoculum with a virulent strain 
causes acute inflammation and diarrhoea; this acute inflammation accounts for the bloody 
diarrhoea however it also prevents systemic spread. An individual who has acquired 
immunity to multiple C. jejuni strains can mount a robust adaptive immune response and 
limiting pathology but not colonisation.  
1.1.2.2 Intestinal and Extra intestinal sequelae of C. jejuni infection 
Inflammatory Bowel Disease 
Crohn’s Disease (CD) and Ulcerative Colitis (UC) are collectively termed Inflammatory Bowel 
Disease (IBD); they represent major chronic inflammatory disorders of the gastrointestinal 
(GI) tract. Increased risk of developing IBD has been associated with both Campylobacter 
and Salmonella infection (Gradel et al. 2009). However, this association remains 
controversial as a more recent study has shown increased sampling bias around the onset 
of IBD is responsible for the increased detection rates of Campylobacter and Salmonella in 
newly diagnosed IBD patients (Jess et al. 2011).   
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Guillain-Barré Syndrome  
Guillain-Barré Syndrome (GBS) is an autoimmune neuropathy resulting from the production 
of auto-antibodies that cause de-myelination of nerve gangliosides in the peripheral 
nervous system. Symptoms often begin in the lower extremities, and can ascend through 
the body resulting in full paralysis requiring ventilator-assisted breathing. The majority of 
GBS cases are preceded by gastroenteritis, and the discovery of molecular mimicry 
between C. jejuni lipooligosaccharide (LOS) and nerve gangliosides identified C. jejuni 
infection as a major aetiological agent of GBS (Aspinall et al. 1994; Mishu and Blaser 1993).  
Host factors are also important as GBS-associated C. jejuni strains have been isolated from 
patients suffering from uncomplicated enteritis (Nachamkin et al. 1999).   
Miller Fisher Syndrome 
Miller Fisher Syndrome (MFS) is a rare variant of GBS which primarily affects the nerves 
involved in eye movement. C. jejuni infection has also been linked to the development of 
MFS (Yuki 1997). 
Reactive Arthritis 
Reactive Arthritis (RA) is a post-infectious inflammatory arthritic disease associated with 
the HLA-B27 allele. Along with other enteropathogens such as Salmonella, C. jejuni is 
associated with the onset of this disease (Doorduyn et al. 2008). 
1.1.3 Disease and colonisation in other species 
C. jejuni can cause enteritis in many animal species. C. jejuni has been isolated from dogs, 
cats, pigs, and ferrets suffering from diarrhoea (Babakhani et al. 1993; Davies et al. 1984; 
Fox et al. 1986). C. jejuni can reside in pigs as a commensal or cause diarrhoeal disease 
(Ketley & Konkel 2005). Outbred pigs with no prior exposure to C. jejuni develop disease 
after inoculation (Mansfield et al. 2003).  Immunocompetent pigs with no alterations to 
enteric bacteria do not suffer enteritis on exposure to C. jejuni, in contrast colostrum-
deprived new born piglets can suffer similar symptoms to human pathology (Babakhani 
1993). These findings suggest that adaptive immunity is important in the clinical 
manifestations of C. jejuni infection in pigs, as noted for humans. C. jejuni is not considered 
to be a major cause of enteritis in cattle and sheep even though it is implicated with 
increased incidence of abortion (Manser and Dalziel 1985).   
Zoonotic transmission is the major route of C. jejuni infection in humans, in particular 
transmission from contaminated poultry is estimated to cause between 20-70% of all 
human infection (Allos 2001). For this reason understanding C. jejuni/chicken GI 
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interactions has received increased attention in recent years. Approximately 75% of all 
commercially reared chickens are infected with C. jejuni (EFSA). C. jejuni is generally 
considered a commensal in poultry although C. jejuni-mediated diarrhoeal disease has 
been reported in inoculated 3 day-old chicks (Ruiz-Palacios et al. 1981). C. jejuni spreads 
rapidly in broiler chickens, which can be colonised at very high numbers of between 106-108 
colony forming units (CFU)/gram in the cecum (Meade et al. 2009). Surprisingly for a 
commensal bacterium, C. jejuni has been isolated from multiple organs in the broilers, 
including the spleen and liver, which indicates systemic spread is possible from the cecum 
(Meade et al. 2009). This also raises questions about its commensal status in chickens. 
Evidence suggests that C. jejuni translocates through the epithelial barrier to enable 
systemic spread by a process that does not elicit an inflammatory response (Van et al. 
2008). The lack of an inflammatory response in chickens is considered to be a result of an 
“immune-dampening” strategy by C. jejuni (Hermans et al. 2011). C. jejuni reduces anti-
microbial peptide (AMP) expression in the chicken gut highlighting one of many potential 
immune evasion mechanisms it employs (Meade et al. 2009).    
In addition to contaminated poultry, other, non-livestock sources, such as contaminated 
milk and water are significant reservoirs of C. jejuni. A study comparing the phylogenetic 
relationship of “livestock” and “non-livestock or environmental” sources found that over 
50% of human clinical strains tested clustered with the “environmental” strains (Champion 
et al. 2005). It is probable that this source of infection may have been under-represented in 
other studies.  
1.1.4 C. jejuni Surface Structures 
The surface structures of C. jejuni, like many other mucosal pathogens are heavily 
glycosylated; ~8% of its genome encodes proteins implicated in surface carbohydrate 
structures (Figure 1-1) (Parkhill et al. 2000). C. jejuni encodes both N-linked and O-linked 
glycosylation pathways for the modification of periplasmic proteins and flagellin proteins 
respectively.  The first genome sequence highlighted the ability of C. jejuni to mediate 
phase-variation of many genes involved in the glycosylation pathways (Parkhill et al. 2000). 
Long stretches of repeated C or G bases called “homopolymeric tracts” increase slip-strand 
mispairing which can result in genes being “switched on” or “switched off”. The importance 
of these glycosylation systems in the pathogenesis of bacterial-driven human disease is just 
beginning to be appreciated. 
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Figure 1-1: C. jejuni surface structure features 
(a) The flagellum is anchored into both the inner and outer membrane. Flagellin proteins, 
FlaA and FlaB, are O-linked glycosylated with sialic-acid like structures. (b) The capsule is a 
highly branched polysaccharide structure. (c) Lipooligosaccharide (LOS) is an essential 
feature of the outer membrane. (d) Periplasmic and outer-membrane embedded proteins 
are modified by the N-linked glycosylation system. Modified from (Young et al. 2007).   
1.1.4.1 Lipooligosaccharide 
Lipopolysaccharide/lipooligosaccharide (LPS/LOS) forms an integral part of the outer 
membrane of Gram-negative bacteria. C. jejuni expresses LOS which consist of a 
hydrophobic lipid A that anchors into the outermembrane and an extracellular 
carbohydrate oligosaccharide (OS) that lacks the repeating carbohydrate O-antigen of LPS 
molecules (Figure 1-2). The lipid A anchor is essential for membrane integrity and complete 
mutation of C. jejuni LOS is lethal (Phongsisay et al. 2007). The OS structure can vary in 
length and composition; this property is a key strategy employed by Gram-negatives’ that 
allows them to evade and modulate the immune system of the intended host. Interestingly, 
severe truncation of the OS to just one sugar moiety proximal to the 3-deoxy-α-D-manno-
oct-2-ulopyranosic acid (KDO) residue does not affect bacterial growth, although it does 
increase the sensitivity of C. jejuni to antibiotics (Figure 1-2b) (Kanipes et al. 2006).  
The sugar components of the disaccharide lipid A backbone can be 2,3-diamino-2,3-
dideoxy-D-glucose (GlcN3N) or a D-glucosamine (GlcN) moiety (Moran et al. 1991). The 
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lipid A backbone is hexacylated with either palmitic (14 carbon) or myristic (16 carbon) acid 
(Moran et al. 1991). GlcN3N contains two amide linked palmitic/myristic acid chains, in 
comparison GlcN contains one amide and one ester linked fatty acid chain (Figure 1-2a). 
The two additional palmitic acid chains are attached to the palmitic and myristic acid of the 
sugar proximal to the OS attachment, making the disaccharide unsymmetrical. The most 
common backbone composition is GlcN3N-GlcN, although both GlcN3N-GlcN3N and GlcN-
GlcN structures have been detected (Szymanski et al. 2003). Mutation of two genes, gnnA 
and gnnB, eliminates the production of the GlcN3N precursor, UDP-GlcNAc3N, resulting in 
the production of C. jejuni LOS bearing only GlcN-GlcN backbone (Van Mourik et al. 2010). 
GlcN3N sugars reduce both the ability of C. jejuni LOS to activate Toll-like receptor 4 (TLR4) 
and the sensitivity of live C. jejuni to cationic AMPs. The disaccharide backbone can be 
modified with the addition of both phosphate (P) and phosphoethanolamine (PEA) on 
either or both sugars (Moran et al. 1991; Szymanski et al. 2003). The gene responsible for 
the addition of PEA groups onto the lipid A, Cj0256, is also responsible for the modification 
of the flagellar rod protein, FlgG, with PEA (Cullen and Trent 2010). The phosphorylation 
pattern and disaccharide composition of C. jejuni varies between strains and can also differ 
between different growths of the same strain; how these properties alter virulence remains 
to be determined (Szymanski et al. 2003). 
The C. jejuni OS consists of a mainly conserved inner core OS proximal to the lipid A 
backbone, and an outer core OS which varies significantly between strains suggesting the 
two OS cores are under differential selective pressure. The OS structure of C. jejuni strain 
NCTC 11168 is shown in Figure 1-2b. The inner core OS contains two KDO residues, two 
heptose (Hep) residues, with two branched glucose (Glu) residues on each heptose, and 
one PEA/P residue on the heptose proximal to the KDO (St Michael et al. 2002). The outer 
core OS of 11168 and other C. jejuni strains are composed of galactose (Gal), glucose, N-
acetyl-D-galactosamine (GalNAc), and N-acetylneuraminic acid (Neu5Ac; sialic acid) 
residues. The number of each sugar varies between strains and some strains lack sialic acid 
and GalNAc residues completely. The LOS biosynthesis locus in the C. jejuni genome is 
hypervariable and is composed of between 10 – 20 genes (Parker et al. 2008). To date 19 
different LOS classes have been identified with varying levels of homology (Parker et al. 
2005; Parker et al. 2008). Figure 1-3 shows the original 6 LOS classes described in 2005 
(Parker et al. 2005). A further 11 loci described in 2008 evolved by the deletion/ insertion 
of single or whole cassettes of genes from either other LOS loci or capsular polysaccharide 
(CPS) loci (Parker et al. 2008). waaC (open reading frame (orf) 1) and waaF (orf13) encode 
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heptosyltransferases for the addition of the inner core Hep residues (Kanipes et al.  2006; 
Oldfield et al. 2002). lgtF (orf3) is predicted to be a potential glycosyltransferase; the two 
domain protein (e.g. class A) transfers a Glu residue to both Hep residues in the inner core, 
the one-domain protein (e.g. class D) transfers only a single Glu to the Hep proximal to the 
KDO residue (Kanipes et al. 2008). Orfs 4, 5, and 6 are predicted to function in the addition 
of Gal residues to the outer core (Karlyshev et al. 2001). Classes A, B, and C contain genes 
responsible for the sialylation of LOS. neuA1 (orf 10) encodes a CMP-Neu5Ac synthase; 
neuB1 (orf 8) encodes a Neu5Ac synthase; neuC1 (orf9) encodes a UDP-GlcNAc 2-
epimerase; and cstII (orf 7) encodes a sialyltransferase (Gilbert et al. 2000; Gilbert et al. 
2002; Linton et al. 2000). Sialic acid may also be modified by an O-linked acetyl group 
catalysed by sialic-acid O-acetyl transferase encoded by soat (orf 11; class A and B) 
(Houliston et al. 2006).  cgtA (orf 5) encodes a GalNAc-transferase critical for the addition 
of GalNAc to the outer core (Guerry et al. 2002). Sequencing of multiple LOS loci has 
revealed minor genetic alteration within strains of the same LOS class as an additional 
mechanism which C. jejuni employs to vary the outer core OS. Phase-variation, gene 
inactivation by single base insertion/deletion and missense mutations are all operational at 
the C. jejuni LOS loci (Parker et al. 2008). 
The high degree of variability in the outer core OS structure suggests that it may be under 
differential selective pressure compared to the inner core. Indeed many structural features 
of the outer core OS are critical in host-interactions (Jeon et al. 2009; Kanipes et al. 2006; 
Naito et al. 2010). An important consequence is the molecular mimicry observed between 
the OS outer core structure and host gangliosides and other glycans (Aspinall et al.  1994; 
Houliston et al. 2011). In addition to gangliosides, C. jejuni LOS can share structural features 
with P-blood group, paragloboside, lacto-N-biose and sialyl-lewis-c units (Houliston et al.  
2011). Presumably, mimicry of host glycans is a potential immune evasion strategy, as 
adaptive immune cells with specificities for these glycans will be deleted leading to 
increased peripheral tolerance.     
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(b) 
 
Figure 1-2: Structure of C. jejuni Lipooligosaccharide (LOS) 
(a) Hexacylated C. jejuni lipid A. (b) Oligosaccharide structure from C. jejuni strain 1116H 
(LOS class C). Hep = heptose; KDO = 2-keto-3-deoxyoctulosonic acid; Glc = glucose; Gal = 
galactose; GalNAc = N-acetylgalactosamine; PEA = phosphoethanolamine; NeuAc = 5-
acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosonic acid. 
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Figure 1-3: C. jejuni LOS classes 
Characterisation of 6 C. jejuni LOS classes. Common genes to all known LOS classes are 
coloured mid-grey; genes involved in sialic acid modification are coloured dark grey; other 
glycosyltransferases are coloured light grey (Parker et al. 2005)   
1.1.4.2 Flagella 
C. jejuni possess a single flagellum at either pole; this structure is critical for motility and 
the colonisation of the avian host (Hendrixson and DiRita 2004). The flagellar filament is 
composed of two structural proteins, FlaA and FlaB.  Mutation of the flaA gene results in a 
non-motile phenotype and severe truncation of the flagellum indicating that FlaA is a major 
structural component (Guerry et al. 1991). In contrast, a ∆flaB mutant bears full length 
flagella and shows only partial reduction in motility. The flagellar filament is embedded into 
both the inner and outer membrane via a basal body and hook complex composed of 
multiple structural proteins which allow free rotation of the filament to drive motility 
(Figure 1-1). The flagellar filament of C. jejuni is a coiled-coiled structure composed of 7 
protofilaments with a central lumen, unlike Salmonella typhimurium which is composed of 
11 protofilaments (Galkin et al. 2008).  
The flagellin proteins are O-linked glycosylated with sialic-acid like structures which 
accounts for ~10% of its total mass. O-linked glycosylation involves the addition of a sugar 
moiety to the hydroxyl group of a serine or threonine residue of a target protein. Unlike N-
linked glycosylation there is no known conserved amino acid sequence that dictates which 
residues are to be modified. O-linked glycosylation of flagellin proteins is considered to be 
critical for the assembly of functional flagella and for colonisation in chickens (Howard et al. 
2009). Initial binding studies utilising sialic-acid specific lectins led to the conclusion that C. 
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jejuni flagellin contains sialic acid moieties, however more recent data indicates that these 
modifications are derivatives of sialic-acid like structures Pseudaminic acid (Pse) and 
Legionaminic acid (Leg) encoded by the Pse and Ptm biosynthesis pathways respectively 
(Figure 1-4) (Doig et al. 1996; Howard et al. 2009; Thibault et al. 2001). All C. jejuni strains 
studied to date express either Pse and its derivatives (e.g. strain 81-176) or derivatives of 
both Pse and Leg (e.g. strain 11168). In strain 11168 the flagellin glycosylation genetic 
cluster is composed of ~50 genes which encode Pse and Leg pathways (Parkhill et al. 2000). 
In contrast, strain 81-176 contains only the Pse synthesis pathway. Mutational analysis of 
strain 81-176 found only 3 of the 19 O-linked glycosylated residues are critical for the 
assembly of functional motile flagella, 5 residues are important for auto-agglutination, and 
11 residues at present have no ascribed function (Ewing et al. 2009). The lack of phenotypic 
alteration upon the removal of ~50% of the glycosylation sites and the exposure of these 
residues on the external surfaces of the flagellin monomers suggest that these 
modifications may play a role in interaction with the host. In fact, mutation of the Leg 
structures in strain 11168 dramatically decreases the ability of C. jejuni to colonise the 
chicken GI tract (Howard et al. 2009). Interestingly, “livestock” strains show a greater 
propensity to encode the Leg synthesis genes compared to “non-livestock/environmental” 
strains (Champion et al. 2005). At present, the role and contribution of the glycosylation 
moiety of C. jejuni flagella in modulating human host-pathogen interactions is unknown. 
Unlike many other well-known Gram-negative enteropathogens (e.g. Salmonella, Yersinia 
sp.), C. jejuni lack a functional type III apparatus, instead C. jejuni secrete effector proteins, 
invasion antigens (Cia proteins) and FlaC through the flagella apparatus (Konkel et al. 
2004). This process requires the basal body and hook structure, and one of the FlaA or FlaB 
proto-filaments but not both.    
C. jejuni flagellin proteins are major immunomodulatory antigens during infection and 
significantly contribute to the heat-labile (HL) serotyping of the bacterium (Lior et al. 1982). 
C. jejuni is able to switch between flagellated and aflagellated phenotype; this property 
may allow the flagellin to perform its dual contrasting role(s), firstly in promoting 
colonisation and yet allowing immune evasion (Caldwell et al. 1985). Only motile flagellated 
bacteria were recovered from the stools of human volunteers when the inoculum 
administered contained a mixture of both flagellated and aflagellated bacteria, this data 
highlights the necessity for flagella expression for colonisation of the human GI tract (Black 
et al. 1988). As an immune evasion strategy, C. jejuni has evolved mutations in the FlaA 
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protein such that it no longer interacts with TLR5; how the loss of this interaction renders a 
selective advantage for C. jejuni is not clear (Andersen-Nissen et al. 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-4: Structure of Neuraminic acid, Legionaminic acid, and Pseudaminic acid 
derivatives 
(a) N-acetylneuraminic acid (5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-
ulopyranosonic acid; Neu5Ac) (b) Legionaminic derivative (5-acetamidino-7-acetamido-
3,5,7,9-tetradeoxy-d-glycero-d-galacto-nonulosonic acid; Leg5Am7Ac) (c) Pseudaminic acid 
derivative (5-acetamido-7-acetamidino-3,5,7,9-tetradeoxy-l-glycero-l-manno-nonulosonic 
acid; Pse5Ac7Am). 
1.1.4.3 Capsule 
The high molecular weight polysaccharide component of the capsule was originally thought 
to be LPS, it was only identified as capsular polysaccharide (CPS) upon the elucidation of 
the genome sequence (Karlyshev et al. 2000; Karlyshev, McCrossan, & Wren 2001). The CPS 
and not the LOS was also found to be the determinant in the heat-stable Penner serotyping 
scheme. The genetic locus for strain 11168 CPS contains 38 genes but this varies widely 
between strains. The genes involved in CPS polymerisation and translocation are conserved 
between strains, however the internal region encoding the CPS repeating units are highly 
(b) (a) 
(c) 
(b) 
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variable (Karlyshev et al. 2005). CPS encoding region can range between 15.2kb and 34.1kb 
in size. Similar to the LOS, phase-variable cps genes have also been identified. The high 
degree of variation implies interaction(s) may occur between C. jejuni CPS and the host. 
Indeed, CPS is important for dampening pro-inflammatory cytokine responses in dendritic 
cells (DCs) as well as invasion of intestinal epithelial cells (IECs) (Bacon et al. 2001; Rose et 
al. 2011)   
1.1.4.4 N-linked Glycosylated Proteins 
C. jejuni was the first bacteria in which an N-linked glycosylation system was identified 
(Wacker et al. 2002). N-linked modified structures bear a sugar moiety attached to the 
amide nitrogen of an asparagine residue. Unlike the glycosylation of other C. jejuni surface 
structures, N-linked glycosylated proteins are highly conserved between strains (Young et 
al. 2002). A heptasaccharide composed of a single bacillosamine moiety attached to a 
linear chain of 5 GalNAc residues with one tertiary glucose residue forms the structure of 
all C. jejuni N-linked carbohydrates. The 12-gene pgl (protein glycosylation) locus encodes 
enzymes required for the synthesis of carbohydrate structures in the cytoplasm and 
subsequent linkage of the heptasaccharides to ~30 target proteins in the periplasm.  
The biological role of the N-linked glycosylation system is not fully understood although 
studies indicate a role in colonisation of the chicken gut, adherence and invasion of human 
IECs and modulation of DC inflammatory cytokine responses (Karlyshev et al. 2004;Rose et 
al. 2011; van Sorge et al. 2009). 
1.1.5 Additional Virulence Factors 
1.1.5.1 Cytolethal Distending Toxin 
Cytolethal Distending Toxin (CDT) is a tripartite complex that causes cell cycle arrest at the 
G1/S or G2/M transition stage (Lara-Tejero and Galan 2000). The active subunit CdtB 
translocates to the nucleus where it acts as a DNase causing DNA damage and cell cycle 
arrest. The role of CDT in pathogenesis is unclear as C. jejuni that lack CDT are still able to 
induce disease in humans (Mortensen et al. 2011). CDT may have a potential role in 
asymptomatic infection as CDT from other species show immunosuppressive capacity via 
induction of apoptosis of T-cells (Shenker et al. 2000).  
1.1.5.2 Invasion Proteins 
C. jejuni secretes Cia proteins via its flagella apparatus. Cia proteins are important in the 
invasion of IECs via the recruitment of Rho GTPase, Rac-1 (Eucker and Konkel 2011). FlaC is 
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structurally similar to FlaA and FlaB. FlaC is secreted via the flagella apparatus and plays a 
role in the invasion of IECs via as yet undefined mechanism(s) (Song et al. 2004).   
1.1.6 Infection Models 
Understanding of C. jejuni pathogenesis lags behind that of other enteric pathogens in part 
due to a lack of good small animal models of disease. Chick models are used for C. jejuni 
colonisation studies, however the pathology associated with human disease is not 
observed. Wild-type (WT) mice of multiple genetic backgrounds show limited colonisation 
of C. jejuni, and pathology is even more infrequent (Chang and Miller 2006; Rathinam et al. 
2008). Until recently, mice with the genetically altered immune systems such as SCID mice 
or IL-10 knock-outs were the most frequently used animal model systems (Chang & Miller 
2006; Lippert et al. 2009; Rathinam, Hoag, & Mansfield 2008). Recently a model replacing 
the enteric flora of WT mice with human flora was described (Bereswill et al. 2011). These 
mice were colonised with C. jejuni and developed inflammatory responses. Larger animal 
models, such as new-borne piglets, are also used for pathogenesis studies however, high 
cost and limited genetic tools make them less desirable (Babakhani, Bradley, & Joens 1993). 
1.2 Gastrointestinal tract 
1.2.1 Ingestion to infection 
The structure of the GI tract, from the mouth to the anus, can be divided into four major 
layers: the mucosa, submucosa, muscularis externa, and serosa. The mucosa broadly 
functions in absorption and secretion: this layer is composed of a single cell epithelial 
lining, beneath which is the “non-organised” lamina propria (LP) containing the majority of 
the immune cells, and a layer a smooth muscle (muscularis mucosae).The structure of the 
mucosa varies widely along the length of the GI tract depending on the function of the 
organ. 
Low pH in the stomach acts as a major chemical defence against ingested pathogens. C. 
jejuni is relatively susceptible to low pH conditions in vitro, surviving less than 60mins at 
pH3.0 (Rotimi et al. 1990). This is in discordance with the low bacterial inoculums of 1000-
10,000 CFU required to cause campylobacteriosis in humans (Black et al. 1988). It has been 
proposed that C. jejuni can withstand the acidic environment via association with food and 
even by inhabiting amoebae as a route into the lower GI tract (Axelsson-Olsson et al. 2010; 
Waterman and Small 1998). 
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The entire GI tract is lined with a single IEC layer that plays a critical in absorption of 
nutrients. The ileum and jejunum lining is organised into crypt and villus macrostructures 
that increase the surface area for absorption of nutrients. The colon lacks villi and functions 
to absorb water and fat-soluble vitamins. Intestinal epithelial cells (IECs or enterocytes) are 
columnar cells with apical invaginations (villi and microvilli) that markedly enhance the 
surface area for optimal absorption. Enterocytes are interspersed with goblet cells that 
secrete mucin, the major component of the mucus layer, which provides a physical and 
chemical barrier keeping commensal and pathogenic microbes at bay and simultaneously 
smoothing the peristaltic movement of passing bolus. Microfold (M) cells are largely found 
in the ileum and lie above the Follicle-Associated Epithelium (FAE) of the Peyer’s Patch (PP). 
M cells allow direct uptake of luminal bacteria and antigens for sampling by the underlying 
immune cells. Stem cells are located in the crypt surrounded by AMP secreting Paneth cells 
(PCs) which provide sterility in a microbe-rich environment. Stem cells differentiate into 
four epithelial lineages which include the enterocytes, PCs, goblet cells, and the neuro-
endocrine cells. Gut-associated lymphoid tissue (GALT) can be subdivided into the 
“organised” tissue of the PPs, isolated lymphoid follicles (LFs), and mesenteric lymph nodes 
(MLNs).  
C. jejuni initially colonises the jejunum and ileum where pathology can occur, however the 
colon is considered to be the major site of pathology in the majority of campylobacteriosis 
cases (Black et al. 1988; Russell et al. 1993). Motility is important in the colonisation of both 
the human and avian gut (Black et al. 1988; Nachamkin et al. 1993). Mucin(s) act as a 
chemoattractant for C. jejuni in part via the L-fucose glycans which can be an energy source 
for specific virulent C. jejuni strains (Hugdahl et al. 1988; Stahl et al. 2011). L-fucose triggers 
the downregulation of CPS which may aid attachment and invasion of IECs. The ability of C. 
jejuni to translocate the IEC layer is considered important in inducing colitis compared to 
eliciting watery diarrhoea (Everest et al. 1992). C. jejuni may translocate the epithelial 
barrier by a number of mechanisms. In a rabbit ileal loop model of infection C. jejuni 
preferentially binds and translocates M cells over enterocytes (Walker et al. 1988).  This 
mechanism of translocation is also important for other enteropathogens such as 
Salmonella, and Yersinia. Both transcellular and paracellular routes of bacterial 
translocation have been demonstrated for C. jejuni in vitro. The ability of C. jejuni to invade 
IECs varies depending on the cell type, however most studies agree that bacterial invasion 
precedes disruption of IEC tight junctions (Bras and Ketley 1999; Wine et al. 2008). The 
advantages for C. jejuni to translocate the epithelium lie in the access to a new ecological 
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niche with limited competition from other bacteria; however the low rates of septicaemia 
associated with infection and the inability to survive within mono-nuclear phagocytes 
suggest C. jejuni is not a particularly successful pathogen within the mucosa (Allos 2001; Hu 
et al. 2006). Recent reports showing the ability of C. jejuni to survive within IECs highlights 
this cell type as a potential harbour for the bacterium in the human intestine (Watson and 
Galan 2008). 
1.3 Epithelial Responses 
1.3.1  Epithelial Adhesion, Invasion & Intracellular Survival 
The ability of C. jejuni to adhere to and invade IECs has been demonstrated in several cell-
lines as well as in human colonic biopsies (Bras & Ketley 1999; Edwards et al. 2010; van 
Spreeuwel et al. 1985; Wine, Chan, & Sherman 2008; Zilbauer et al. 2007). C. jejuni 
manipulates both the microtubular and actin cytoskeleton to gain entry into IECs (Eucker & 
Konkel 2011; Watson & Galan 2008). C. jejuni binds to fibronectin and integrin complexes 
on IECs via fibronectin-binding proteins triggering epidermal growth factor receptor (EGFR)-
mediated-signalling (including phosphinositide 3-kinase (PI3K) activation)  and subsequent 
endocytosis (Eucker & Konkel 2011), the latter depending upon lipid rafts and caveolin for 
formation of a C. jejuni-containing vacuole (CCV) (Watson & Galan 2008). The CCV follow a 
non-canonical endocytic pathway and avoid lysosomal fusion allowing C. jejuni to survive 
within IECs for >24h.  
1.3.2 Pathogen Recognition 
Adhesion and invasion of IECs by C. jejuni is associated with the secretion of the pro-
inflammatory cytokines, IL-8 & IL-6, and the induction of AMPs human beta-defensins 2 & 3 
(hBD-2 & 3) (Friis et al. 2009; Watson and Galan 2005; Zilbauer et al. 2005). C. jejuni-
mediates activation of multiple IEC signalling pathways; these include nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB), mitogen-activated protein kinases 
(MAPKs), and PI3K activation. The MAPK, extracellular signal-related kinase (ERK), is critical 
for IL-8 responses (Watson & Galan 2005). Interestingly, the ∆flaA mutant exhibits reduced 
ERK-stimulating capability, suggesting receptors independent of TLR5 are important for the 
recognition of C. jejuni flagellin in IECs. The only IEC pattern recognition receptors (PRRs) 
identified to date that recognises C. jejuni are NOD-1, which reduces intracellular bacterial 
survival and drives IL-8 and hBD-2 expression, and TLR2 which induces IL-6 secretion (Friis 
et al. 2009; Zilbauer et al. 2007).  
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1.4 Innate Immunity to C. jejuni 
1.4.1.1 Host Factors  
Host genetics and acquired immunity play important roles in the clinical manifestations of 
C. jejuni infection. Acquired immunity to C. jejuni limits symptomatic disease but not 
eliminate colonisation. In addition, genetic factors have been implicated as important in 
the development of campylobacteriosis and post-infection sequelae (Janssen et al. 2008). A 
single-nucleotide polymorphism (SNP) in the first intron of the interferon gamma (IFNγ) 
gene is associated with C. jejuni-associated enteritis (Nielsen et al. 2012). This association 
implicates T helper 1 (Th1) responses in host immunity to C. jejuni infection.  Two possible 
scenarios could explain this association. Firstly, an inappropriate overt IFNγ-mediated 
increase in pro-inflammatory responses may directly promote immune-mediated enteritis 
and pathology or an initial suboptimal IFNγ response may lead to unsuccessful bacterial 
clearance, a trigger for exacerbation of inflammation. As the impact of this SNP on cytokine 
induction is unknown theoretically both scenarios are plausible explanations for this 
association. Interestingly, the same SNP is associated with the development of RA, however 
again either of these two scenarios could explain this association.  Interestingly, IL-10 
promoter and TLR4 promoter polymorphisms have been associated with GBS which also 
implicates the regulation of the immune response to the development GBS (Myhr et al. 
2003; Nyati et al. 2010).    
1.4.2 Innate Immune Cells of the GI mucosa 
After translocation through the epithelial barrier, C. jejuni is sensed by innate immune cells 
of the LP. In addition, infected IECs signal to underlying immune cells. Chemokines, such as 
IL-8, drive an influx of neutrophils which promote bacterial clearance and halt systemic 
spread and yet overt presence of neutrophils is characteristic of the inflammatory 
pathology (Figure 1-6) (van Spreeuwel et al. 1985). Activated professional antigen 
presenting cells (APCs) trigger an adaptive immune response which further stimulates the 
innate system to clear C. jejuni and limit bacteraemia (Fernandez-Cruz et al. 2010). 
APCs that reside in the LP under homeostatic conditions generally express a more 
“tolerogenic” phenotype and sense commensal bacteria in the lumen either directly or 
indirectly via the epithelium without activating an inflammatory response. However, during 
infection migrating APC are able to activate pro-inflammatory adaptive immunity either in 
the draining lymph nodes (LN) or within the LP. 
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1.4.2.1 Dendritic Cells 
Dendritic cells (DCs) bridge the innate and adaptive immune response by acting as APCs 
that have the capacity to promote naïve CD4+ T helper cell differentiation and functions. 
Upon encountering bacteria DCs phagocytose, process and present antigen to T-cells in the 
context of MHC class II or cross-presentation on MHC class I. In addition, DCs undergo a 
maturation process that involves the upregulation of co-stimulatory molecules and 
secretion of a plethora of cytokines that tailors the adaptive immune response to the 
nature of the infectious insult. Although the IEC layer acts as a barrier between the lumen 
and the GALT, DCs can make direct contact with luminal antigens by sampling via DC 
protrusions (Rescigno et al. 2001) or indirectly as antigens pass through M-cells and IECs.  
Functionally, DCs have the challenging task of remaining tolerogenic to gut microflora 
whilst retaining the capability to mount appropriate immunity to potential pathogens. It is 
therefore logical that multiple subsets of DCs exist with more specialised functions. In the 
murine mucosa CD103+ (the receptor for E-Cadherin, an IEC adhesion molecule) DCs 
migrate to the MLN via expression of CCR7 and induce the differentiation of regulatory T-
cell (Tregs) (Coombes et al. 2007). However, under inflammatory conditions CD103+ DC 
induce Th1 and Th17 responses (Laffont et al. 2010). CX3CR1+ positive-DCs are able to 
extend dendrites and directly sample luminal antigens (Niess et al. 2005). Interestingly, 
CX3CR1+ DCs are programmed with more pro-inflammatory capabilities than CD103+ DCs. 
CX3CR1+ DC lack migratory properties, they are therefore hypothesised to play a greater 
role in modulating local mucosal immunity (Schulz et al. 2009). Absence of enteric 
microflora reduces CX3CR1+ but not CD103+ DC numbers (Niess and Adler 2010). This 
suggests that under inflammatory conditions an increase in pro-inflammatory CX3CR1+ DCs 
may drive T-cell polarisation directly in the LP towards a Th1/Th17 phenotype.  
For purpose of investigation, human peripheral blood monocyte-derived DCs or murine 
bone marrow-derived DCs (BMDCs) are frequently used in in vitro co-culture assays. Both 
DC types model a more inflammatory monocyte-derived DC subset, which is more likely to 
be present during intestinal infection and inflammation. C. jejuni is readily phagocytosed 
and killed by human monocyte-derived DCs and murine BMDCs (Hu et al. 2006; Rathinam, 
Hoag, & Mansfield 2008). In contrast other enteropathogens such as Salmonella enterica 
survive within APCs which may explain greater incidence of systemic disease (Abrahams 
and Hensel 2006) when compared to campylobacteriosis. H. pylori can also replicate within 
BMDCs for a limited time. A >1 log fold-increase between 2 and 6h post-innoculation has 
been observed, declining thereafter (Wang, Gorvel et al. 2010).  
34 
 
1.4.2.2 Macrophages 
Resident gut–associated macrophages largely reside within the LP and lack inflammatory 
responsiveness to many microbe-associated molecular patterns (MAMPs), this is due to low 
expression of TLR-associated adaptor molecules (Smythies et al. 2010). Intestinal 
macrophages are able to phagocytose whole bacteria and cellular debris but secrete the 
anti-inflammatory cytokine IL-10 and not pro-inflammatory cytokines (Denning et al. 2007). 
This is in contrast to the chronic inflammatory setting of IBD where a CD14+ subset of 
macrophages secretes a number of pro-inflammatory cytokines that contribute to disease 
pathogenesis (Kamada et al. 2008). This suggests that macrophages that migrate to the gut 
retain pro-inflammatory capabilities that may activate adaptive immunity whereas resident 
macrophages may function to clear IECs debris or commensal bacteria without eliciting a 
strong inflammatory response.  
Studies performed to date analysing macrophage responses to C. jejuni have utilised 
phorbol 12-myristate 13-acetate (PMA)-stimulated THP-1 cells which display a phenotype 
between the monocyte/macrophage stages of differentiation. Unlike resident intestinal 
macrophages, PMA-stimulated THP-1 cells are capable of eliciting pro-inflammatory 
responses to TLR ligands. C. jejuni induces IL-1β secretion from PMA-stimulated THP-1 cells 
(Siegesmund et al. 2004). In addition C. jejuni induces apoptosis via a caspase-1 and -9 
independent pathways which is partially reliant on the ability of C. jejuni to produce Cia 
invasion antigens. This suggests that bacterial driven macrophage apoptosis may be a 
potential immune evasion strategy, however at present the effects of C. jejuni on resident 
intestinal macrophages is unknown. Phagocytosed C. jejuni is readily killed by murine BM 
macrophages; earlier studies however suggested C. jejuni can survive within 
monocytes/macrophages for up to 7 days (Kiehlbauch et al. 1985; Watson & Galan 2008). 
The use of different cell types may account for this discrepancy, it is however interesting to 
speculate that a potential difference in the bactericidal activity of resident intestinal 
macrophages may allow them to harbour viable C. jejuni.    
1.4.2.3 Polymorphonuclear Cells 
Polymorphonuclear (PMN) cells or granulocytes include neutrophils, eosinophils, basophils, 
and mast cells. Eosinophils, basophils, and mast cells play an important role in Th2 
mediated pathology of allergic disease and shall not be discussed further. Neutrophils 
engulf and rapidly kill bacteria via production of reactive oxygen species (ROS) within the 
phagolysosome. Neutrophils play a critical role in resolution of many infections as they 
have the most potent phagocytic and bactericidal capability of all the phagocytes. The level 
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of PMN infiltration in the GI mucosa of children during C. jejuni infection correlates with 
the degree of inflammation (Everest et al. 1992), this evidence implicates PMNs in the 
acute inflammatory pathology seen in some C. jejuni infections. A similar association is also 
seen in a rabbit ileal loop model of C. jejuni infection (Everest et al. 1993). Interleukin 8 (IL-
8) and leukotriene B4 (LTB4), are neutrophil chemoattractants secreted by IECs and 
neutrophils respectively and are both induced in response to C. jejuni infection (Everest et 
al. 1993; Watson & Galan 2005). Although the main function of neutrophils is to limit 
systemic spread of C. jejuni, they may also contribute to pathology by the release of toxic 
ROS (Figure 1-6). In addition, neutrophils can migrate between IECs and into the lumen 
thus disturbing barrier integrity (Sun et al. 2011).  
Interestingly, colonisation of the avian GI tract by C. jejuni induces IL-8, and yet this 
increase is not associated with an increase in heterophil numbers (the avian equivalent to 
neutrophil) (Meade et al. 2009), although an increase in circulating 
monocytes/macrophages is observed. Potentially the lack of heterophils may account for 
the persistent colonisation and yet disease free status of the avian gut in response to C. 
jejuni.  
1.4.2.4 Natural Killer cells,  Lymphoid Tissue-Inducer Cells & Gamma-Delta T cells 
Local, mucosal sources of IFNγ, IL-22, and IL-17 provide an early host defence shield in 
response to infection, long before the adaptive immune system comes into play. Natural 
killer (NK) cells, lymphoid tissue-inducer (LTi) cells, and gamma-delta (γδ) T cells are innate 
immune cells that reside within the LP and GALT and are able to produce an array of host-
defence peptides. In an ex vivo human intestinal biopsy model of infection C. jejuni induced 
IFNγ, IL-22, and IL-17A within 8h of infection suggesting a robust  source of these cytokines 
is present in the LP and GALT (Edwards et al. 2010). C. jejuni expands γδ T cells in the 
presence of CD4+ T cells, suggesting this cell population may also be activated during 
infection (Van Rhijn et al. 2003). At present there is no data available on the cytokine 
responses of this cell population. C. jejuni LOS bearing a α2, 8-linked sialic acid moiety 
interacts with the inhibitory sialic-acid binding immunoglobulin-like lectin 7 (Siglec-7) on NK 
cells but the functional consequence of this interaction remains unclear (Avril et al. 2006).   
1.4.3 Soluble Mediators of Innate Defense 
1.4.3.1 Complement 
Complement activation is a key part of the innate immune defence towards limiting 
systemic spread of pathogens. C. jejuni is susceptible to human serum suggesting sensitivity 
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towards complement components (Blaser et al. 1985). However, C. fetus is less sensitive to 
human serum. It has been hypothesised that the discrepancy between the sensitivity of the 
two species may account for why C. fetus is more frequently found in patients suffering 
from septicaemia.  
1.4.3.2 Anti-microbial peptides 
Anti-microbial peptides (AMPs) are a diverse group of small cationic peptides that possess 
bactericidal activity by targeting the cell membrane of microbes. Two IEC AMPs, HBD-2 and 
-3 are induced in response to C. jejuni (Zilbauer et al. 2005). C. jejuni is sensitive to the 
effects of HBD-2 and -3 which cause a “peeling” of the cell wall and loss of cytoplasmic 
contents. Surprisingly elimination of the capsule does not increase sensitivity to AMPs. 
Indeed, other studies have shown the importance of the LOS structure but not the capsule 
for resistance to the antibiotics erythromycin and polymixin B (Jeon et al. 2009; Naito et al. 
2010). The PEA modification of the lipid A and oligosaccharide of C. jejuni LOS are 
important for AMP resistance, which is likely to involve charge interactions as both PEA and 
sialic acid residues are negatively-charged (Cullen & Trent 2010; Naito et al. 2010). 
Interestingly, C. jejuni colonisation of chicken reduces expression of 7 different AMP genes 
in comparison to Salmonella typhimurium which induces expression (Meade et al. 2009). 
Reduced AMP expression is hypothesised to contribute to the observed high C. jejuni 
bacterial load and may also contribute to systemic spread. In humans, a robust AMP 
response may limit C. jejuni numbers in the intestine and therefore halt systemic spread.   
1.4.4 Cytokine Responses to C. jejuni infection 
C. jejuni-mediated infection induces a pro-inflammatory response from IECs, innate, and 
adaptive immune cells. Chemokines such as IL-8, monocyte chemoattractants chemokine 
(C-C motif) ligand 2 (CCL2; MCP-1) and CCL4 (MIP1β) are secreted from C. jejuni-stimulated 
IECs (Hu and Hickey 2005; Watson & Galan 2005). Co-culture experiments with human ex 
vivo intestinal biopsies also show elevated IL-8 levels (MacCallum et al. 2006).  
C. jejuni also stimulates pro-inflammatory cytokine induction in DC and macrophages 
(Edwards et al. 2010; Hu et al. 2006;Rathinam, Hoag, & Mansfield 2008). Increase in acute-
phase response inducers tumour necrosis factor-alpha (TNF-α) and IL-6, as well as Th1 and 
Th17 polarising cytokines IL-12 and IL-23 respectively has also been noted (Edwards et al. 
2010). Similar to IEC responses, no dramatic difference between human and chicken C. 
jejuni-stimulated macrophages/monocytes has been observed (de Zoete et al. 2010). 
Minimal levels of IL-1β have also been detected in ex vivo stimulated biopsies (Edwards et 
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al. 2010). A recent report suggested that induction of the potent anti-inflammatory 
cytokine IL-10 may be flagellin-dependent (Rose et al. 2011). Whether the induction of IL-
10 by C. jejuni is an immune evasion strategy has yet to be investigated. 
1.4.5 Microbial detection by the innate immune system   
To detect microbes, immune and non-immune (e.g. IEC) cells express a plethora of PRRs 
that bind to evolutionary conserved microbe-associated molecular patterns (MAMPs) 
leading to appropriate cellular activation. This model was first proposed by Charles 
Janeway in 1989 (Janeway, Jr. 1989) but it is now widely accepted that the same system 
can also detect endogenous danger signals as suggested by Polly Matzinger (Matzinger 
2001). It is now recognised that components from both commensal bacteria MAMPs and 
pathogens (PAMPs) activate PRRs. It is therefore predicted that availability of 
MAMPs/PAMPs for their cognate receptors largely detects activation of inflammatory 
responses in the gut. The thick mucus layer likely goes some way to minimise contact 
between commensal microflora and cells of the mucosa. 
1.4.5.1 Toll-like receptors 
Toll-like receptors (TLRs) were the first PRR family to be implicated in mediating anti-fungal 
immunity in drosophila (Lemaitre et al. 1996). Subsequently a human homolog of TOLL, 
TLR4, was identified (Medzhitov et al. 1997). TLRs are type-1 transmembrane proteins, 
comprised of a C-terminal Leucine-Rich Repeat (LRR) domain that is ligand (MAMP)-
binding, a single membrane spanning domain, and an N-terminal cytoplasmic Toll/IL-1R 
(TIR) homologous interacting domain that is capable of binding adaptor molecules to 
orchestrate signalling cascades. There are 11 known mammalian TLRs that function as 
homo- or hetero-dimers. TLRs are expressed either on the cell surface or within 
endosomes. TLRs are known to bind a diverse array of microbial products of viral, bacterial 
and fungal origin. The best characterised of these is the receptor for LPS/LOS, TLR4. Jules 
Hoffmann and Bruce Beutler were awarded a share of the 2011 Nobel Prize for Medicine 
for the discovery of the TLR-mediated antifungal cascade and elucidation of the interaction 
between LPS/LOS and TLR4 respectively; these discoveries are seen as pivotal to our 
current understanding of fundamental signals employed by the innate immune system to 
detect and respond to infection (Poltorak et al. 1998). 
Signalling downstream of TLRs is mediated by a number of scaffolding proteins that contain 
TIR-containing adaptor molecules; myeloid differentiation primary response protein 
(MyD88), MyD88 adaptor-like (Mal), TIR domain-containing adaptor inducing IFN-β (TRIF), 
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and TRIF-related adaptor molecule (TRAM). TLR signalling cascades result in activation of 
MAPK, NF-κB, and interferon regulatory factor (IRF) pathways which are central master 
regulators of inflammatory response(s) (Figure 1-5) (Kawai and Akira 2006). TLR signalling 
has also been implicated in the phagocytosis and the maturation of the phagolysosome 
(Blander and Medzhitov 2004).  
C. jejuni activates human TLR1/2/6, and TLR4/MD2 (de Zoete et al. 2010). C. jejuni di- and 
tri-acylated lipoproteins are the predicted ligands for TLR 1/2 and TLR 2/6, and LOS is the 
known ligand for TLR4/MD-2 (Kuijf et al. 2010). TLR signalling is a critical regulator in the 
gut. TLR5-/- mice have increased bacterial load and develop spontaneous colitis which is 
associated with elevated pro-inflammatory cytokine levels (Vijay-Kumar et al. 2007). 
Interestingly, TLR5-/- TLR4-/- double knock-out mice have increased bacterial load but do not 
develop colitis suggesting TLR signalling within the gut is important for regulating the 
enteric flora but under certain circumstances can also drive inflammatory pathology. C. 
jejuni can successfully colonise MyD88-/- but not WT mice highlighting the role for TLR 
signalling in colonisation resistance in this model (Watson et al. 2007). Expression of TLRs in 
the gut may vary between species which may contribute to the different outcomes 
observed. C. jejuni is able to stimulate chicken TLR2 and TLR4 homologs (de Zoete et al. 
2010). Interestingly, the chicken TLR9 ortholog, chTLR21, is able to sense C. jejuni DNA 
unlike the human counterpart. In addition, activated chicken TLR4 is unable to induce a 
type 1 IFN response unlike human TLR4. Whether these discrepancies play a role in the 
different outcomes of C. jejuni infection between humans and chickens requires 
clarification.  
1.4.5.2 Nucleotide Oligomerisation Domain-like receptors 
The nucleotide oligomerisation domain (NOD)-like receptors (NLRs) are a group of 
cytoplasmic microbial sensors. NLRs are composed of an effector domain, a nucleotide-
binding domain (NBD), and an LRR ligand binding domain. The NBD is implicated in complex 
oligomerisation which is necessary for NLR function. NLRs can be subdivided based on the 
presence of a caspase-recruitment effector domain (CARD) or pyrin effector domain (PYD). 
NOD1 and NOD2 are two NLRs that recognise muropeptide iE-DAP and muramyl dipeptide 
(MDP) respectively, two subcomponents of peptidoglycan (PGN) which is found in the cell 
wall of both Gram-positive and Gram-negative bacteria. Activation of NOD1 and NOD2 
triggers the formation of a signalling complex containing receptor-interacting 
serine/threonine kinase-2 (RIP2) and cellular inhibitor of apoptosis (cIAP) 1 and 2 which 
leads to the activation of NF-κB and MAPK cascades (Bertrand et al. 2009). NOD1 and 
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NOD2 can synergise with TLR signalling to either dampen or stimulate pro-inflammatory 
responses depending on the cellular context (Fritz et al. 2005; Watanabe et al. 2004). 
In IECs, C. jejuni activates NOD1 but not NOD2 to induce the secretion of HBD2 and IL-8 
(Zilbauer et al. 2007). NOD1 activation also minimises intracellular C. jejuni numbers. C. 
jejuni can also activate NOD2 in a reporter cell-line but the functional consequences of this 
is unknown (Al-Sayeqh et al. 2010; Zilbauer et al.2007). 
The inflammasome 
A subfamily of the NLRs activates caspase-1 rather than the NF-κB signalling pathways. 
Upon activation these NLRs form a complex called the “inflammasome” in the cytoplasm 
that cleaves pro-caspase-1 to active caspase-1 (Martinon et al. 2002). NLR proteins utilise 
their PYD and CARD domains to form the inflammasome, the complex formation 
culminates in the recruitment of apoptosis-associated speck-like protein containing a CARD 
(ASC) and procaspase-1. Autocatalytic cleavage of the latter releases active caspase-1, the 
enzyme responsible for cleaving pro-IL-1β, pro-IL-18, and pro-IL-33 resulting in their release 
from the cell. Bioactive IL-1β and IL-18 are potent pro-inflammatory activators with 
multifactorial properties, not surprisingly overt expression and release is tightly regulated 
at multiple levels. Transcription levels are controlled by TLRs and NOD1/NOD2 pathways 
and post-translation modification by the inflammasome. This is called the “two-hit” 
hypothesis. Activation of the inflammasome can also trigger cell death via pyroptosis. The 
activation of the inflammasome is triggered by a diverse variety of PAMPs and also by 
endogenous danger-associated molecular patterns (DAMPs). The presence of circulating 
binding proteins (e.g. IL-1 receptor antagonist and IL-18 binding protein) provides another 
level of regulation for this family of cytokines. 
The Inflammasome has been implicated in the sensing of multiple enteropathogens 
including Salmonella typhimurium and Escherichia coli (Miao et al. 2010b). Inflammasome 
activation is critical for clearing pathogens when cleavage of IL-1β/IL-18/IL-33 and/or the 
induction of pyroptosis are required. In a murine model of Salmonella typhimurium, 
infection leads to systemic disease and death. However, infection with S. typhimurium 
which constitutively expresses the flagellin protein (flagellin is recognised by the NLR 
member, IPAF, causing pyroptosis of infected macrophages and clearance by PMNs) does 
not lead to death, mainly due to inflammasome function (Brodsky et al. 2010; Miao et al. 
2010a). It is not surprising that some pathogens have evolved mechanisms to suppress 
inflammasome function. Mycobacterium tuberculosis produces a zinc metalloprotease 
40 
 
which inhibits inflammasome activation in macrophages (Master et al. 2008). Yersinia sp. 
secretes an effector protein YopK, which interferes with recognition of its type III secretion 
system by macrophages (Brodsky et al. 2010). To date the potential role of the 
inflammasome during infection with the order Campylobacterales has not been reported  
1.4.6 Glycan Receptors 
Glycosylation of surface structures lends microbes with potential fitness advantages. These 
include survival in harsh and varying environments; assembly of surface structures; 
adherence and invasion of target cells; and disguise antigenic surface proteins during 
engagement with the host immune system. Glycans are less immunogenic than protein 
counterparts as they are not generally presented on MHC molecules to T cells, and are 
therefore T-cell independent antigens with some noted exceptions. For example, recent 
findings have demonstrated the capacity of polysaccharides from commensal bacteria to 
influence the mucosal immune system. Polysaccharide A (PSA) is a component of the CPS of 
the human commensal bacterium Bacteroides fragilis. PSA can bind directly to TLR2 on 
mucosal CD4+ T cells and generate Treg differentiation by inducing IL-10, TGF- β, and Foxp3 
which subsequently inhibit Th17 responses (Round et al. 2011). The induction of Tregs 
allows closer association of B. fragilis with the epithelium in a mouse model, which 
suggests this could also be a mechanism exploited by pathogens although this has not been 
investigated. Bacterial glycan structures can bind to a wide variety of host receptors 
expressed on immune and non-immune cells. These interactions have been shown to both 
enhance and dampen pro-inflammatory immune responses to C. jejuni (Kuijf et al. 2010; 
van Sorge et al.2009). 
1.4.6.1 Sialic-acid binding Ig-like receptors  
Sialic-acid binding immunoglobulin-like receptors (Siglecs) are a group of receptors largely 
expressed on the surface of haemopoeitic cells. Siglecs are composed of a single trans-
membrane domain, multiple extracellular immunoglobulin (Ig) domains that bind ligand, 
and a cytoplasmic intracellular inhibitory motif (ITIM) domain which exerts regulatory 
function. Some Siglecs contain an intracellular growth factor receptor binding protein-2 
(Grb2) binding motif and ITIM-like motifs that do not conform to canonical ITIM sequences, 
the functional consequences of these domains upon receptor ligation remains largely 
uncharacterised (Crocker et al. 2007). There are two sub-categories of Siglec receptors 
based on sequence similarity. The first includes Sialoadhesin, CD22, Siglec-4 and -15; the 
second subset share sequence homology with CD33 and are termed the CD33-related 
siglecs (Crocker, Paulson, & Varki 2007; Crocker and Redelinghuys 2008). The CD33-related 
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Siglecs are rapidly evolving, with variation in the numbers of receptors between species, 
even in higher order mammals.  There are currently 10 known human CD33-related Siglecs 
which are expressed on both innate and adaptive immune cells (Lock et al. 2004). Although 
humans display the most rapid rate of Siglec evolution, lower Siglec expression in human 
compared to chimpanzee T cells has been implicated in the heightened reactivity of human 
T cells to many stimuli (Soto et al. 2010). Additionally, the lower expression is hypothesised 
to contribute to the “over-reactivity” of the human immune system which leads to diseases 
such as asthma and RA.  
Siglecs bind sialylated structures (most often sialylated glycans) via the terminal V-set Ig 
domain, and have varying specificities for the linkage of the sialic acid and the underlying 
glycan structure which can be present on both host cells and microbes. Interestingly, recent 
reports have also highlighted the ability of Siglecs to bind to both host and pathogen non-
sialylated ligands. Siglec-5 can bind the β-protein of group B Streptococcus (Carlin et al. 
2009a), and Siglec-10 can bind vascular adhesion protein-1 (Kivi et al. 2009). However it is 
unlikely that these interactions occur via the sialic-acid binding pocket.  
Siglec engagement has been implicated in many cellular processes including endocytosis, 
apoptosis, cellular activation, and proliferation (Crocker, Paulson, & Varki 2007). The 
immunomodulatory capability of Siglecs is often via the modulation of TLR signalling (Boyd 
et al. 2009). Siglecs can bind to host cell surface sialic acid both via cis (on the same cell) 
and trans (different cell) interactions. Binding of Siglec-10 (murine Siglec-G) by the receptor 
CD24 (ligated to the DAMPs, high mobility group box 1 (HMGB1) or heat shock proteins) 
leads to down-regulation of NF-κB signalling, protecting  mice in a inducible liver necrosis 
model (Chen et al. 2009). This suggests that Siglecs play a role in limiting immune responses 
to DAMPs. This immune modulatory capability of Siglecs may have been exploited by 
pathogens during evolution as binding to these receptors potentially reduces immune 
activation and therefore increase chances of establishing infection. Many sialylated 
pathogens engage Siglecs, including C. jejuni (Avril et al. 2006; Heikema et al. 2010). 
Engagement of Siglec-9 by sialylated CPS and Siglec-5 by β-protein by Group B 
Streptococcus reduces the oxidative burst of neutrophils and increases intracellular survival 
(Carlin et al. 2009a; Carlin et al. 2009b). Engagement of murine Siglec-E by Trypanosome 
cruzi reduces DC IL-12 production which alters subsequent T-cell activation (Erdmann et al. 
2009). C. jejuni strains that contain terminal α2,8-linked and α2,3-linked sialic-acid on the 
LOS bind to Siglec-7 and Sialoadhesin respectively (Avril et al. 2006; Heikema et al. 2010). 
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The differential expression of these linkages drives alternative T cell responses, a factor 
which is hypothesised to impact on the development of GBS post C. jejuni-infection (Bax et 
al. 2011). 
Multiple hypotheses have been proposed for the cause of rapid evolution of CD33-related 
Siglecs. One hypothesis is a need to keep pace with the changing host sialome (Crocker, 
Paulson, & Varki 2007). As high percentage of sialic-acid containing pathogens infect 
humans; this raises a second hypothesis that rapid evolution may allow Siglecs to act as 
potential PRRs aiding in microbe detection (Crocker, Paulson, & Varki 2007). However, the 
evolution of Siglec “paired-receptors” which share structural identity of the ligand binding 
domain but lack the intracellular signalling domain suggest this could be a decoy strategy 
by the host to counteract the immune inhibition pathogens achieve on Siglec engagement, 
therefore supporting the first hypothesis (Crocker & Redelinghuys 2008). Until further 
studies detailing the functional consequences of Siglec engagement during infection are 
performed their exact role in either microbe recognition or/and immune evasion strategies 
remains open.  
1.4.6.2 C-type Lectin Receptors 
Similar to Siglecs, C-type lectin receptors (CLRs) are group of receptors that are prominently 
found on the surface of immune cells. CLRs contain a single trans-membrane domain, a C-
type lectin-like domain (CTLD) involved in ligand binding, and often an intracellular 
signalling domain (Osorio and Reis e Sousa 2011). Upon engagement CLRs potentially 
initiate or dampen/modulate immune responses. Similar to Siglecs, engagement of CLRs 
often leads to modulation of TLR signalling, and has therefore been described as an 
immune evasion strategy in some instances. Mycobacterium tuberculosis and Candida 
albicans are able to induce IL-10 secretion by engaging the CLR DC-SIGN, via prolonged NF-
κB activation (Gringhuis et al. 2007). As a consequence of modulating innate immune 
effector responses, engagement of CLRs can have downstream effects on T-cell 
polarisation. H. pylori interaction with DC-SIGN reduces DC cytokine induction which stunts 
Th1 responses (Bergman et al. 2004). Neisserria gonorrhoea activates DC-SIGN or the CLR 
macrophage-binding galectin (MGL) on DCs depending on the terminal sugar moiety on its 
LOS (van Vliet et al. 2009). Engagement of MGL skews T helper responses towards an 
unproductive Th2 response.  
GalNAc residues on N-linked glycosylated proteins on the surface of C. jejuni bind the CLR 
MGL. In addition the LOS from certain strains bearing a terminal GalNAc residue can also 
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bind MGL. This interaction with MGL has shown to reduce DC IL-6, indicating that certain C. 
jejuni surface structures may actively promote immune suppression (van Sorge et al. 2009).  
1.4.7 Signalling 
Linking microbial recognition to innate immune cell effector responses and T helper cell 
polarisation involves a complex network of intracellular signalling cascades. Many cellular 
events are triggered in innate immune cells by microbes; three of the major pathways that 
are activated downstream of MyD88-dependent TLR signalling are the NF-κB, MAPKs, IRFs 
(Figure 1-5). 
1.4.7.1 Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells  
The NF-κB family is comprised of five related transcription factors, p50, p52, p65, RelA, and 
RelB. In unstimulated cells, inhibitor of NF-κB (IκB) sequesters inactive NF-κB in the 
cytoplasm. Upon cellular activation, IκB is degraded allowing NF-κB to undergo nuclear 
translocation and initiate transcription of NF-κB responsive genes by binding to κB sites in 
gene promoter or enhancer regions. NF-κB molecules form functional heterodimers before 
translocation to the nucleus (Ghosh and Hayden 2008).  
In vitro inhibitor studies have revealed a critical role for NF-κB signalling in the induction of 
inflammatory cytokines both in C. jejuni-stimulated IECs and DCs (Lippert et al. 2009). In a 
gnotobiotic IL-10-/- NF-κB-reporter murine model, pathology is associated with NF-κB 
activation in lamina propria mononuclear cells (LPMC) and induction of IL-12p40 and TNF-α 
(Lippert et al. 2009). However, the use of NF-κB inhibitors did not ameliorate C. jejuni-
mediated pathology suggesting this signalling pathway alone is not responsible for the 
inflammatory nature of campylobacteriosis in this model. 
1.4.7.2 Mitogen-Activated Protein Kinases 
MAPKs are a family of serine/threonine kinases that have multiple roles in cellular biology 
including: cellular proliferation/survival, transcription induction, cellular movement, as well 
as induction of inflammatory responses after microbe recognition. MAPKs are activated by 
upstream MAPK kinases, which in turn must be activated by MAPK kinase kinases (MAP3K). 
Once activated MAPKs regulate a number of different transcription factors that are 
involved in immune function. Regulation of activation is tightly controlled, for example 
MAPKs can regulate their own activation by negative feedback mechanisms involving 
activation of one of three classes of protein phosphatases (Jeffrey et al. 2006). 
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There are three major MAPK family members: Extracellular signal-regulated kinases (ERKs), 
c-Jun N-terminal kinase (JNK), and p38. They exert cell-specific effects on cellular processes. 
p38 and JNK are linked to pro-inflammatory responses. p38 was first identified as the target 
of pyridinyl imidazoles, a group of compounds capable of inhibiting monocyte TNF-α and IL-
1 secretion (Lee et al. 1994). ERK has been linked to pro-inflammatory responses in DCs 
(Boele et al. 2009), but it can also influence IL-10 and TGF-β expression, and the 
development of Tregs (Escors et al. 2008). MAPKs activate transcription factors that 
differentially regulate inflammatory gene expression. For example TLR-mediated ERK-
dependent activation of AP-1 is essential for IL-23 p19 gene expression, although this 
pathway does not elevate IL- 12/IL-23 p40 expression (Liu et al. 2009). The profile of 
transcription factor activation by these pathways tailors a specific immune response. TAK1 
is an important MAP3K, downstream of many PRRs including TLRs, and is capable of 
activating all three MAPK members. In addition, TAK1 can activate NF-κB directly through 
the ubiquitination and degradation of inhibitory IKK molecules (Sato et al. 2005). In 
addition to gene regulation, MAPK can also participate in microbe uptake. Syk is a tyrosine 
kinase downstream of many CLRs and is involved in multiple immune functions including 
cytoskeletal rearrangement for phagocytosis. ERK-mediated Syk activation has been linked 
to the phagocytosis of Francisella tularensis by macrophages (Parsa et al. 2008). C. jejuni 
induces ERK and p38 activation in IECs leading to IL-8 production (Watson & Galan 2005).  
No studies to date have investigated the role of MAPK signalling in C. jejuni-mediated 
innate immune cell activation. 
1.4.7.3 Interferon-regulatory transcription factors   
Interferon-regulatory transcription factors (IRFs) are a family of transcription factors 
involved in the regulation of type 1 interferon genes. IRF3 is downstream of TRIF-mediated 
signalling (Figure 1-6). IRF3 phosphorylation in response to C. jejuni occurs in a TLR-
dependent manner, this molecular signature is associated with an upregulation of IFN-β 
secretion (Rathinam et al. 2009). Much less is known about the role of type 1 interferons 
during intracellular bacterial infection than viral infections, although evidence suggests that 
IFN-β may enhance anti-bacterial effects through a positive feedback mechanism (Gautier 
et al. 2005).     
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Figure 1-5: TLR signalling pathways 
TLR engagement leads to activation of two major downstream signalling pathways. The 
MyD88-dependent pathway is downstream of all TLRs except TLR3 and leads to the 
activation of NF-κB and MAPK. The TRIF-dependent pathway (or MyD88-independent 
pathway) is downstream of TLR3 and TLR4 and involves the activation of IRF3 and induction 
of type 1 IFN inducible genes. 
1.4.7.4 Phosphoinositide-3-Kinase  
PI3K signalling pathways have been implicated in a diverse array of cellular function 
including growth, proliferation, survival, and motility. Recent findings have implicated PI3K 
in the dampening of pro-inflammatory NF-κB signalling in response to LPS (Weichhart et al. 
2008). Mammalian target of rapamycin complex-1 (mTORC1) is downstream of PI3K 
activation, and is inhibited by rapamycin. Interestingly, treatment with rapamycin, an 
inhibitor of mTOR signalling, inhibits colitis in the gnotobiotic IL-10-/- murine model of 
infection (Sun, Threadgill, & Jobin 2011).  The inhibition of mTORC1, contrary to the LPS 
reports, decreases NF-κB activation. However, it is unlikely that it is this effect which 
46 
 
reduces pathology as NF-κB inhibition alone does not ameliorate disease (Lippert et al. 
2009). Rapamycin inhibits production of IL-17 and IL-1β in this model which is associated 
with a decrease in neutrophil infiltration. IL-17 is a potent chemoattractant for neutrophils 
therefore IL-17 levels may be responsible for the observed reduction in neutrophil 
infiltration. Interestingly, the source of IL-17 in this model is not CD4+ T-cells as depletion of 
these cells had no effect on pathology. Other potential sources of IL-17 in the LP include γδ 
T cells, NK cells and LTi cells.   
1.5 Adaptive Immune Response to Gastrointestinal Pathogens 
A critical role for adaptive immunity in limiting C. jejuni infection in humans is 
demonstrated by the prolonged infection and increase in bacteraemia seen in 
immunocompromised individuals (Fernandez-Cruz et al. 2010). Both humoural and cellular 
immunity has been implicated in bacterial clearance and subsequent protection from re-
infection (Janssen et al. 2008). 
Dimeric secretory IgA (sIgA) cross the IEC monolayer and directly interact with bacteria in 
the GI lumen. sIgA is abundant in breast milk and is passed to infants during feeding, 
conferring  protection against microbes including C. jejuni (Ruiz-Palacios et al. 1990). 
Hypoagammaglobulinemic patients, who lack antibodies, suffer from prolonged and often 
systemic campylobacteriosis suggesting a critical role for antibodies in limiting infection 
(van den Bruele et al. 2010). Interestingly, IgM but not IgG antibody transfer reportedly 
clears infection in these patients, implying a role for IgM in clearance of C. jejuni (Borleffs et 
al. 1993).  
In addition to a correlation with fecal IgA, a human volunteer study highlighted a significant 
association between protection from C. jejuni-mediated pathology during re-infection and 
IFNγ levels (Tribble et al. 2010). The susceptibility of HIV patients to systemic C. jejuni 
infection also implicates cellular-mediated immunity in bacterial clearance during infection 
(Fernandez-Cruz et al. 2010).    
APCs present antigen on MHC class II which together bind to the T-cell receptor (TCR) 
complex on CD4+ T cells. In the presence of co-stimulatory molecules naïve CD4+ T cells 
differentiate into T helper effector cells upon TCR ligation. The T cell effector phenotype 
generated is dependent on the cytokine milieu in the local environment, primarily derived 
from activated APCs. T helper (Th) 1 cells broadly activate professional phagocytes by 
producing IFNγ, increasing their phagocytic capability and bactericidal activity; in contrast, 
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Th2 cells secrete IL-4 which is necessary for B-cell activation and Ig-class switching. In 
addition to the conventional Th1/Th2 paradigm, the recently discovered Th17 cells are 
associated with immune responses to pathogenic bacteria and also autoimmunity 
(Harrington et al. 2005). The production of IL-17 by Th17 cells recruits neutrophils to the 
site of inflammation. In addition to these T helper subsets there are multiple subsets of 
suppressor T cells that can either be generated in the thymus (regulatory T cells – Tregs) or 
induced in the periphery (inducible (i)Tregs). Regulatory T cells play an important role in 
limiting inflammation-associated damage during infection.      
In vitro assays with C. jejuni-stimulated human DCs show the potential of these cells to 
expand both Th1 and Th17 memory cells as well a unique IFNγ+ IL-17+ double-positive T cell 
subset (Edwards et al. 2010). Murine DCs also show the potential for C. jejuni-stimulated 
cells to differentiate naïve CD4+ T cell into Th1 effector cells (Rathinam, Hoag, & Mansfield 
2008). In a gnotobiotic IL-10-/- murine model IL-17 production in the mucosa was associated 
with colitis, although this was also not produced by CD4+ T cells (Sun, Threadgill, & Jobin 
2011). During infection, IFNγ likely aids the clearance of C. jejuni however as seen in IBD 
overt activation of cellular immunity may contribute to the severity of inflammation. The 
contribution of elevated IFNγ levels driven by prior exposure to C. jejuni to clearing bacteria 
more rapidly upon re-infection is a likely explanation for the observed association between 
IFNγ levels and protection (Tribble et al. 2010). 
Multiple bacterial pathogens have been shown to manipulate T cell polarisation in order to 
evade the host immune response. H. pylori promote Treg skewing via induction of DC IL-10 
and TGF-β (Kao et al. 2010). One hypothesis is that C. jejuni actively inhibits cellular 
mediated immunity in chickens resulting in impaired heterophil chemotaxis thus promoting 
colonisation (Meade et al. 2009). Current understanding of chicken mucosal T-cell 
responses remains limited although systemic spread of C. jejuni triggers a T-cell response in 
the liver (Jennings et al. 2011; Meade et al. 2009). In contrast to the human mucosal 
response to C. jejuni, chickens produce limited IL-6 and IL-1β upon colonisation (Meade et 
al. 2009; Shaughnessy et al. 2009); this may limit the activation of T-cells in the chicken 
mucosa which subsequently may limit heterophil influx.    
48 
 
 
Figure 1-6: Model for C. jejuni pathogenesis in the human intestine 
C. jejuni motility is critical to traverse the thick mucus lining of the epithelium. C. jejuni 
invade IECs leading to s IL-8 production and barrier disruption. C. jejuni may also invade the 
LP via M-cells. DCs phagocytose C. jejuni in the LP and trigger T cell differentiation. 
Cytokines and chemokines attract and activate innate professional phagocytes such as 
neutrophils and mononuclear cells to the site of infection. Professional phagocytes clear 
infection but this may come at a cost of pathologic inflammation in susceptible individuals.   
1.5.1 Vaccine Development 
The high socioeconomic cost of campylobacteriosis means significant efforts are being 
made to develop vaccines against infection primarily in chickens, but also in humans. The 
finding that chicks up to the age of 3 weeks are protected from C. jejuni colonisation by 
maternal IgG antibodies suggest a protective humoural response can be induced in 
chickens (Sahin et al. 2003). Epidemiological studies suggest the ability of humans to mount 
a protective immune response to C. jejuni-mediated pathology but not colonisation, 
suggesting a human vaccine could limit disease. A human volunteer study showed short-
term veterans (<50 days since initial C. jejuni challenge) were protected from pathology and 
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partially to colonisation when re-infected with the same C. jejuni strain, observed by lower 
excretion levels (Tribble et al. 2010). Approximately half of long-term veterans (1 year since 
initial C. jejuni challenge) were protected from pathology when re-infected. This suggests 
minimal length of protection of C. jejuni adaptive immune responses, and therefore 
repeated exposure in developing countries most likely boosts immune responses in adults.  
Studies to date have looked at multiple methods of vaccination in multiple species 
(Jagusztyn-Krynicka et al. 2009).  A commercially available inactivated Campylobacter 
whole-cell vaccine against Campylobacter fetus and Campylobacter jejuni (CampyVax) is 
available for protection against Campylobacter-mediated abortion and diarrhoea in sheep. 
A similar vaccine was used for a Phase III human vaccine trial started after a successful 
Phase II trial performed in 2002 however results have not been released from the 
company, Antex. Whole-cell vaccines of C. jejuni may be considered risky due to the 
association of C. jejuni with post-infectious neuropathies, therefore other vaccination 
strategies are being researched but are in early stages of design. Subunit vaccines based on 
flagellin, flagellin-exported proteins, and CPS-conjugate vaccines are currently being 
researched.  
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1.6 Project Aims & Hypotheses 
In the present study we wished to test the hypothesis that C. jejuni modulates host innate 
immune responses via glycosylated surface determinants which may favour either pro- or 
anti-inflammatory responses 
The specific aims of the project were: 
1. To investigate the role of the C. jejuni capsule, N-linked glycosylation 
system, and O-link glycosylated flagellin proteins in the activation of DC 
responses. 
2. To identify potential host innate immune receptors that may be involved in 
recognition of C. jejuni and modulation of subsequent immune outcome. 
3. To determine whether differences in C. jejuni LOS structures aid in defining 
the livestock and environmental phylogenetic clades, and whether LOS 
structural differences alter innate immune responses.  
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2.1 Bacterial Culture 
2.1.1 Campylobacter jejuni Strains 
The hyper-motile strain 11168H is a variant of NCTC 11168 wild-type (WT) C. jejuni, a strain 
that was originally isolated from a diarrheic patient by Martin Skirrow in 1977 (Karlyshev et 
al. 2002). 81-176 is a strain isolated from a milk-borne outbreak in the USA (Korlath et al. 
1985). Isogenic mutant bacteria were the kind gift of Professor Brendan Wren (LSTMH). 
Isogenic mutants were constructed by inserting a kanamycin resistance cassette into the 
gene of interest and introducing the construct into the chromosome by double 
homologous recombination, leading to a disruption of the gene. The isogenic mutant 
strains utilised in this study are listed in Table 2-1.   
Gene  Phenotype Reference 
∆flaA Lacks FlaA flagellin protein, one of two structural 
proteins constituting the flagella. Aflagellate 
bacteria; secretion positive. 
(Wassenaar et al. 1994) 
∆rpoN Disruption of the alternative sigma factor σ54 
(RpoN). Aflagellate bacteria; secretion negative. 
(Jagannathan et al. 2001)  
∆pglB Lacks the conserved N-linked glycosylation 
system thus denuding periplasmic and outer 
membrane proteins  
(Young et al. 2002)  
∆kpsM Capsular polysaccharide (CPS) negative  (Karlyshev et al. 2001)  
ΔCj1316 Flagellin monomers modified with only 
pse5Ac7Ac  but not pse5Ac7Am (or further 
derivatives) 
(Guerry et al. 2006)  
∆waaF Lacks a LOS heptosyltransferase truncating the 
OS to just one heptose residue proximal to the 
KDO residue 
(Oldfield et al. 2002)  
Table 2-1 C. jejuni Isogenic Mutants 
2.1.2 C. jejuni Culture 
C. jejuni was routinely cultured on 7% blood agar (Oxoid, Basingstoke, Hampshire, UK) 
under micro-aerobic [Variable Atmosphere Incubator (VAIN; Don Whitley Scientfific, 
Shipley, UK); 85% N2, 10% CO2, and 5% O2] conditions at 37
oC. Alternatively, C. jejuni was 
grown in 2.5L gas jars (Oxoid) using micro-aerobic generating sachets, CampyGen (Oxoid) in 
a 37oC incubator.  
2.1.2.1 Growth on Blood Agar Plates 
Agar was prepared by dissolving 18.5g Columbia blood agar (BA) base (Oxoid) in Milli-Q 
0.22µm-filtered water (Millipore, London, UK) made up to 500mL and subsequently 
sterilising by autoclaving at 121oC for 15mins. 35mL of pre-warmed (to 37oC) defibrinated 
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horse blood (Oxoid) and one vial of Campylobacter selective supplement (a cocktail of 
vancomycin, trimethoprim, and polymyxin B; Oxoid) was added to 500mL Columbia blood 
agar base prior to plate (Fisher Scientific, Leicestershire, UK) preparation. For growth of 
isogenic mutant strains, 50µg/mL kanamycin (Sigma, Gillingham, UK) was also included. 
Frozen bacterial stocks were used as inoculums; cultures were passaged bi-weekly for up to 
4 weeks (stock plates). To obtain bacterial cultures in log phase growth for experiments, 
fresh BA plates were inoculated with C. jejuni from the stock plates and grown for 24h prior 
to experimentation. C. jejuni were subsequently resuspended in phosphate buffered saline 
(PBS; Invitrogen, Paisley, UK) and adjusted to the correct colony forming units (CFU)/mL 
using optical density (OD) measurements at 600nm. 
2.1.2.2 Growth in Brucella Broth 
Large scale preparation of C. jejuni (for lipooligosaccharide (LOS) isolation) was achieved by 
growing C. jejuni in Brucella broth. 28g BBL™ Brucella broth (Becton Dickinson (BD), Oxford, 
UK) was dissolved in 1L Milli-Q water and autoclave sterilised. Starter cultures were grown 
overnight by inoculating 3mL Brucella broth with a streak of C. jejuni from a fresh culture 
plate (<24hrs old) under micro-aerobic conditions with shaking at 200rpm at 37oC. Starter 
cultures were used to inoculate 500mL cultures which were subsequently grown to 
stationary phase under micro-aerobic conditions, at 37oC for 24-48h.   
2.1.3 Bacterial Quantification 
Bacterial cultures were resuspended in PBS and quantified in cuvettes (10mm path length; 
Fisher Scientific) using a spectrophotometer (Jenway 6300 Spectrophotometer; Jenway, 
Essex, UK) at 600nm. The OD600 was determined for individual bacterial suspensions.  
2.1.3.1 CFU count 
CFU counts were performed to determine the absolute number of bacteria. 10-fold serial 
dilutions of bacterial suspensions were performed in PBS. 10µL aliquots of each dilution 
were spotted in duplicate onto BA agar plates with up to 12 spots per plate. Biological 
replicates were also performed for each serial dilution. Colonies were counted for the 
lowest two serial dilutions with colonies present from both plating replicates and biological 
replicates, which were then used to calculate CFU counts.  For both WT and isogenic 
mutant strains an optical density (OD) reading of 1 at 600nm equalled 3 x 109 colony 
forming units (CFU). 
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2.1.4 Preparation of Frozen Bacterial Stocks 
Using a sterile 10µL plastic loop, a streak of C. jejuni (grown on BA plates for 24h) was used 
to inoculate a microbank vial (Pro-lab, Neston, Cheshire, UK) and subsequently stored at -
80oC. 
2.1.5 FITC labelling of C. jejuni 
A fresh saturated solution of Fluorescein isothiocyanate (FITC; Sigma) dissolved in sterile 
PBS was filter sterilised (0.22µm). Resuspended C. jejuni (OD 1) was mixed 1:1 with the 
saturated FITC solution. The mix was incubated in the dark at 37oC for 1h with gentle 
agitation. After incubation bacteria were pelleted by centrifugation at 10,000g for 2mins. 
The supernatant was discarded and the bacterial pellet resuspended in fresh PBS. The wash 
step was repeated three times before resuspending the pellet in PBS to a desired OD for 
co-culture studies.   
2.2 C. jejuni gene analysis  
2.2.1 Isolation of Bacterial Genomic DNA 
Bacteria grown overnight were harvested into 1mL PBS then pelleted at 10,000g for 2mins. 
Supernatant was decanted and the pellet was resuspended in 467µL TE buffer (10mM TRIS 
pH 7.6, 1mM EDTA) by repeated pipetting. 30µL of 10% sodium dodecyl sulphate (SDS) and 
3µL of 20mg/mL proteinase K (Sigma) was added prior to incubation for 1h at 37oC to allow 
bacterial lysis and protein digestion. An equal volume of Phenol:Chloroform (Sigma) was 
added and the suspension mixed gently to avoid shearing the genomic DNA. The mixture 
was spun at 10,000g for 10mins and the upper aqueous phase transferred to a fresh 1.5mL 
eppendorf. An equal volume of Phenol:Chloroform was added and the suspension gently 
mixed prior to centrifugation at 10,000g for 10mins. 1/10 volume of 3M sodium acetate 
(pH 5.2) was added to the collected aqueous layer followed by addition of 6/10 volume of 
isopropanol to precipitate the DNA. DNA was pelleted at 10,000g for 5mins and 
resuspended in the appropriate volume of water. DNA was quantified by NanoDrop 
(Thermo Scientific, Wilmington, USA). DNA was stored at -20oC until required. 
2.2.2 PCR analysis of gene content 
To confirm the presence of specific genes in different C. jejuni strains, PCR analysis was 
performed utilising gene specific primers. Reaction mixtures constituted: 10µL of Biomix 
Red PCR master mix (containing 1.5mM MgCL2, 200µM dNTPs, and Taq polymerase; 
Bioline, London, UK), 2pmol of both forward and reverse primers (Eurofins MWG Operon, 
Ebersberg, Germany), and 100ng bacterial genomic DNA template. Reactions were made to 
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20µL in volume with MilliQ water. Primers utilised in this study are listed in Table 2. For 
multiple reactions, master mixes were prepared to reduce intra-experimental variation. 
Reaction contents were vortexed briefly then centrifuged. PCR amplification was 
performed in a thermal cycler (Techne TC-512, Staffordshire, UK) utilising the following 
cycling conditions: 
Initial denaturation: 95oC for 5min - 1 cycle 
Denaturation: 95oC for 1 min  
Annealing: 55oC for 30sec              30 cycles 
Extension: 72oC for 90sec 
Final extension: 72oC for 10min – 1 cycle 
PCR products were separated by agarose gel electrophoresis. 1g agarose (Sigma) was 
dissolved in 1 x Tris Borate EDTA (TBE) buffer (Sigma) by heating in the microwave. Once 
cooled to ~50oC 1/10,000 Gel Red (Sigma) was added to the solution. The agarose was 
poured into a gel caster and allowed to set. Gels were placed in a gel electrophoresis tank 
containing 1 x TBE buffer (Sigma). Samples were separated at 100V for ~30mins. Bands 
were visualised using a UV imager. 
   Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) Product size 
(bp) 
lgtF (Cj1135) 
set 1  
ACTTAACAATGAAAGTAGCGAT
AATACCCTAA  
GCCACCAACCACATGCCTTT
ATCC  
290 
lgtF (Cj1135) 
set 2 
ACTTAACAATGAAAGTAGCGAT
AATACCCTAA  
GCCAAATGTGTTTTAAAGGG
CAAGGA  
854 
lgtF (Cj1135) 
set 3 
CCATCAAGATTGGCTTGGTTTT
GG  
ATTGTGCATAAAGCTTTGCT
ATGATAAAACCTC  
518 
NeuB1 
(Cj1140) 
GCAGGnGCTAAGATnATAAAnC
AnCAAAC 
TAATnCTnACTACnCTnGCAA
AnGCAAAATCAAT 
748 
orf 8ab*  
  
ATTATAGCCATTTGCTCACTTTG AAAGCACCCTTAGTCGTACC
TG 
755 
orf 7ab*  ACTACACTTTAAAACATTTAATC
CAAAATCA 
CCATAAGCCTCACTAGAAGG
TATGAGTATA 
579 
orf  8c* 
(Cj1140) 
CCTTTGATAATCCCTGAAATAG
GT 
TCCTTTGCACTTATACCACCT
T 
910 
orf  7c* 
(Cj1139) 
TTGAAGATAGATATTTTGTGGG
TAAA 
CTTTAAGTAGTGTTTTATGTC
ACTTGG 
745 
SOAT  CCTCATTATGCAAAAGTTGGAA
GGTATTG 
ATCAGCAAAATGATATTTCC
ACCATTGAAT 
424 
htrB* 
(Cj1133) 
GTTACTTTTATGCCTGAGTGTAT
CTTGCA 
CGCTTTCGTTTTCTACACAGT
CTTGATC 
546 
Table 2-2 PCR primers used to study genetic composition of C. jejuni strains 
n = G, C, A, or T                  * denotes primer pairs where annealing temperature was 52oC 
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2.3 Mammalian cell Culture 
2.3.1 Heat-inactivation of Foetal Calf Serum 
Foetal calf serum (FCS; Invitrogen, Paisley, UK) was defrosted overnight at 4oC. Heat 
inactivation (HI) was achieved by incubating FCS at 55oC for 30mins in a water bath in order 
to inactivate heat-labile complement proteins present in the serum. FCS was aliquotted and 
stored at -20oC.  
2.3.2 Cell-lines  
2.3.2.1 THP-1 cell line 
The non-adherent human acute monocytic leukaemia cell line THP-1 was cultured in RPMI 
1640 medium (Invitrogen) containing 2mM L-glutamine supplemented with 10% HI FCS, 
100U/mL penicillin and 100mg/mL streptomycin (Invitrogen). This media is referred to as 
complete RPMI media hereafter. Cells were passaged bi-weekly and maintained at 1 x 105 – 
1 x 106 cells/mL in T75 culture flasks. Cells were stimulated with 10ng/mL phorbol myristate 
acetate (PMA; Sigma, Poole) for 18h to differentiate the cells from a pro-monocytic to a 
monocyte/macrophage phenotype (Daigneault et al. 2010). PMA-stimulation resulted in 
the majority of cells becoming adherent.  
2.3.2.2 HEK/TLR cell lines  
The semi-adherent Human Embryonic Kidney (HEK) cell-line stably transfected with human 
TLR4/CD14/MD2 and a inducible secreted embryonic alkaline phosphatase (SEAP) reporter 
gene (HEK-blueTM hTLR4; InvivoGen, Nottingham, UK) were cultured in high glucose 
Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen) containing 2mM L-glutamine 
supplemented with 10% HI FCS, penicillin/streptomycin and 100µg/mL Normicin 
(InvivoGen). This media is referred to as complete DMEM media hereafter. Cells were 
grown to 80% confluency, and passaged on average bi-weekly. Cells were used up to 
passage 15. 
2.3.2.3 Siglec-CHO cell-lines 
The adherent Chinese Hamster Ovary (CHO) cell-line either non-transfected or transfected 
with human Siglec-10 or Siglec-7 were the kind gift of Prof. Paul Crocker (University of 
Dundee, UK). Cells were cultured in F12 Ham media containing 2mM L-glutamine 
supplemented with 10% HI FCS, penicillin/streptomycin. Cells were grown to 80% 
confluency and passaged bi-weekly. Cells were washed in sterile PBS before addition of 
2mM EDTA in PBS. Cells were incubated at 37oC for 5mins to detach the cells. On addition 
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of complete media cells were pelleted at 1600rpm for 7mins. Cells were resuspended in 
complete media and cultured in T75 flasks. 
2.3.3 Counting viable cells 
10µL of cell suspensions was mixed 1:1 with 0.4% Trypan blue (Sigma, Poole) for 1min. 
10µL of this mixture was placed onto a haemocytometer counting chamber (Hawksley, 
Sussex, UK). Live cells (clear) were counted (40X magnification) with a light microscope 
(Phase Contrast 2, Nikon). The viable cell count was calculated as follows: 
Cell number within a 25 field box x dilution factor = total cell number x 104/mL 
A minimum of four 25 box fields were counted. 
2.3.4 Freezing cells 
Cells were pelleted (1600rpm, 7mins) and resuspended at ~1 x106/mL in 90% FCS 
containing 10% dimethyl sulphoxide (DMSO; Sigma). 1mL aliquots were made in Nunc 
cryovials (Fisher Scientific) and slowly frozen in a Nalgene Mr. Frosty (Sigma) containing 
isopropanol at -80oC. For long term storage cells were stored in liquid nitrogen. 
2.4 Primary Cell culture 
2.4.1 Mice 
A colony of WT C57BL/6 mice were kept at ICH Western labs animal facility. MyD88-/- , TRIF-
/-, single and double knock-out mice were the kind gift of Dr. Caetano Reis e Sousa (Cancer 
Research UK). IPAF-/-, ASC-/-, NOD2-/-, and NALP3-/- knock-out mice were the kind gift of Dr. 
Claire Bryant (University of Cambridge). 
2.4.2 Generation of Murine Bone-Marrow Derived Dendritic Cells (BMDCs) 
The muscle from femurs and tibias of 6-12wk old C57BL/6 mice were removed by scalpel, 
and bones sterilised in 70% ethanol. The bone marrow was flushed out with sterile PBS 
containing 2% FCS and 10μg/mL gentamicin (Invitrogen). Bone marrow was resuspended by 
gentle pipetting, and pelleted by centrifugation at 1600rpm for 7mins. Red blood cells were 
lysed in Red Blood Cell Lysis Buffer (Sigma) for 5mins, pelleted and washed twice in PBS. 
Cells were resuspended and plated at 0.5 x 106 cells/mL in Iscove’s Modified Dulbecco’s 
Medium (IMDM; Invitrogen) containing 10% HI FCS, penicillin/streptomycin, 2mM L-
glutamine, 50μM β-Mercaptoethanol (Invitrogen), 10μg/mL gentamicin, (termed complete 
media) with 20ng/mL murine GM-CSF (Peprotech, London, UK, or from Invitrogen). Cells 
were seeded at ~1 x 105 cells/mL in 6-well plates. On day 3 or 4, non-adherent cells were 
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collected, spun down and resuspended in fresh IMDM complete media containing GM-CSF. 
Fresh media was added when necessary on day 6. Cells were used on days 7 or 8. BMDCs 
were ~80% positive for CD11c as assessed by flow cytometry from two independent 
experiments. 
2.4.3 Murine Naïve T cell Isolation 
Spleens were removed from 6-12 wk old C57BL/6 mice. Single cells suspensions were 
achieved by pushing spleens through nylon 70µm cell strainer (BD Biosciences, Oxford, UK) 
with the plunger of a 5mL syringe with PBS. Splenocytes were pelleted by centrifugation at 
1600rpm, 7mins. Red blood cells were lysed by resuspending the cell pellet in 1mL of Red 
Blood Cell Lysis Buffer and incubating at room temperature (RT) for 5mins. Splenocytes 
were subsequently washed twice in PBS. CD3+ CD4+ CD62L+ CD44low Naïve CD4+ T cells were 
isolated using a negative selection MagCellect Mouse Naïve CD4+ T cell Isolation kit (R&D 
systems, Abingdon, UK) according to manufacturer’s protocols. Typically 1 x 108 
splenocytes were extracted from one spleen. Splenocytes were resuspended in chilled 1 x 
MagCellect Buffer at a density of 2 x 108/mL and transferred to a 5mL sterile polystyrene 
tube. 200µL of MagCellect Mouse Naïve CD4+ T Cell Biotinylated Antibody Cocktail was 
added per mL and gently mixed by pipetting and incubated at 4oC for 15mins. 250µL of 
MagCellect Streptavidin Ferrofluid was added to the suspension per mL, mixed gently by 
pipetting, and incubated at 4oC for 15mins. The suspension was subsequently adjusted to a 
total of 3mL volume with 1 x MagCellect buffer and mixed gently by pipetting. The 
suspension was placed in an EasySep magnet (Stemcell Technologies, Grenoble, France) for 
6mins at RT to allow the magnetically labelled cells to migrate to the magnet leaving the 
naïve T cells in suspension. Naïve T cells were collected by inverting the tube whilst still in 
the magnet and collecting the suspension into a fresh tube. Naïve T cells were pelleted and 
washed twice in PBS. Naïve T cells were used immediately for subsequent experimentation. 
Cells were >95% CD3+ CD4+ as assessed by flow cytometry from two independent 
experiments. 
2.4.4 Human Peripheral Blood Monocyte Isolation 
50 – 100mL blood was obtained from consented healthy adults at the Institute of Child 
Health and collected in tubes containing heparin. Blood was mixed 1:1 with RPMI then 
carefully layered onto 2/3 volume lymphoprep without disrupting the interface (Axis Shield, 
Uxbridge, UK). Peripheral blood mononuclear cells (PBMCs) were separated by density 
centrifugation at 2,200rpm for 25mins, with acceleration set at grade 4 and the brake off. 
PBMCs were carefully collected from the interface of the lymphoprep through the upper 
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media layer using a sterile Pasteur pipette. PBMCs were pelleted at 1,600rpm for 7mins, 
washed in RPMI and re-pelleted. Monocytes were extracted by CD14+ magnetic bead 
isolation (Miltenyi Biotec, Surrey, UK). PBMCs were carefully resuspended in 80µL MACS 
buffer (pre-chilled PBS containing 2mM EDTA, 1% FCS) per 107 cells. 20µL of magnetically 
labelled anti-CD14 beads were added per 107 cells and mixed gently prior to incubation at 
4oC for 20mins. 10mL MACS buffer was added to the PBMCs and mixed before pelleting. 
PBMCs were resuspended in 500µL MACS buffer. An LS MACS column (Miltenyi Biotec) was 
placed in a MACS magnet (Miltenyi Biotec) and primed by passing 3mL of MACS buffer 
without collection. PBMCs were passed through the column which was subsequently 
washed three times with 3mL MACS buffer. The column was removed from the magnetic 
field and the CD14+ eluted from the column by passing 5mL MACS buffer through it using 
the sterile plunger provided. CD14+ cells were washed in RPMI and pelleted, and were 
ready for further experimentation. Cells purified were >95% positive for CD14 as assessed 
by flow cytometry from two independent experiments.  
2.4.5 Generation of Human Monocyte-derived Dendritic Cells 
Isolated CD14+ monocytes were cultured in complete RPMI containing 50ng/mL 
recombinant human IL-4 and 100ng/mL GM-CSF (R&D systems) for 5-7 days at a density of 
2.5 x 105 cells/mL in 6-well plates. DCs were harvested and used immediately for further 
experimentation.  Cells were >95% positive for CD11c as assessed by flow cytometry from 
two independent experiments. 
2.5 Co-culture experiments 
2.5.1 BMDC Co-cultures 
BMDCs were seeded at 1 x 106/mL in RPMI containing 10% HI FCS in poly-propylene tubes 
to limit cell adhesion upon activation unless otherwise stated. Cells were treated with C. 
jejuni multiplicity of infection (MOI) 100, PBS alone, or 1μg/mL E. coli 0111:B4 LPS (Sigma), 
all prepared in 100µL PBS. Cells were incubated for 24h at 37oC, and pelleted by 
centrifugation at 1600rpm for 7mins. Supernatants were collected and stored at -80oC for 
cytokine analyses, cells were used immediately for surface marker analyses.  
2.5.2 Cytokine Secretion 
Cytokine levels were assessed using Ready-SET-Go! Enzyme-linked immunosorbent assay 
(ELISA) (eBioscience, Hatfield, UK) following manufacturer’s protocols. Plates were read at 
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450nm on a Multiskan EX Multiplate Photometer (Thermo Scientific). Data was analysed 
using Ascent software (London, UK). 
2.5.3 Surface Marker Analyses 
Cells were assessed for expression of maturation markers that increase upon DC 
maturation. Cells were washed in FACS wash buffer (PBS, 2% FCS, 0.02% sodium azide) 
then blocked with 1/100 anti-murine Fc Receptor antibody (BD Bioscience, Oxford, UK) for 
20mins on ice to eliminate binding of antibodies utilised to Fc receptors. Cells were then 
either stained for maturation markers (ebioscience; Table 0-3) or with an isotype control, 
or left unstained for 30mins on ice in staining buffer (FACS wash buffer containing 10% 
FCS). Cells were pelleted and washed with FACS wash buffer twice, and fixed in 4% 
paraformaldehyde (PFA) for 20mins. Cells were pelleted and resuspended in PBS. Surface 
marker expression was investigated by flow cytometry on a FACScan machine (BD 
Bioscience). Analysis was performed using FlowJo software (Tree Star, Oregon, USA).  
Antibody Fluorochrome Concentration 
Anti-CD40 PE 1/40 
Anti-CD80 PE-Cy5 1/200 
Anti-CD86 FITC 1/200 
Anti-MHC Class II FITC 1/200 
Table 2-3 Antibodies for BMDC maturation markers expression 
2.5.4 C. jejuni-mediated Activation of DC Signalling Pathways 
BMDCs were seeded at 1 x 106/well in 1mL media RPMI containing 2mM L-glutamine and 
0.05% FCS a day prior to infection; this was to reduce growth related mitogen-activated 
protein kinase (MAPK) signalling. BMDCs were stimulated with C. jejuni at an MOI 100 in 
100μL PBS. 100μL PBS was added to unstimulated controls. After inoculation, co-cultures 
were spun at 1500rpm for 5mins to promote association of C. jejuni/BMDCs. Co-cultures 
were incubated at 37oC for the duration of the infection. Cells were lysed in 50µL lysis 
buffer [1% Triton-X 100 (Sigma), 150mM sodium chloride, 50mM Tris pH 8.0, complete-
mini protease inhibitors (Roche, Sussex, UK), phosphatase inhibitor cocktail (Roche)]  at 
specified time points. After 5mins, lysates were collected and incubated on ice for a further 
30mins to ensure complete lysis. Lysates were spun at 13,000rpm for 2mins to pellet 
insoluble membranes and DNA, then aliquoted and stored at -80oC.  
61 
 
2.5.5 DC/T cell Co-cultures 
1 x 105/mL BMDCs were co-cultured with C. jejuni, media alone, or C. jejuni LOS (100ng/mL) 
for 24h in RPMI containing 2mM L-glutamine and 10% FCS. Cells were pelleted (1600rpm 
6mins) and supernatants were collected and passed through a 0.22µm filter. BMDCs were 
resuspended in complete RPMI containing 150µg/mL gentamicin and incubated at 37oC for 
2h to kill extracellular bacteria. BMDCs were subsequently pelleted and the supernatant 
discarded. BMDCs were washed once in PBS to remove residual dead bacteria then 
resuspended in the original sterile filtered supernatants. BMDCs were plated into 96-well 
plates at 1 x 104 BMDCs/well in 100µL. Naïve T cells were suspended at 1 x 106/mL in RPMI 
(10% FCS) containing 20µg/mL gentamicin, 10U/mL IL-2 (Peprotech), and anti-CD3/CD28 
Dynabeads (bead to cell ratio 1:1; Invitrogen). 1 x 105 Naïve T-cells (1:10 DC:T cell ratio) 
were added to the wells in 100µL making a final volume of 200µL per well, and 10µg/mL 
gentamicin. Media alone was added to BMDC only and naïve T cell only control wells. DC/T 
cell co-cultures were incubated for 4 days. Supernatants were collected and stored at -80oC 
prior to cytokine analyses.  
2.5.6 Human DC co-cultures 
1 x 105 monocyte-derived DCs were seeded into 96-well plates in 200µL RPMI containing 
2mM L-glutamine and 10% FCS. DCs were stimulated with WT C. jejuni and various isogenic 
mutants at an MOI 100. 24h post-infection supernatants were collected and stored at -80oC 
for further cytokine analysis. 
2.5.7 Siglec-CHO co-cultures 
Adherent Siglec-CHO cells were washed once in PBS then detached in PBS containing 2mM 
EDTA (Sigma) for 5mins at 37oC. Cells were pelleted at 1600rpm for 7mins and resuspended 
in F12 media containing 0.5% FCS at 1 x 106/mL cell concentration. 300µL of the 
resuspended cells was placed in a 1.5mL eppendorf and chilled to 4oC. Cells were co-
cultured with various FITC-labelled C. jejuni strains at an MOI 100 for 2h with gentle 
rotation on a MACSmix Tube Rotator (Miltenyi Biotec) at 4oC. Cells were collected and 
pelleted (1500rpm, 5mins, 4oC) in 5mL polystyrene FACS tubes. Cells were carefully washed 
once in 0.5mL chilled PBS re-pelleted and fixed in 4% PFA for 15mins. Cells were pelleted 
and resuspended in 100µL PBS alone. Adherence of C. jejuni strains was assessed by flow 
cytometry.     
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2.5.8 THP-1 co-cultures 
Adherent PMA-stimulated THP-1 cells were washed once in PBS then detached in 1mL 
trypsin (Invitrogen) for 5mins at 37oC. 200µL (1 x 105 cell/ml) of cell suspension in RPMI 
containing 2mM L-glutamine and 10% FCS was seeded into individual wells of a 96-well 
plate. Cells were allowed to adhere for 2h prior to stimulation with either various live 
strains of C. jejuni or isolated LOS. 20h after stimulation supernatants were collected and 
stored at -80oC for further analysis.   
2.5.9 Monocyte co-cultures 
1 x 105 CD14+ monocytes were seeded into 96-well plates in 200µL RPMI containing 10% 
FCS. Monocytes were stimulated with various concentrations of LOS purified from different 
C. jejuni strains. 20h post-infection supernatants were collected and stored at -80oC for 
further analysis. 
2.5.10 HEK-TLR4 co-cultures 
HEK-TLR4 SEAP cells (Invivogen) were detached by agitation and subsequently pelleted at 
1,600rpm for 7mins. Cells were counted and seeded into 96-well plates at 2.5 x 104 
cells/well in 200µL DMEM containing 2mM L-glutamine and 10% FCS. Cells were stimulated 
with purified C. jejuni LOSs’ for 18h. At the end of the co-culture 20µL of supernatant was 
added to 180µL of HEK-Blue Detection Reagent (180µL) in a fresh 96-well ELISA plate 
(Nunc). Plates were incubated at 37oC for 15min-2h until colour change from pink to purple 
was observed. Colour changes were read on an ELISA plate reader at 650nm.  
2.6 Gene expression assays 
2.6.1 Total RNA Isolation 
Cells were washed in PBS and either had RNA isolated immediately or stored at -80oC until 
required. Cell pellets were resuspended in 1mL of monophasic phenol and guanidine 
isothiocyanate based-TRIzol® in a 1.5mL eppendorf. 200µL chloroform (Sigma) was added 
to the tubes and vigorously vortexed for 10 seconds to ensure complete mixing. This 
mixture was allowed to stand for 3mins at RT before centrifugation (12000rpm, 15mins, 
4oC) to allow separation of the organic (lower) and aqueous (upper) phases. The aqueous 
phase (containing nucleic acids) was carefully extracted into a clean 1.5mL eppendorf 
without disturbing the denatured proteins found at the interface between the two layers. 
600µL of isopropanol was added to the nucleic acid solution, mixed well, and left overnight 
at -20oC to allow maximal precipitation of the total RNA. Tubes were then centrifuged 
(12000rpm, 10mins, 4oC) to pellet the precipitated RNA. Waste was removed and RNA 
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pellets were washed twice in 1mL 70% ethanol to remove salts. RNA pellets were re-spun 
and the 70% ethanol removed. Pellets were air-dried completely to remove remaining 
ethanol, then resuspended in 30µL 1 x ambion DNAse turbo buffer (Ambion, Paisley, UK) 
made in RNAse free water. 1µL of DNAse enzyme (Ambion) was added and the reaction 
was allowed to proceed at 37oC for 30mins to ensure complete removal of contaminating 
DNA. 3µL of DNAse Stop Solution (Ambion) was added and incubated at RT for 5mins with 
gentle flicking. Tubes were centrifuged (10,000g, 1.5mins) to separate the Stop Solution 
from the RNA. The aqueous layer containing the RNA was carefully removed into a fresh 
eppendorf. RNA was quantified using a NanoDrop machine. RNA was either used directly 
for conversion to cDNA or stored at -80oC for later use. 
2.6.2 Generating cDNA from total RNA 
In an RNAse free PCR tube, 1-5µg of total RNA was added with 1µL oligo dT (Bioline, 
London, UK), 1µL random hexamers (Bioline). The mixtures were heated at 65oC for 5mins 
in a thermal cycler and directly quenched on ice. For each sample  a master mix containing 
4µL 5 x Bioscript buffer (Bioline), 4µL dNTPs (Bioline), 1.5µL RNAse free water, 0.5µL 
Bioscript (Bioline) was made, and added directly to the PCR tubes containing the quenched 
total RNA solution. Contents were gently mixed, cDNA was synthesised using the following 
parameters in a PCR machine: 25oC for 10mins (primer extension), 42oC for 1 h (reverse 
transcription), 75oC for 10mins (enzyme inactivation). cDNA was stored at 4oC or -20oC for 
short- and long-term storage respectively. 
2.6.3 Real-time PCR 
To quantify the relative levels of transcripts for specific genes, real-time PCR was 
performed on cDNA from BMDCs from co-culture studies. Reaction master mixes contained 
10µL SYBR Green (Invitrogen), 5pmol forward primer, 5pmol reverse primer (Table 0-4), 
brought to 20µL total volume with MilliQ water. Master mix was pipetted into the bottom 
of the PCR tube (Qiagen). 2µL of cDNA was added to the master mix in the PCR tube. PCR 
was performed in duplicate using a Rotor-Gene 6000 Real-time PCR machine (Qiagen) 
utilising the following conditions: 
Initial denaturation: 95oC for 10min - 1 cycle 
Denaturation: 95oC for 15sec  
Annealing: 58oC for 30sec              40 cycles 
Extension: 72oC for 30sec 
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Melt Step: Increasing temperature by 1o each cycle from 70o-95o. 90sec wait after 
first step and a 5sec wait after subsequent steps. 
 
Lasers used: Green 470nm (excitation) 510nm (emission) Gain 10 
                       Yellow 530nm (excitation) 555nm (emission) Gain 5 
 
Data were analysed using Rotor-Gene 6000 Series Software 1.7. Relative levels of 
transcripts were determined using delta delta cycling threshold method (ΔΔct). ct 
levels were determined from duplicates of individual samples, and were expressed 
as a relative number to GAPDH transcript levels using the following equation: 
Δct = 2(GAPDH ct value – transcript of interest ct value) 
                     
Gene 
Forward Primer (5’-3’) Reverse Primer (5’-3’) 
IL-10 GGTTGCCAAGCCTTATCGGA 
 
ACCTGCTCCACTGCCTTGCT 
 
p35 CCTCAGTTTGGCCAGGGTC 
 
CAGGTTTCGGGACTGGCTAAG 
 
p40 GGAAGCACGGCAGCAGAATA 
 
AACTTGAGGGAGAAGTAGGAAT 
 
IL-6 GTTCTCTGGGAAATCGTGGA 
 
TGTACTCCAGGTAGCTATGG 
 
IL-1β CCAAAAGATGAAGGGCTGCT 
 
AGAAGGTGCTCATGTCCTCA 
 
GAPDH CCTGGAGAAACCTGCCAAGTATG 
 
AGAGTGGGAGTTGCTGTTGAA 
 
Table 2-4 Real-time PCR primers 
2.7 Intracellular Bacteria Counting 
2.7.1 Gentamicin Protection Assay 
BMDCs were seeded at 2 x 105/well in 24-well plates in a total volume of 1mL RPMI 
containing 2mM L-glutamine and 10% FCS. Cells were infected with C. jejuni at an MOI 100. 
Plates were spun at 1500rpm for 5mins to initiate bacterial/DC interactions. Co-cultures 
were incubated at 37oC for various time periods to allow internalisation of C. jejuni. 
Infection media was removed and cells washed twice with sterile PBS. Media was replaced 
with 1mL RPMI containing 150µg/mL gentamicin, and incubated at 37oC for 2h to kill 
extracellular bacteria. Media was removed and cells washed twice with sterile PBS. Cells 
were subsequently lysed in 0.5mL 0.1% Triton-X 100 (Sigma) in PBS for 5mins prior to 
undergoing 10-fold serial dilutions. CFU analysis was performed on BA plates. Plates were 
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incubated at 37oC in gas jars containing a CampyGen sachet (Oxoid) to generate a micro-
aerophillic atmosphere. Colonies were counted after 48h.  
2.8 Activation of host signalling pathways  
2.8.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE) and Western Blot 
Analysis 
10% SDS-polyacrylamide gels were prepared on the day of use as follows: 
Resolving Gel:  
2.5mL R-Buffer (1.5M TRIS, 0.4% SDS, pH8.8) 
3.5 mL 30% Acrylamide  
4mL Milli-Q Water 
100µL 10% Ammonium Persulphate 
10µL Tetramethylethylenediamine (TEMED) 
 
Stacking Gel: 
1.2mL S-Buffer (0.5M TRIS, 0.4% SDS, pH 6.8) 
1.2mL 30% Acrylamide 
2.2mL Milli-Q Water 
120µL 10% Ammonium Persulphate 
10µL TEMED 
 
Resolving gel was poured first into a gel cast filling ¾ of the space. 200µL of Milli-Q water 
was placed onto this layer to reduce contact with the air during polymerisation. After 
polymerisation the water was removed and the Stacking gel was poured onto the resolving 
gel with the addition of 10-well combs. Gels were allowed to fully polymerise before the 
combs were removed.  
Lysates were mixed 1:1 ratio with 2x laemmli buffer [4% SDS (Sigma), 10% β-
mercaptoethanol (Sigma), 20% glycerol (Sigma), 0.004% bromophenol blue (Fisher 
Scientific), 0.125M Tris HCl, pH 6.8]. Samples were boiled at 95oC for 5mins. Samples were 
loaded and gels subjected to electrophoresis at 125V for 1.5 h in electrophoresis buffer 
(25mM Tris, 190mM glycine, 0.1% SDS). Gels were routinely run in a mini-protean 3 cell 
unit (Bio-Rad, Hertfordshire, UK). Proteins were transferred onto nitrocellulose membrane 
(GE Healthcare, Buckinghamshire, UK) by the wet transfer method. Transfers were 
conducted at 200mA for 60mins in transfer buffer (48mM Tris, 39mM glycine, 0.04% SDS, 
20% methanol). Membranes were blocked in 5% milk (Marvel, Premier Foods, 
Hertfordshire, UK) in Tris-buffered saline (TBS) with 0.1% Tween-20 (TBS/T) for 2h at RT 
with gentle agitation. Phospho-specific primary antibodies (all from Cell Signalling, MA, 
USA) were used at 1/1000 concentration or anti-IL-1β (1/250; Santa Cruz, Heidelberg, 
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Germany) in 5% milk in TBS/T (except P-ERK and P-p38 2% BSA in TBS/T). All primary 
antibodies were incubated at 4oC for 8h/overnight. Membranes were washed three times 
for 5mins in TBS/T. Secondary goat anti-rabbit conjugated to horseradish peroxidase 
(DAKO, Stockport, UK) was used at 1/1000 in TBS/T (except P-ERK and P-p38 3% BSA in 
TBS/T). Secondary antibodies were incubated for 2h at RT for P-ERK and P-p38, and 
overnight at 4oC for P-JNK and IκBα detection. Membranes were washed 3 times for 5mins 
in TBS/T. 1mL Enhanced chemiluminescence (ECL; GE Healthcare, Buckinghamshire) was 
prepared according to manufacturer’s protocol and added to the membranes for 2mins. 
Membranes were exposed to X-ray film (ECL hyperfilm; GE Healthcare) for various lengths 
of time and developed. To ensure equal loading of samples, membranes were stripped in 
stripping buffer (2% SDS, 0.8% β-mercaptoethanol, 0.0625M Tris pH 6.8) at 50oC in the 
fume-hood for 20mins, stripping buffer was discarded and this step repeated to ensure 
complete removal of bound antibodies. Membranes were re-blocked in 5% milk in TBS/T 
for 2h then re-probed with total ERK primary antibody (Cell Signalling).    
2.8.2 Analysis of NF-κB activation in BMDCs using an NF-κB reporter plasmid 
2.8.2.1 Lentivector Production 
Lentiviral vectors were produced in a HEK 293T packaging cell line. A combination of 3µg 
lentivector plasmid, 1.5µg Vesicular stomatitis virus glycoprotein G (VSV-G) plasmid (pMD-
G; (Naldini et al. 1996)) 1.5µg packaging plasmid (pCMVR8.91; (Naldini et al. 1996)) was 
made to 100µL in sterile water. 27µL Fugene 6 (Promega, Southampton, UK) was added to 
100µL OptiMEM media (Invitrogen). Fugene/OptiMEM was added to the DNA and mixed 
thoroughly by vortexing and incubated at RT for 15mins to allow complex formation. 
DNA/Fugene complexes were added to a 70% confluent T75 flask of HEK 293T cells in 
complete media. Media was collected and replaced daily for up to 5 days. Collected media 
containing lentivectors was placed on top of a 3mL sterile 20% sucrose cushion in a 38.5mL 
Ultra-ClearTM centrifuge tube and centrifuged at 25,000rpm for 2h (Beckman Coulter, High 
Wycombe, UK). Pelleted lentivectors were carefully resuspended in 300µL PBS by repeated 
pipetting, aliquoted, and stored at -80oC.   
2.8.2.2 Lentivector Titration by qPCR 
5 x 105 HEK 293T cells were transduced with 2µL lentiviral vectors in 24-well plates. 24h 
post-transduction cells were collected and genomic DNA extracted using DNeasy Blood & 
Tissue Kit following manufacturer’s protocol (Qiagen). A lentivector plasmid of known 
concentration was used to make the standard curve. A stock concentration of 1mg/mL 
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plasmid was diluted 2:175 in water to give a copy number of 109. From this stock a 10-fold 
serial dilution was made from 105-101 copies/µL. Master mixes were made as follows: 7.5 
pmol fwd primer GT 249: 5’ GAGTCCTGCGTCGAGAGAGC 3’, 7.5pmol rev primer GT 248: 
TGTGTGCCCGTCTGTTGTGT, 3.75pmol probe FAM-CAGTGGCGCCCGAACAGGGA-TAMRA, 
12.5µL QuantiTect PCR mix (Qiagen) made to 20µL with MilliQ water. 5µL of sample or 
standard was added to 20µL master mix in real-time PCR tubes. qPCR was performed as 
described in 0. Titres were calculated from the standard curve. 
2.8.2.3 Lentivector Transduction of NF-κB reporter plasmid 
On day 4 of differentiation, BMDCs were seeded at 1 x 105/well in 24-well plates in a total 
volume of 300µL of complete IMDM media containing 20ng/mL murine GM-CSF. Cells were 
transduced with lenti-viruses containing the NF-κB reporter plasmid that drives luciferase 
production depicted in Figure 2-1 the kind gift from Dr. David Escors (UCL) at an MOI 10. 
5µg/mL protamine sulphate (Sigma) was used in transduction mixtures to neutralise the 
negative charge of the plasma membrane and enhance transduction efficiencies. 6h post-
transduction, complete IMDM media containing GM-CSF was added to a total volume of 
1mL. Cells were grown for an additional 4 days. Media was replaced when necessary by 
removing the top 0.5mL and replacing it with fresh complete media containing GM-CSF.  
 
 
Figure 2-1: NF-κB inducible lenti-viral plasmid 
An NF-κB responsive element drives expression of luciferase protein from a minimal 
cytomegalovirus (CMV) promoter.   
2.8.2.4 NF-κB reporter Co-cultures 
1 x 105 transduced BMDCs in 100µL RPMI containing 10% FCS were stimulated with C. jejuni 
(MOI 100 or 10) or purified C. jejuni LOS (100ng/mL) for 6h in sterile white 96-well plates. 
AmpR 1464...2123
ColE1 origin 2221...2903
SV40 early promoter 3264...3460
IgK chain 7764...7815
NF-kB responsive prom 7763...7846
CMV promoter 7848...7928
Luciferase 7948...8658
SIN-NFkBprom-
luciferase
9323 bp
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Cells were equilibrated to RT before the addition of 100µL Bright-GloTM (Promega) reagent. 
Cells were incubated at RT for 2mins to allow for complete lysis before luciferase activity 
was measured in a luminometer (FLUOStar Optima, BMG Labtech, Aylesbury, UK).  
2.9 Lipooligosaccharide Structural Analysis 
2.9.1 Lipooligosaccharide (LOS) Isolation 
Bacterial pellets were resuspended in 5mL water in 50mL falcon tubes. Cultures were 
frozen at -80oC before being freeze dried. After complete freeze drying bacteria were 
resuspended in 30mL water and mixed 1:1 with 90% phenol (made fresh with water; 
Sigma). Bacterial/phenol mixtures were stirred at 68-70oC for 2h to ensure removal of the 
LOS from the outer membrane. Bacterial/phenol mixtures were dialysed with in 1KD cut-off 
Spectra/POR dialysis tubing (Spectrum Laboratories, California, US) for 3-4 days, water was 
replaced twice daily, at the end of the dialysis, the lack of phenol smell was indicative of its 
removal.  After dialysis supernatants were spun at 5000rpm for 20mins to remove cell 
precipitate. The clear supernatant was frozen at -80oC in 50mL falcons and freeze-dried. 
The freeze dried bacterial constituents’ were resuspended in 30mL 1mM TRIS-EDTA 
containing 60µg/mL DNAse (Sigma) and 30µg/mL RNAse (Sigma) and incubated at 37oC 
with shaking (100rpm) for 4h. 30µg/mL proteinase K (Sigma) was subsequently added and 
the mixture incubated overnight at 37oC with gentle shaking prior to O/N dialysis in 1KD 
cut-off tubing. The dialysed solution was spun at 5000rpm for 20mins to remove any 
residual precipitate. Supernatants were frozen at -80oC in 50mL falcons and freeze-dried. 
Freeze-dried material was resuspended in 10mL milliQ water and spun at 35,000rpm for 4h 
at 4oC to pellet the LOS. Pelleted LOS was resuspended in 5mL water and freeze-dried 
overnight. Purified LOS was quantified using a micro-balance and stored either in the 
lyophilised form at -20oC or re-suspended in milliQ water at 1mg/mL at -80oC.     
2.9.2 Silver Stain  
1µg/mL of purified LOS was run on pre-made 7-15% TRIS-glycine gradient gels (BioRad). 
Gels were fixed O/N at 4oC in methanol: acetic Acid: water mixture at a 2:1:11 ratio. Gels 
were washed twice in water for 5mins with shaking and then incubated for 10mins with 
1.4% periodic acid. Gels were washed four times in water for 10mins. Silver stain solution 
was prepared fresh: 5mL 20% silver nitrate (freshly made in water) was added dropwise to 
2.8mL 1M NaOH, 2.5mL concentrated NH4OH with swirling; final volume was made to 
150mL with water. Gels were stained for 10mins with silver stain solution and then washed 
three times in water for 20mins. Gels were developed in development solution: 10mg citric 
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acid, 100µL concentrated formaldehyde made to 200mL in water. Gels were developed to 
the desired strength of staining; development was stopped by incubating gels in 5% acetic 
acid for 30mins. Gels were washed twice in water for 20mins and photographed.    
2.9.3 O-deacylation of LOS 
Samples were O-deacylated prior to Matrix-assisted laser desorption/ionisation time of 
flight (MALDI-TOF) mass spectrometry (MS) analysis to aid acquisition of highly resolved 
peaks. ~300µg of LOS from each strain was placed in a 1.5mL eppendorf and 200µL of 
anhydrous hydrazine (Sigma) was added. The samples were incubated at 37oC in a water 
bath for 2h with intermittent vortexing. The solution was cooled to RT and the reaction 
stopped by the addition of 1mL of pre-cooled acetone (-20oC). The precipitated O-
deacylated samples were pelleted by centrifugation at 12,000g for 20mins. Supernatants 
were removed and the pellet washed in 1mL chilled acetone before re-pelleting at 12,000g 
for 20mins. Supernatants were removed and the pellet resuspended in 500µL of MilliQ 
water. Samples were frozen at -80oC before being lyophilised.  
2.9.4 Mass Spectrometry  
MS was performed in the linear mode on a Voyager-DE STR model TOF instrument 
equipped with a 337-nm nitrogen laser and delayed extraction by Dr. Constance John, 
UCSF, USA. Spectra were obtained in the negative-ion mode with an average of 500 pulses 
per spectrum. The acceleration voltage was −20 kV. External calibration of the mass 
spectrometer was performed using the average masses of the molecular ions of the 
peptides porcine renin substrate, bovine insulin, and oxidized insulin chain B (Sigma). 
During each acquisition period internal calibration was performed using LOS isolated from 
Neisseria menigitidis of known mass. Spectra were analysed using Data Explorer Software 
(Applied Biosystems). All spectra were smoothed at 39 points Gaussian Smooth before 
analysis.  
2.9.4.1 Intact LOS Sample Preparation 
Intact samples were resuspended in methanol: water (1:1) containing 5mM EDTA at 1-
2µg/mL concentration. Samples were de-salted to remove sodium ions using Dowex 
50WX8-200 cation-exchange beads (Sigma) on a piece of parafilm. The sample was mixed 
1:1 with 20mM dibasic ammonium citrate (Sigma) on a piece of parafilm and 0.5µL was 
placed onto the MS sample plate on top of a thin layer of matrix using a glass capillary 
pipette. The make the MS matrix, nitrocellulose transblot membrane (Bio-Rad) was 
dissolved in acetone:isopropanol (1:1) to a concentration of 15mg/mL; to this 2,4,6-
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trihydroxyacetophenone (THAP; Sigma) dissolved in methanol to 200mg/mL was added in a 
4:1 ratio. Small drops of this matrix (0.3-0.9µL) was deposited onto the MS sample plate 
and allowed to air dry before the intact sample was placed on top.  
2.9.4.2 O-deacylated Sample Preparation 
O-deacylated samples after desalting as described above then were mixed 1:1 in 2,5-
dihydroxybenzoic acid (DHB) matrix. The matrix was prepared by dissolving 10 mg DHB in 
acetone. Samples were spotted onto the MS plate using a glass capillary pipette and allow 
to air dry. 
2.10 Statistics 
Data for experiments of >5 repeats which showed normal distribution (parametric data) 
when plotted on a box and whisker plot were subjected to analysis by paired t-test. 
Experiments of <5 repeats where normal distribution of the data points was unknown 
Wilcoxon matched pairs test was used to analyse the data. For comparison of more than 
two groups in the same experiments Repeated Measures ANOVA was used for parametric 
data using the Tukey post test to compare all columns of data. For non-parametric data 
when comparing more than two groups in the same experiment Friedman test analysis was 
performed with Dunns post test to compare all columns of data. All statistical analysis was 
performed using GraphPad 5 software.     
 
  
71 
 
 
 
 
 
 
Chapter 3.  
The Role of Campylobacter jejuni 
Surface Determinants in Mediating 
Dendritic Cell Activation 
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3.1 Background 
Upon recognition of microbial products APCs undergo a maturation process that allows 
them to trigger T cell immunity via the presentation of three activation signals:  antigen 
presentation on MHC class II; the upregulation of co-stimulatory receptors; and the 
secretion of cytokines. The collective impact of all these three signals plus local 
environmental factors together shape the type and extent of T-cell response(s) induced. 
Upon encounter, multiple microbe-host (MAMP/PRR) interactions come into play leading 
to APC activation. Evidence suggests that TLR engagement promote specific cellular 
functions; e.g. the engagement of TLR2 from various pathogens (Yersinia pestis and 
Candida albicans) preferentially induces IL-10 (Netea et al. 2004; Sing et al. 2002). 
However, other PRRs are also capable of inducing IL-10, often working synergistically to 
amplify responses (Gringhuis et al. 2007). It is a challenge to decipher whether the tailoring 
of specific innate responses are beneficial to the host and/or pathogen. For instance, the 
induction of IL-10 may be beneficial to the pathogen as it may aid colonisation by immune 
suppression as demonstrated with H. pylori infection (Kao et al. 2010; Panthel et al. 2003).  
PRRs bind to specific microbial components that are generally surface exposed. The 
availability of C. jejuni isogenic mutants has greatly aided in improving our understanding of 
host/pathogen interactions involved in both the in vitro and in vivo settings. Several surface 
structure mutations of C. jejuni have been characterised, interestingly many of these 
mutations have little impact on bacterial growth rate and viability (Dr. Nick Dorrell & 
Professor Brendan Wren, LSHTM, UK; personal communication). The capsule, N-linked 
glycosylation system, and the flagella have been implicated in the adherence and invasion 
of IECs (Bacon et al. 2001;Golden and Acheson 2002;Karlyshev et al. 2004). Additionally the 
N-linked glycosylation of C. jejuni proteins can modulate DC cytokine responses via 
interaction(s) with the PRR MGL (van Sorge et al. 2009). In this chapter we sought to 
identify the role of specific surface determinants, in particular the role of CPS, N-linked 
modifications and the O-linked flagella on DC activation. Murine bone-marrow derived 
dendritic cells (BMDCs) were used as an in vitro model for DC activation in response to C. 
jejuni. 
C. jejuni isogenic mutants employed in this study are listed in Table 2-1. A ∆kpsM isogenic 
mutant strain of C. jejuni 11168 lacks the capsule as determined by electron microscopy of 
alcian blue stained whole bacteria (Karlyshev, McCrossan, & Wren 2001). A ∆pglB isogenic 
mutant of C. jejuni 11168 lacks the conserved N-linked glycosylation, thus denuding 
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multiple periplasmic proteins and outer-membrane proteins (Young et al. 2002). A ∆flaA 
mutant of C. jejuni strain 81116 is non-motile and contains only truncated flagella bearing 
no FlaA structural filaments, this mutant has not been characterised in strain 11168 
(Wassenaar et al. 1994). Mutation of the flagellar transcription activator rpoN encoding the 
alternative sigma factor 54 results in aflagellated bacteria (Jagannathan, Constantinidou, & 
Penn 2001). Due to the elimination of transcription of multiple proteins involved in the 
flagellum hook structure the ∆rpoN is secretion negative in contrast to the ∆flaA mutant 
which is secretion positive (Konkel et al. 2004).   
C. jejuni strains potentially contain two separate biosynthesis pathways for the production 
of derivatives of pseudaminic acid (Pse) and legionaminic (Leg) acid residues which are 
subsequently attached to flagellin proteins either on serine or threonine residues (O-linked 
glycosylation). The Ptm and Pse pathways encode proteins necessary for the generation of 
Leg and Pse derivatives respectively. Although the pathways are distinct in their apparent 
specificities i.e. strains that encode the Pse pathway only contain Pse modifications, 
mutations in one pathway however alters the production of the alternative flagellin 
modification. For example, mutation of the Cj1324 gene (involved in the synthesis of Leg 
modifications) leads to a  lack of both Pse5Ac7Am as well as Leg5Am7Ac structures (and 
other legionaminic acid derivatives) (Howard et al. 2009). Mutations in genes involved in 
the Pse biosynthesis pathway lead to truncation of the flagella structure. This is due to the 
requirement of some but not all of the Pse-Ser/Thr modifications in filament 
polymerisation (Ewing, Andreishcheva, & Guerry 2009). Although complete ablation of the 
Pse pathway results in a non-motile phenotype; mutation of pseA (Cj1316) results in 
flagellin monomers (strain 81-176) with only pse5Ac7Ac present and not pse5Ac7Am (or 
further derivatives) (Guerry et al. 2006).    
3.2 The role of C. jejuni capsular polysaccharide, N-linked 
glycosylation system, and flagella in mediating BMDC responses 
Bacteria are readily phagocytosed by professional APCs such as DCs. Successful pathogens 
have evolved multiple mechanism(s) to evade host immunity including manipulating the 
process of phagocytosis. In a series of experiments the ability of BMDCs to phagocytose 
and subsequently kill WT C. jejuni was assessed by the standard gentamicin protection 
assay (Figure 3-1a and b respectively). C. jejuni were phagocytosed by BMDCs within 2h of 
co-culture (Figure 3-1a). The number of intracellular bacteria increased in a progressive  
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Figure 3-1: C. jejuni are phagocytosed and killed by murine bone-marrow derived 
dendritic cells  
(a) 2 x 105 BMDCs were infected with WT C. jejuni strain 11168H at an MOI 100 for the 
indicated times, treated for 2h with 150µg/mL gentamicin to kill extracellular bacteria then 
subsequently lysed in 0.1% triton-X. CFU counts were performed to enumerate intracellular 
bacteria numbers. (b) 2 x 105 BMDCs were infected for 2h with C. jejuni MOI 100, treated 
for 2h with 150µg/mL gentamicin then subsequently lysed (0h time-point) or incubated in 
media containing a lower concentration of gentamicin for the indicated times before lysis. 
Rate of survival was calculated and are given as a percentage of the bacterial numbers 
enumerated at the 0h time point. Values are expressed as mean ± standard error of the 
mean (SEM) from three independent experiments performed in duplicate. One-way 
ANOVA statistical analysis performed with Tukey post-test. No stars = not significant; * 
<0.05; ** <0.01; ***<0.001.  
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manner up to 6h post-infection, where a ~ ratio of 1 intracellular bacterium/DC was 
observed. The number of viable intracellular bacteria decreased from ~ 100,000 CFU at 6h 
to 1,000 CFU at 24h (Figure 3-1a). In contrast to the reduction in internal bacteria at 24h 
post-infection the CFU count in the supernatant increased by ~10-fold (data not shown). 
This data showed that BMDCs phagocytosed C. jejuni in a time-dependent manner, 
however this phagocytic capability decreased over extended time periods (p<0.05).  
The ability of BMDCs to kill intracellular C. jejuni was assessed (Figure 3-1b). The number of 
intracellular bacteria enumerated after 2h co-culture and subsequent killing of extracellular 
bacteria (Figure 3-1a 1st bar) was considered 100% (Figure 3-1b 1st bar). After a subsequent 
4h incubation a significant reduction (45%; p = 0.03) in viable intracellular bacterial 
numbers was observed. After 24h incubation no viable bacteria were recovered. Taken 
together, BMDCs phagocytosed and exerted bactericidal activity against C. jejuni. This 
signified C. jejuni was unable to replicate within this cell-type.   
 The ‘glycosylation’ moieties of microbe surface structures can engage and modulate the 
phagocytic process. We hypothesised that glycosylated surface determinants of C. jejuni 
may alter BMDC function by interfering with phagocytosis. To analyse whether three 
known glycosylated components of C. jejuni play a role in BMDC mediated phagocytosis, 
co-cultures with isogenic mutant strains lacking specific constituents were set-up for 4h 
and viable intracellular bacteria enumerated (Figure 3-2). No significant difference in 
phagocytosis of the capsule mutant, ∆kpsM (Figure 3-2a), N-linked glycosylation mutant, 
∆pglB (Figure 3-2b), or the flagellin mutant, ∆flaA (Figure 3-2c) was observed.  These 
experiments clearly showed that the glycosylation system alone or its modifications on the 
capsule and flagella did not affect bacterial uptake.  
Upon activation by MAMPs DCs upregulate the expression of co-stimulatory molecules 
(CD86, CD40, CD80) and MHC class II in order to engage T-cells leading to their 
differentiation and activation.  The contribution of C. jejuni glycosylation to modulate these 
maturation markers was assessed by flow cytometry 24h post-infection (Figure 3-3). 
Unstimulated BMDCs did not express CD40 (Figure 3-3a). Upon stimulation with WT or 
ΔkpsM C. jejuni a ~1.8 fold increase in CD40 MFI was observed (Figure 3-3b). In contrast, 
both the ΔpglB and ΔflaA mutants increased CD40 expression ~1.5 fold which was 
comparable to LPS-stimulation (positive control). The difference between the WT and ΔflaA 
strain was significant (p<0.05). Induction of CD80 was low, showing a ~1.3 fold increase for 
the WT strain and all the mutants tested. The WT strain induced MHC class II expression by  
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Figure 3-2: C. jejuni capsule, N-linked glycosylation system, and flagella do not alter 
phagocytosis rates 
2 x105 BMDCs were co-cultured for 4h with WT C. jejuni strain 11168H and various isogenic 
mutants at an MOI 100 and intracellular bacteria were enumerated by gentamicin 
protection assay 4h post-infection (a) WT and ∆kpsM strains (b) WT and ∆pglB strains (c) 
WT and ∆flaA strains. Values are expressed as means ±SEM from three independent 
experiments performed in duplicate. Paired t-test statistical analysis performed. No stars = 
not significant. 
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Figure 3-3: Stimulation of BMDCs with ΔflaA C. jejuni strain alters CD40 expression 
1 x 106 BMDCs were co-cultured for 24h with WT C. jejuni strain 11168H and various 
isogenic mutants at an MOI 100. The expression of maturation markers CD40, CD80, and 
MHC class II was analysed by flow cytometry. (a) Representative histograms for the 
maturation markers are shown. Unstimulated isotype control (dashed line); unstimulated 
stained control (solid grey); C. jejuni stimulated (black line) (b) Average data for fold 
induction of geometric mean fluorescence intensity (MFI) over basal expression on 
unstimulated cells. Data from at least 3 independent experiments. Data are means ± SEM. 
One-way ANOVA statistical analysis performed with Tukey post-test. * <0.05; no stars = not 
significant.  
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~1.5 fold over the unstimulated cells. The ΔkpsM mutant induced higher levels of MHC 
class II, at ~2 fold; however this difference was not statistically significant.  The ΔpglB and 
ΔflaA mutants showed comparable levels to that noted with the WT strain. This data 
showed that BMDCs upregulate multiple co-stimulatory markers and MHC class II in 
response to C. jejuni. The flagella directly impacted on the upregulation of CD40 whilst 
having little impact on other maturation markers.   
In addition to the upregulation of maturation markers, DCs secrete an array of both pro- 
and anti-inflammatory cytokines in response to stimuli. BMDCs were co-cultured with WT 
and isogenic mutants of C. jejuni and the level of cytokines secreted was assessed. WT C. 
jejuni induced both pro- and anti-inflammatory cytokines as measured 24h post-infection 
(Figure 3-4; Figure 3-5; Figure 3-6). IL-6 was markedly induced by C. jejuni at ~35000pg/mL 
(Figure 3-4b). High levels of TNF-α were also detected at ~5000pg/mL (Figure 3-4a).  
Interestingly, IL-1β levels (<500pg/mL) in comparison were low (Figure 3-4c). IL-12 family 
members, IL-12, IL-23, and IL-27 were modest at ~ 100pg/mL, 20pg/mL, and 100pg/mL 
respectively in response to infection (Figure 3-4d). Importantly, high levels of IL-10 at 
~2500pg/mL were detected (Figure 3-4e). E. coli LPS, a potent inducer of TLR4, was used as 
both a positive control for individual experiments and also for comparison in the levels of 
cytokines induced by C. jejuni. Interestingly, levels of particular cytokines induced by C. 
jejuni differed from that of LPS alone. LPS induced higher levels of IL-12 family cytokines, 
and significantly higher levels of IL-6 (p <0.05) (Figure 3-6). In contrast, WT C. jejuni induced 
significantly higher IL-1β (p <0.05) and IL-10 (p <0.05) than LPS alone. These observations 
revealed the cytokine milieu generated by BMDCs in response to C. jejuni.  Additionally, the 
cytokine profile differed considerably when compared to LPS-mediated response(s).  
To assess the contribution of particular surface components, isogenic mutants of C. jejuni 
were co-cultured with BMDCs and cytokines quantified. The capsule mutant, ∆kpsM, 
induced similar levels of TNF-α, IL-1β, and IL-10 to WT C. jejuni (Figure 3-4). There was 
however a trend towards higher levels of both IL-6 and all IL-12 family in response to the 
∆kpsm strain. ∆pglB showed little difference compared to the WT strain (Figure 3-5). IL-1β 
levels were reduced with the ∆pglB mutant, however this was not statistically significant. 
The ∆flaA strain induced similar levels of TNF-α and IL-6 compared to the WT strain (Figure 
3-6). Similarly, comparable levels of IL-12 family were induced by the flagella mutant. 
Interestingly, there was a significant reduction in the induction of both IL-10 (p <0.01) and  
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Figure 3-4: Cytokine release by BMDCs exposed to a C. jejuni capsule mutant   
1 x106 BMDCs were co-cultured with WT C. jejuni and capsule mutant ∆kpsM at an MOI 100 
for 24h. Cytokine analysis was subsequently performed by ELISA. (a) TNF-α and IL-6 (b) IL-
1β (c) IL-12 family cytokines: IL-12, IL-23, and IL-27 (d) IL-10. Values are means ± SEM from 
a minimum of three independent experiments. One-way ANOVA statistical analysis 
performed with Tukey post-test. No stars = not significant 
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Figure 3-5: C. jejuni N-linked glycosylation system does not alter cytokine induction in 
BMDCs 
1 x106 BMDCs were co-cultured with WT C. jejuni and N-linked glycosylation mutant ∆pglB 
at an MOI 100 for 24h. Cytokine analysis was subsequently performed by ELISA. (a) TNF-α 
and IL-6 (b) IL-1β (c) IL-12 family cytokines: IL-12, IL-23, and IL-27 (d) IL-10. Values are 
means ± SEM from a minimum of three independent experiments. One-way ANOVA 
statistical analysis performed with Tukey post-test. No stars = not significant 
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Figure 3-6: C. jejuni flagellum modulates BMDC IL-10 production 
1 x106 BMDCs were co-cultured with WT C. jejuni and flagella mutant ∆flaA at an MOI 100 
for 24h. Cytokine analysis was subsequently performed by ELISA. (a) TNF-α and IL-6 (b) IL-
1β (c) IL-12 family cytokines: IL-12, IL-23, and IL-27 (d) IL-10. Values are means ± SEM from 
a minimum of three independent experiments. One-way ANOVA statistical analysis 
performed with Tukey post-test. No stars = not significant; * <0.05; ** <0.01; ***<0.001. 
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IL-1β (p <0.05) by ∆flaA strain. The contribution of C. jejuni flagella in mediating high IL-10 
was a novel finding and therefore deserved further attention.   
3.3 Campylobacter jejuni flagella induces early transcription and 
secretion of BMDC IL-10  
The above study identified the flagella moiety to be a major candidate involved in 
modulating C. jejuni-mediated BMDC responses. The absence of the flagella had an impact 
on CD40 expression as well as IL-1β and IL-10 induction.  We next wished to assess if C. 
jejuni flagella mediated effects were operating on cytokine transcriptional and/or 
translational levels (Figure 3-7). Both WT and ΔflaA induced IL-6 gene expression as early as 
1h post-infection, followed by a steady increase with maximal expression noted 4-6h post-
infection (Figure 3-7a). Similarly, IL-1β mRNA was detected at early time-points with peak 
levels seen 2-4h post-infection (Figure 3-7b). p35 and p40 form the two subunits of IL-12 
p70. p40 mRNA was induced at 1h post-infection and peaked at 6h, however p35 levels 
were only detectable at 2h post-infection peaking at 6h with ~25 times lower number of 
transcripts compared to p40 at 4h post-infection (Figure 3-7c & d). IL-10 mRNA was 
detectable at 1h post-infection and peaked at 6h. Interestingly, the transcripts for all the 
cytokines analysed declined after 4-6h post-infection suggesting early signalling events play 
an important role in C. jejuni-mediated cytokine responses. However, transcripts were still 
detectable 24h post-infection for all the cytokines analysed albeit at low levels. 
The ∆flaA mutant induced lower levels of IL-6 and p40 than WT C. jejuni however this was 
not statistically significant (Figure 3-7a and c). The induction of IL-1β and p35 were similar 
between the mutant and WT throughout the duration of the time-course (Figure 3-7b and 
d). Interestingly, IL-10 transcription levels were markedly reduced in response to infection 
with the ∆flaA mutant (Figure 3-7e). The difference in IL-10 transcript levels between the 
WT and ∆flaA were noted as early as 1h post-infection, however significant difference was 
not achieved until 6 and 8h post-infection. Whereas IL-10 mRNA levels from BMDCs 
stimulated with WT strain peaked at 6h post-infection, levels induced by the ∆flaA 
plateaued between 2-6h at approximately half the level detected in response to WT 
infection. No differences were observed between the conditions at the 24h time point. This 
data indicated that the difference in IL-10 protein levels seen in response to the WT and 
∆flaA may be due to effects on gene transcription. In contrast, differences in transcription 
did not account for the effect on IL-1β protein levels seen in response to the two infections.  
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Figure 3-7: IL-10 transcription is reduced in response to infection with ∆flaA C. jejuni   
1 x 106 BMDCs were co-cultured with WT and ∆flaA C. jejuni at an MOI 100 for the 
indicated time points. Quantitative real-time PCR analysis was performed and relative 
levels of transcripts calculated using the ∆∆ct method, utilising the expression of a house-
keeping gene, GAPDH, as a control. Values are expressed at means ± SEM from at least 
three independent experiments. Paired t-test statistical analysis performed. No stars = not 
significant; * <0.05; ** <0.01; ***<0.001. 
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Time-dependent changes observed in IL-10 transcription were also followed at the protein 
level (Figure 3-8). The differential induction of IL-10 by the WT and ∆flaA strains was 
observed at 2h post-infection; however, the difference did not become statistically 
significant until 6h post-infection, a profile similar to its transcription regulation.  
As modulation of IL-10 levels by the ∆flaA mutant were seen early in infection, we 
speculated that direct bacterial mediated signalling events were the likely drivers rather 
than subsequent secondary effects such as autocrine cytokine mediation affecting cytokine 
production. We next wished to identify which BMDC signalling events may be involved in 
regulating IL-10 in response to C. jejuni. 
3.4 C. jejuni flagella modulates p38 but does not alter NF-κB 
activation 
NF-κB signalling is a central regulator of inflammatory responses in APCs. To assess the 
activation of NF-κB, an NF-κB reporter construct driving the expression of luciferase was 
transduced at an MOI 10 into BMDCs on day 3 of differentiation. Luciferase activity induced 
by C. jejuni was analysed 6h post-infection. No luciferase activity was detected in 
untransduced cells either when unstimulated or stimulated with C. jejuni (Figure 3-9a). 
Unstimulated transduced cells showed minimal luciferase activity [less than 1000 arbitrary 
fluorescent units (AFU)]. A dose-dependent increase in luciferase activity was observed 
with WT C. jejuni at an MOI 10 and 100 confirming the ability of the assay to detect 
differential activation of NF-κB.  
IkBα is an inhibitory molecule that sequestors NF-κB in the cytoplasm. Upon upstream 
signalling IkBα is phosphorylated and subsequently degraded, this process releases NF-κB 
to translocate to the nucleus. IkBα is degraded rapidly, within 30mins, in response to C. 
jejuni (Figure 3-9b). New protein synthesis allowed IkBα levels to return to basal levels by 
2h post-infection. This highlighted that NF-κB signalling is rapidly activated in BMDCs in 
response to C. jejuni stimulation.  
The activation of NF-κB in response to the ∆flaA strain was also assessed (Figure 3-9c). 
Similar levels of luciferase activity were observed between the WT and ∆flaA mutant 
suggesting the flagella may not be important for NF-κB activation.  
MAPK signalling is often triggered in addition to NF-κB after the engagement of PRRs. To 
assess the potential activation of MAPK pathways by C. jejuni, time-course experiments 
were performed. All three MAPK pathways, p38, ERK, and JNK were activated (as measured  
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Figure 3-8 Differential IL-10 protein induction in response to infection with WT and ∆flaA 
C. jejuni 
1 x106 BMDCs were co-cultured with WT C. jejuni and flagella mutant ∆flaA at an MOI 100 
for the indicated time-points. IL-10 cytokine analysis was subsequently performed by ELISA. 
Values are means ± SEM from a minimum of three independent experiments. Paired t-test 
statistical analysis performed. No stars = not significant; * <0.05; ** <0.01; ***<0.001.  
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Figure 3-9: C. jejuni mediated BMDC NF-κB activation is not influenced by the flagella 
(a) and (c) BMDCs were transduced with an NF-κB reporter lentivector on day 3 of 
differentiation at an MOI 10. On day 8, 1 x 105 untransduced or transduced BMDCs were 
infected with (a) WT C. jejuni at an MOI 10 or 100 or (c) WT or ∆flaA C. jejuni MOI 100 for 
6h. Bright-glo luciferase reagent was subsequently added and luminescence measured. 
Values are means ± SEM from two independent experiments performed in duplicate. (b) 1 
x106 BMDCs were infected with WT C. jejuni MOI 100 for the indicated time-points. Cell 
lysates were subjected to SDS-PAGE followed by Western blotting with an IκBα antibody. 
Membrane were stripped and re-probed for β-actin as a loading control. Western blots are 
representative of at least three independent experiments. One-way ANOVA statistical 
analysis performed with Tukey post-test. No stars = not significant; * <0.05; ** <0.01; 
***<0.001. 
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by degree of phosphorylation) in response to WT C. jejuni (Figure 3-10a and b). p38 
activation peaked within 30-60mins post-infection, and declined after 2h although 
phosphorylated p38 was detectable 6-8h post-infection. Phospho-ERK was seen within 
30mins post-infection, levels peaking between 60mins-2h, again phospho-ERK was present 
6-8h post-infection. Kinetics of JNK phosphorylation was slow compared to p38 and ERK, as 
phospho-JNK was detected only between 60-90mins post-infection. In addition, JNK 
activation diminished more rapidly, with minimal levels seen at 2h with none detectable at 
4h.  
p38 showed lower magnitude and slower kinetics of activation in response to the  ∆flaA 
isogenic mutant when compared to the WT C. jejuni (Figure 3-10b). Strong activation was 
not observed with the mutant until 90mins post-infection compared to 60mins with the WT 
counterpart. ERK and JNK activation were similarly activated by the ∆flaA and WT strain. 
This suggested a possible role for p38 signalling in the differential cytokine response 
observed between the WT and the ∆flaA strain.  
3.5 Inhibition of MAPK signalling pathways alters cytokine 
production with minimal effect on maturation markers 
Once the activation of BMDC MAPK signalling pathways by C. jejuni was established, the 
potential role of MAPK in the induction of maturation was investigated.  Small chemical 
inhibitors of MAPK have been used successfully in both in vitro and in vivo analysis of the 
role of MAPK in health and disease. U0126 is a potent MEK1/2 inhibitor, the upstream 
kinase of ERK1; PD90859 is a MEK1 inhibitor (Alessi et al. 1995;Favata et al. 1998). U0126 
has a ~ IC50 value of 72nM for MEK1 and 58nM for MEK2 in vitro, whereas PD90859 has a ~ 
IC50 value of 2µM and is therefore used at higher concentrations compared to other MAPK 
inhibitors. SP600125 is a competitive inhibitor of ATP binding for JNK1, 2, 3 and has IC50 
values of 40nM for JNK1 and 2 and 90nM for JNK3 (Bennett et al. 2001). SB203580 and 
SB239063 inhibit the ATP binding site of p38 α and β but not γ or δ isoforms, or ERK and 
JNK (Cuenda et al. 1995;Underwood et al. 2000). Both SB203580 and SB239063 have IC50 
values of ~50nM.  As all the inhibitors were solubilised in DMSO, 1% DMSO was added to 
control media. Cells were pre-treated with the inhibitors or DMSO control for 1h prior to 
stimuli.   
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Figure 3-10: C. jejuni ∆flaA mutant strain mediated delayed p38 activation with minimal 
impact on ERK or JNK  pathways 
1 x 106 BMDCs were co-cultured with (a) WT (b) WT and ∆flaA C. jejuni MOI 100 for the 
indicated time-points. Lysates were subjected to SDS-PAGE followed by Western blot 
analysis for the phosphorylated forms of p38, ERK, and JNK. Blots were stripped and 
probed for total ERK as a loading control. Blots are representative of at least three 
independent experiments. 
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Prior to investigation, it was important to establish if the inhibitors had any effect on the 
rate of bacterial phagocytosis, as this cellular process is critical for multiple downstream 
events. In the presence of a standard concentration of 10µM for p38 and ERK inhibitors 
SB203580 and U0126 rates of bacterial phagocytosis were assessed as described above 
(Figure 3.1). The presence of the inhibitors had minimal effect on the rates of phagocytosis 
measured 4h post-infection (Figure 3-11). Next, effect of MAPK inhibition on C. jejuni-
mediated BMDC maturation marker and cytokine responses was investigated. Two 
concentrations (1 and 10μM) of inhibitors were tested in this series of experiments to 
elucidate if a dose-dependent effect was noted.  Overall inhibition of MAPKs had little 
effect on the expression of maturation markers (Figure 3-12). DMSO treated control cells 
stimulated with C. jejuni showed similar upregulation of CD40, CD80, CD86 and MHC class II 
as seen in the absence of DMSO (Figure 3-12 and Figure 3-3). Inhibition of ERK by U0126 
and PD98059 increased expression of CD40 without the addition of C. jejuni, suggesting a 
possible regulatory role for ERK in the constitutive expression of CD40 (Figure 3-12a). No 
increase in CD40 expression was observed with the addition of C. jejuni under these 
conditions suggesting the CD40 expression had plateaued with the addition of the inhibitor 
alone. The presence of ERK inhibitors had minimal impact on either unstimulated or C. 
jejuni-mediated CD80, CD86, and MHC class II expression (Figure 3-12b, c, and d). Inhibition 
of JNK with SP600125 at either 1µM or 10µM had no effect on CD40, CD80, CD86, and MHC 
class II expression either when unstimulated or stimulated with C. jejuni (Figure 3-12). 
Inhibition of p38 similarly had no effect on the expression of CD40 (Figure 3-12a). Infection 
in the presence of SB203580 and SB239023 marginally increased CD80, CD86, and MHC 
class II although this increase was not statistically significant (Figure 3-12 b, c and d).  
The importance of MAPK signalling in the induction of both pro- and anti-inflammatory 
cytokines has been well documented (Escors et al. 2008). Next, MAPK inhibitors were 
utilised to decipher the importance of MAPK signalling in C. jejuni-mediated cytokine 
induction (Figure 3-13). Inhibition of ERK affected TNF-α secretion at 10µM of both U1026 
and PD90859 (Figure 3-13a). Reduction in IL-6 was also observed with ERK inhibitors but a 
dose-response was not seen and this effect was not statistically significant (Figure 3-13b). 
ERK inhibition had minimal effect on the IL-12 family members (Figure 3-13d, e, and f). 
However, both PD90859 and U0126 caused a significant reduction in IL-10 protein levels 
(Figure 3-13g). PD90859 only affected secretion at 10µM (p<0.01), whereas U0126 
significantly reduced secretion at both 1µM and 10µM concentration (p <0.05, and p 
<0.001 respectively). 
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Figure 3-11: Inhibition of p38 and ERK MAPKs does not alter C. jejuni phagocytosis  
2 x 105 BMDCs were pre-treated with 10µM MEK1/2 (U0126) or p38 (SB203580) inhibitors 
or 1% DMSO as a vehicle control for 1h prior to infection with WT C. jejuni MOI 100 for 4h. 
Intracellular bacterial numbers were assessed by gentamicin protection assay. Values are 
means ± SEM from two independent experiments performed with two biological replicates. 
One-way ANOVA statistical analysis performed with Tukey post-test. No stars = not 
significant 
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Figure 3-12: Inhibition of MAPKs does not alter C. jejuni-mediated maturation marker 
induction 
1 x106 BMDCs were co-cultured with WT C. jejuni MOI 100 for 24h. The levels of (a) CD40 
(b) CD80 (c) CD86 and (d) MHC class II were assessed by flow cytometry. Values are mean 
fold change in the geometric mean fluorescent intensity (MFI) over the expression in 
uninfected  cells ± SEM from a three independent experiments. One-way ANOVA statistical 
analysis performed with Tukey post-test. No stars = not significant 
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Figure 3-13: Inhibition of MAPKs resulted in reduced IL-10 production with minimal effect 
on IL-12 family members 
1 x 106 BMDCs were pre-treated with inhibitors of MAPK pathways, MEK1/2 (U0126 & 
PD90859), JNK (SP600125), or p38 (SB203580 & SB239063) at a concentration of 1µM or 
10µM for 1h prior to infection (PD90859 was used at 5µM and 50µM concentrations). 
BMDCs were co-cultured with WT C. jejuni MOI 100 for 24h in the presence of the 
inhibitors. Supernatants were assessed for the levels of (a) TNF-α (b) IL-6 (c) IL-1β (d) IL-12 
(e) IL-23 (f) IL-27 and (g) IL-10 by ELISA. Values are means ± SEM from three independent 
experiments. One-way ANOVA statistical analysis performed with Tukey post-test. No stars 
= not significant; * <0.05; ** <0.01; ***<0.001. 
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Inhibition of JNK signalling had minor effects on the secretion of TNF-α, IL-6, and IL-1β at 
10µM concentration, and this was not statistically significant (Figure 3-13 a, b, and c). 
Secretion of IL-12 family members was largely unaffected by the SP600125 inhibitor apart 
from IL-27 at 10µM (Figure 3-13d, e and f). IL-10 secretion was reduced at 10µM inhibitor 
concentration, although this was less than that observed in the presence of the p38 and 
ERK inhibitors (Figure 3-13g).  
At higher inhibitor concentration (10µM) TNF-α and IL-6 production was reduced by ~50% 
in the presence of SB203580 and SB239023 (p< 0.05; Figure 3-13a and b). Interestingly, IL-
1β secretion was enhanced by both p38 inhibitors (Figure 3-13c). Similar to the ERK and 
JNK, p38 inhibition had minimal effect on the IL-12 cytokine family, in contrast this pathway 
had the most pronounced effect on IL-10 protein levels (Figure 3-13g). A ~60% reduction in 
IL-10 secretion was observed at 1µM concentration of both inhibitors (p <0.001 for both). 
This reduction increased to 85% in the presence of 10µM SB203580 (p <0.001). p38 
inhibition had a far greater impact on IL-10 secretion than the other MAPK inhibitors 
suggesting a greater role for this signalling pathway in IL-10 secretion, although inhibitors 
of all three MAPK pathways affected IL-10 secretion. 
As (a) host MAPK signalling and the flagella of C. jejuni modulated IL-10 levels (Figure 3-6, 
Figure 3-13), and (b) the flagella appeared to be important for p38 signalling in particular 
(Figure 3-10), collectively the evidence supported the notion that in BMDC, C. jejuni flagella 
by mechanism(s) yet unknown impacts on p38 signalling leading to downstream 
modulation of IL-10 expression.  We next tested this emerging hypothesis. The ∆flaA 
mutant was used to stimulate BMDCs in the presence of MAPK inhibitors (Figure 3-14).  As 
observed previously, the ∆flaA mutant induced ~60% less IL-10 than the WT C. jejuni strain, 
and the p38 inhibitors had a potent effect at 1µM. In the presence of 1µM SP600125, no 
significant change was observed as a similar ~60% reduction was seen in response to 
infection with the ∆flaA mutant (Figure 3-14). This suggested that C. jejuni flagella accounts 
for 60% of the IL-10 induced by the whole bacterium, and this induction is JNK-
independent. Interestingly, in the presence of 1µM SB203580 and SB239023 only a 36% 
and 43% reduction in IL-10 was seen with the ∆flaA respectively, and 25% less at the higher 
10µM concentration of SB203580.  In the presence of 1µM U0126 also only a 45% 
reduction of IL-10 was observed between the WT and the ∆flaA mutant. These results 
suggested that C. jejuni flagella induced IL-10 in BMDCs via a p38 and ERK-dependent 
mechanism.  
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Figure 3-14: C. jejuni flagella modulates IL-10 production via p38 and ERK pathways  
1 x 106 BMDCs were pre-treated with inhibitors of MAPK pathways, MEK1/2 (U0126 & 
PD90859), JNK (SP600125), or p38 (SB203580 & SB239063) at a concentration of 1µM or 
10µM for 1h prior to infection (PD90859 was used at 5µM and 50µM concentrations). 
BMDCs were co-cultured with WT C. jejuni or ∆flaA mutant MOI 100 for 24h in the 
presence of the inhibitors and supernatants were assessed for IL-10 protein by ELISA. 
Values are means ± SEM from three independent experiments. 
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3.6 Critical role for the flagella ‘glycosylated’ moieties in BMDC IL-
10 production    
During host-microbial crosstalk, bacterial carbohydrate structures and secreted proteins 
can specifically enhance host anti-inflammatory cytokine response(s), as a means of host 
immune evasion. (Nagamatsu et al. 2009; van Vliet et al. 2009). The ∆flaA mutant utilised 
above did not allow delineation of the contribution of the flagellin protein versus the 
contribution of the carbohydrate moiety to IL-10 levels. To rectify this, a variety of specific 
flagella isogenic C. jejuni mutants were employed.  
 Utilising the ∆rpoN mutant (which lacks both the extracellular flagella structure and 
membrane hook complex and is therefore secretion negative), comparable reduction in IL-
10 was observed to the ∆flaA mutant (Figure 3-15). This finding suggested that active 
secretion of C. jejuni via the flagella plays a minimal role in host IL-10 responses. Different 
strains of C. jejuni bear different sugar structures on their flagella (Champion et al. 2005). 
11168H contains both Pse and Leg structures and their derivatives while strain 81-176 
encodes only the Pse structures. To assess whether the flagella alters IL-10 secretion from a 
strain modified with only Pse structures, strain 81-176 was employed. The WT and ∆flaA 
mutant of 81-176 mediated IL-10 response(s) similar to that noted for the 11168H WT and 
its ∆flaA isogenic mutant (Figure 3-16).  The ∆flaA mutant strains induced less IL-10 than 
their WT counterparts, although the reduction in IL-10 secretion for the 81-176 ∆flaA was 
marginally less than for the 11168H ∆flaA. These observations add weight to the notion 
that the flagella from multiple C. jejuni strains are involved in modulating host IL-10 
responses.  
To directly assess the role of flagellin glycosylation in IL-10 induction, a series of 
glycosylation mutants were utilised. Due to the importance of flagellin glycosylation in the 
assembly of the flagella complex the complete carbohydrate mutant is aflagellated and 
therefore could not be used in this assay (Goon et al. 2003). The ∆Cj1324 mutant lacks two 
derivatives of Leg, Leg5AmNMe7Ac and Leg5Am7Ac, and in addition lacks a form of Pse, 
Pse5Ac7Am. Interestingly the complement restores the expression of the Leg structures 
but not the Pse structure (Howard et al. 2009). The ∆Cj1316 or ∆pseA mutant has been 
described in strain 81-176 and lacks Pse5Ac7Am modification of the flaA protein (Guerry et 
al. 2006). The ∆Cj1324 mutant induced less IL-10 than the WT strain (p <0.05), although it 
induced statistically more IL-10 than the ∆flaA mutant (p <0.05; Figure 3-17a).  
Interestingly, the ∆Cj1324 complement did not restore IL-10 secretion to levels of the WT.   
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Figure 3-15: C. jejuni flagella secreted proteins play a minimal role in IL-10 production 
1 x106 BMDCs were co-cultured with WT C. jejuni, ∆flaA (secretion positive) or ∆rpoN 
(secretion negative) isogenic mutants at an MOI 100 for 24h. IL-10 protein levels were 
analysed by ELISA. Values are means ± SEM from a minimum of three independent 
experiments. One-way ANOVA statistical analysis performed with Tukey post-test. No stars 
= not significant; * <0.05; ** <0.01; ***<0.001. 
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Figure 3-16: The flagella of C. jejuni 11168H & 81-176 influences IL-10 production 
1 x 106 BMDCs were co-cultured with WT 11168H or 81-176 C. jejuni or with the 
corresponding flagella isogenic mutant ∆flaA strains at an MOI 100 for 24h. IL-10 protein 
was analysed by ELISA. Values are means ± SEM from a minimum of three independent 
experiments. One-way ANOVA statistical analysis performed with Tukey post-test. No stars 
= not significant; * <0.05; ** <0.01; ***<0.001. 
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Figure 3-17: The Glycosylation moiety of C. jejuni flagella contributes to BMDC derived IL-
10 production 
1 x 106 BMDCs were co-cultured with (a) WT 11168H, ∆flaA, or flagella glycosylation 
mutant ∆Cj1324 or complement (b) WT 11168H, ∆flaA, or flagella glycosylation mutant 
∆Cj1316 at an MOI 100 for 24h. IL-10 levels were analysed by ELISA. Values are means ± 
SEM from a minimum of three independent experiments. One-way ANOVA statistical 
analysis performed with Tukey post-test. No stars = not significant; * <0.05; ** <0.01; 
***<0.001. 
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These observations suggested a potential role for the Pse5Ac7Am structure which is not 
complemented in the strain. This finding was confirmed with the ∆Cj1316 mutant, which 
also showed reduced IL-10 secretion when compared to the WT strain (Figure 3-17b). As 
there was no statistical difference between the ∆Cj1316 and ∆flaA mutant-mediated IL-10 
levels we hypothesised that the Pse5Ac7Am modification is a major component involved in 
the induction of IL-10.     
Reduction in IL-10 secretion was also seen when infections with the ∆flaA and ∆Cj1316 
mutants were conducted in human monocyte-derived DCs (Figure 3-18). This was an 
important observation, as it confirmed that findings in murine BMDCs can be extrapolated 
to human DCs, and therefore the use of BMDCs is an appropriate model to study C. jejuni 
flagella/host interactions. 
3.7 Discussion 
 Various surface determinants of C. jejuni are known to modulate adhesion/invasion and/or 
cytokine induction in IEC and innate immune cells (Bacon et al. 2001; Golden et al. 2004; 
van Sorge et al. 2009). The aim of the present study was to determine the role of three 
principal surface structures of C. jejuni in the modulation of DC responses.   
The ability of BMDCs to phagocytose and kill C. jejuni was confirmed in the present study 
(Figure 3-1). The data obtained was similar to published reports (Hu et al. 2008). This 
highlighted the inability of C. jejuni to replicate within DCs. To quantify intracellular viable 
bacteria the gentamicin protection assay was used. The seemingly low ratio of total 
intracellular bacteria/DC obtained by this assay may reflect a change in the culturability of 
bacteria once exposed to the phagosome/lysosome. However, the ratios obtained in this 
study were similar to previous reports (Rathinam, Hoag, & Mansfield 2008). Confocal 
microscopy would be useful to assess the total number of internalised bacteria, in 
comparison to the viable numbers assessed by the gentamicin protection assay. The 
reduced phagocytic capability of BMDCs seen at 24h most likely reflects the maturation 
process of the DCs, as it correlated with the upregulation of maturation markers (Figure 
3-3, Figure 3-7). In comparison to neutrophils and macrophages, DCs have reduced 
capability to acidify their phagolysosomes, which is critical to fulfil their primary role as 
antigen presenters opposed to pathogen killers (Savina et al. 2006).This likely accounts for 
why not all internalised bacteria are killed after 4h (Figure 3-1b). In contrast to DCs and 
macrophages, C. jejuni has been reported to survive in IECs for greater than 24h by 
avoiding delivery to the lysosome (Watson & Galan 2008). This is thought to be important  
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Figure 3-18: The Glycosylation moiety of C. jejuni flagella modulates human monocyte-
derived DC IL-10 protein  
1 x 105 human monocyte-derived DCs were stimulated with WT C. jejuni, ∆flaA, or ∆Cj1316 
mutants at an MOI 100 for 24h. Supernatants were assessed for IL-10 protein levels by 
ELISA. Values are means ± SEM from 3 donors. One-way ANOVA statistical analysis 
performed with Tukey post-test. * <0.05; ** <0.01.  
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in disease pathogenesis. The ability of DCs and other APCs to kill C. jejuni is likely to be 
critical in inhibiting dissemination of the bacterium throughout the body. This may aid the 
eventual clearance of the pathogen negating a chronic infectious state as seen in other 
pathogenic microbial infections, such as Mycobacterium tuberculosis, which is able to 
inhibit phago-lysosome fusion within APCs (Wolf et al. 2007). 
 Although the capsule of other pathogenic bacteria are known to aid evasion of 
phagocytosis, no change in the rate of C. jejuni phagocytosis was observed when a capsule 
isogenic mutant was utilised (Figure 3-2)(Evrard et al. 2010; Unkmeir et al. 2002). The 
capsule however is important for reduced serum sensitivity and invasion of IECs suggesting 
it does play a role in interactions with other host cells (Bacon et al. 2001) Professional APCs 
express a plethora of phagocytic receptors and redundancy between them is an essential 
part of the host-immune response. This redundancy may explain the lack of difference in 
phagocytosis observed between the WT and the isogenic mutants of the capsule, N-linked 
glycosylation system, and the flagella (Figure 3-2). 
Despite finding no differences in phagocytosis between the structural mutants and the WT 
strain, alteration in maturation marker and cytokine expression was observed (Figure 3-3, 
Figure 3-4, Figure 3-5, Figure 3-6). Figure 3-4 highlights a potential role for the CPS in the 
inhibition of IL-6 and IL-12 family members. An increase in IL-6, TNF-α, and IL-10 with the 
capsule mutant has subsequently been reported by Rose and colleagues (Rose et al. 2011) 
A component of the CPS, O-methyl phospharamidate (MeOPN), is important for C. jejuni 
virulence in the Galleria mellonella (wax moth) infection model (Champion et al. 2010). 
Whether C. jejuni CPS engages in specific glycan-binding receptors that suppress immune 
responses or alternatively masks underlying bacterial components from the host immune 
system remains to be determined.  
On human monocyte-derived DCs, the GalNAc binding receptor, Macrophage-Galactose-
type Lectin (MGL) can interact with C. jejuni N-linked glycosylated protein(s) leading to a 
reduction in IL-6 (van Sorge et al. 2009). However in the present study no significant 
differences were observed between the WT and N-linked glycosylation mutant strain in 
BMDCs (Figure 3-5). Although BMDCs do express the murine orthologs of human MGL, 
MGL1 and MGL2, whether these receptors have the same modulatory effects on DC 
function as the human counterpart remains unknown and may explain the lack of 
observable difference (Denda-Nagai et al. 2010).   
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Due to specific mutations in its primary amino acid sequence, C. jejuni FlaA protein can no 
longer be recognised by TLR5 (Andersen-Nissen et al. 2005). It was therefore interesting to 
find that the flagella mutant, ∆flaA, induced ~50% less IL-10 than the WT strain whilst IL-6, 
TNF-α, and IL-12 family member cytokine levels were unaffected (Figure 3-6). This data 
clearly indicated that C. jejuni flagellin may be interacting with other, as yet unknown 
receptors to modulate IL-10 expression. IL-10 is a critical cytokine in gut homeostasis, and 
IL-10 deficient mice develop spontaneous colitis (Kuhn et al. 1993). Due to the potent anti-
inflammatory effects of IL-10 it is interesting to speculate that the specific modulation of IL-
10 by C. jejuni is an immune-evasion strategy. In addition, the ∆flaA mutant induced less IL-
1β suggesting a potential role for the NLR IPAF which recognises intracellular flagellin, in C. 
jejuni-mediated IL-1β secretion (Miao et al. 2010b). Investigation of the potential effect of 
C. jejuni-BMDC crosstalk in IL-1β secretion is reported in Chapter 4. In agreement with 
these findings it has subsequently been reported by Rose and colleagues that the ∆flaA 
mutant does indeed induce less IL-10 compared to the WT strain, accompanying only a 
minor reduction in pro-inflammatory cytokines (Rose et al. 2011).  
 Although all three MAPKs are linked to the induction of pro-inflammatory cytokines and 
maturation markers in DCs, p38 and JNK appear to be more critical for these functions 
(Escors et al. 2008;Miao et al. 2010b). It was therefore surprising to find a trend towards 
enhanced IL-1β production in the presence of p38 inhibitors (Figure 3-13). This may be 
explained by the intricate cross-talk that occurs between MAPK pathways. p38 causes the 
phosphorylation and inhibition of the regulatory subunit of a complex containing the 
MAP3K TAK-1, a MAP3K involved in the activation of p38, JNK, and NF-κB (Cheung et al. 
2003). Therefore, p38 inhibition can lead to an increase in JNK phosphorylation and NF-κB 
activation, this enhances inflammatory responses. This is just one example that highlights 
the challenge in dissecting the role of individual MAPKs in DC function. The reduction of C. 
jejuni-induced IL-10 production by p38 inhibition may be linked to another regulatory step 
in the MAPK signalling web, i.e. activation of the kinases MSK1 and MSK2 (Figure 3-13). 
Downstream of p38 and ERK, MSK1 and MSK2 activate the transcription of DUSP1 (a 
regulatory phosphatase of MAPKs) and IL-10, creating a negative feedback loop on the 
activation of these two MAPKs (Ananieva et al. 2008). This may also explain the reduction 
in IL-10 observed under MEK1/2 inhibition (Figure 3-13). Both ERK and p38 signalling 
pathways have been implicated in the induction of IL-10 (Ma et al. 2001; Saraiva and 
O'Garra 2010). Interestingly, previous reports show TLR stimulation in the presence of ERK 
and p38 inhibitors almost completely abolishes IL-10 secretion suggesting these pathways 
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combine to induce IL-10 in DCs and macrophages (Saraiva & O'Garra 2010). A dependence 
on ERK and p38 for IL-10 induction may also explain why the ∆flaA mutant affects p38 
signalling, and IL-10 induction (Figure 3-9; Figure 3-10; Figure 3-6). A minimal effect on 
other signalling pathways, such as NF-κB, may explain why the ∆flaA and MAPK inhibitors 
failed to impact on IL-12 family members (Figure 3-6; Figure 3-13).   
The use of a secretion positive (∆flaA) and secretion negative (∆rpoN) flagella mutant 
strains revealed that proteins secreted from C. jejuni flagella play no role in IL-10 induction 
(Figure 3-16). Use of C. jejuni flagella glycosylation mutants implied that the carbohydrate 
modification of C. jejuni flagellin protein, FlaA, is involved in modulating BMDCs and human 
monocyte-derived DC IL-10 levels (Figure 3-17; Figure 3-18).  In particular, the Pse5Ac7Am 
moiety appeared to be critical. Pse and Leg are structurally related to sialic-acid. Siglecs are 
receptors that engage sialic acid both on host cells and microorganisms and are generally 
regarded as immunomodulatory (Crocker, Paulson, & Varki 2007; Crocker & Redelinghuys 
2008). It has been suggested that interaction between pathogens and host Siglecs 
receptors may promote mechanisms involved in immune evasion, including the induction 
of IL-10 (Ando et al. 2008). We next wished to delineate any potential cross-talk between 
Pse and Leg-linked C. jejuni flagella and Siglec receptors, interactions that remain largely 
unexplored in C. jejuni-mediated disease pathogenesis.            
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Chapter 4.  
Recognition of C. jejuni by innate 
immune cells is both TLR-dependent 
and TLR-independent 
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4.1 Background 
The activation of PRRs leads to a wide plethora of cellular phenotypic changes; changes 
that depend on the PRR engaged, and in addition the specificity of the ligand involved. 
PRRs can both activate and modulate immune signalling within DCs. The most widely 
studied PRRs are the TLRs, which are critical for stimulating inflammatory responses via the 
activation of MAPK, NF-κB, and IRF3 signalling pathways. In comparison the role of other 
PRRs such as glycan binding receptors in pathogen recognition and host defence is just 
starting to be appreciated. Additionally, the role of intracellular PRRs such as the NLR family 
in activation of the inflammasome which aids pathogen clearance has recently gained 
attention in innate immune research. 
TLR2 and TLR4 are important for the recognition of C. jejuni by BMDCs (Rathinam et al. 
2009). TLR4 signalling is particularly crucial for the induction of IL-12, IL-6, and TNF-α; 
however the role of TLR signalling in IL-10 responses has not been reported.  Our 
observations (Chapter 3) suggested that the C. jejuni flagellin protein, FlaA, and in 
particular the pse5Ac7Am modification on the flagellin monomers may be important for 
the induction of IL-10. Mutations in the C. jejuni FlaA protein (also seen in other ε-
proteobacteria FlaA proteins) results in a PAMP that is unable to bind to its cognate TLR; 
TLR5 (Andersen-Nissen et al. 2005). The only other known PRR for flagellin protein is the 
NLR member, IPAF (NLRC4). IPAF is also capable of detecting the type three secretion 
system (TTSS) of multiple pathogens (Miao et al. 2010b). The mechanism for this multi-
specificity involves the detection of either flagellin or TTSS rod proteins by different NLR 
family Apoptosis Inhibitory Protein (NAIP) members upstream of IPAF which upon ligand 
binding induce interaction between NAIPs and IPAF causing the activation of the 
inflammasome (Zhao et al. 2011). NAIP5 is the intracellular receptor for flagellin proteins 
for Salmonella and Legionella and most likely may interact with other bacterial species. 
Mutational studies have identified specific amino acid residues in the carboxyl-terminal of 
flagellin protein that are involved in mediating IPAF-dependent inflammasome activation 
(Miao et al. 2010b). No studies to date have analysed if and how Campylobacter sp. 
activates the inflammasome.  
Candidate receptors for the engagement of these sialic-acid like structures include the 
Siglec family of glycan receptors. In a previous study the ability of C. jejuni to bind to Siglec-
10 was reported; this interaction was considered to be independent of sialylated LOS as the 
C. jejuni/Siglec-10 interaction was not sensitive to sialidase treatment and purified LOS did 
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not bind the receptor (Avril et al. 2006). However, as the LOS is the only known sialylated 
structure on C. jejuni it was concluded that this interaction was likely to be non-specific 
(Professor Paul Crocker, University of Dundee; personal communication). The ability of 
sialic-acid like structures on the flagella to engage Siglec-10 remains unclear. Although sialic 
acids are the best characterised ligands for Siglecs, recent emerging data suggests that 
multiple ligands may bind and activate Siglec receptors (Carlin et al. 2009a; Kivi et al. 2009). 
The 9-carbon pseudaminic acid (Pse) and legionaminic acid (Leg) share many of the 
reported critical residues required for binding to the Siglec sialic-acid binding pocket (May 
et al. 1998). Recognition of structures similar to Neu5Ac by Siglecs has not been extensively 
studied. A single report found discrepancy between human and chimpanzee Siglec-9, which 
have greater affinities for Neu5Ac and Neu5Gc respectively, as during evolution of higher 
primates humans have lost the ability to produce Neu5Gc (Sonnenburg et al. 2004).  
4.2      TLR signalling is essential for the activation of BMDCs in 
response to C. jejuni 
TLR signalling is essential for the activation of APCs in response not only to a plethora of 
microbes but also to endogenous danger ligands, DAMPs. At the start of this study, little 
was known of the role of TLR engagement in C. jejuni-mediated DC activation; although the 
ability of C. jejuni CPS to stimulate IEC TLR2 leading to IL-6 production was known (Friis, 
Keelan, & Taylor 2009). MyD88 and TRIF are two essential adaptor molecules for TLRs 1, 2, 
4, 5, 6, 7, 8, 9, and TLR 3, 4 respectively (Takeda et al. 2003). TLR4 is the only TLR known to 
utilise both MyD88 and TRIF adaptor molecules.  To investigate a potential role for TLR 
signalling in DC responses to C. jejuni, BMDCs were generated from singular and combined 
double knock-outs (DKO) in the two adapter molecules (MyD88-/-, TRIF-/-, MyD88-/- TRIF-/-
(DKO) and WT). Co-cultures studies were performed and DC cellular processes including 
phagocytosis, the regulation of maturation markers, cytokine secretion, and signalling 
pathways were analysed.  
TLR signalling increases rate of macropinocytosis (West et al. 2004). It was therefore 
essential to assess the rate of C. jejuni phagocytosis in the knock-out cells prior to 
commencing detailed analysis. Figure 4-1 shows abolishing TLR signalling did not alter the 
rate of uptake of C. jejuni as measured 4h post-infection. This data indicated that TLR 
signalling may not be essential for early internalisation of C. jejuni. 
The upregulation of maturation markers, CD40 and CD80, in WT BMDCs in response to C. 
jejuni infection was similar to results reported in Chapter 3 (Figure 3-3); a ~2-fold increase  
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Figure 4-1: TLR signalling does not alter C. jejuni phagocytosis by BMDC  
2 x10 5 BMDCs from WT (WT), TRIF-/-, MyD88-/-, and TRIF-/-MyD88-/- double knock-out (DKO) 
were co-cultured with C. jejuni 11168H MOI 100 for 4h. Viable intracellular bacterial 
numbers were enumerated by the gentamicin protection assay. Values are means ± SEM. 
One-way ANOVA statistical analysis performed with Tukey post-test. No stars = not 
significant.  
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in the MFI of both markers was observed (Figure 4-2). The upregulation of CD40 in both 
MyD88-/- and TRIF-/- DC was ~ 50% of the response to that seen in WT DCs. Co-culture with 
the DKO resulted in no upregulation of CD40 (p=0.03). A similar phenotype was also 
observed for CD80, both single mutations approximately halved the induction of CD80 
whereas the DKO completely abolished upregulation. Upregulation of CD40 and CD80 in 
response to the LPS control was very similar to live C. jejuni. This pattern suggested a 
combined impact of both MyD88- and TRIF-dependant TLR signalling pathways in the 
induction of CD40 and CD80, and that these signalling adaptors may act in an additive 
manner in mediating regulation of CD40 and CD80. 
The activation of TLRs is known to drive differential cytokine expression (Sing et al. 
2002;Takeda, Kaisho, & Akira 2003). It was therefore important to study the cytokine 
expression profiles induced by C. jejuni in the different KO cells (Figure 4-3). LPS mediates 
TLR signalling via TLR4 which utilises both TRIF and MyD88 adaptor molecules and was 
therefore included as a control. Marked increase in IL-6 was observed in WT BMDCs upon 
infection, similar to those reported in Chapter 3 (Figure 4-3a; Figure 3-4). A trend for 
decreased IL-6 induction was noted in TRIF-/- BMDCs but this gained greater significance in 
the MyD88-/- BMDCs. Complete abrogation of IL-6 was seen in DKO BMDCs. LPS-mediated 
IL-6 was more markedly reduced in TRIF-/- BMDCs than for C. jejuni. However, similar to C. 
jejuni-stimulation, a greater reduction in LPS-mediated IL-6 was noted in MyD88-/- 
compared to TRIF-/- BMDCs. Together data suggested greater dependence on MyD88 
signalling for the induction of IL-6 by C. jejuni whereas LPS induced IL-6 required both 
signalling pathways.  
Conversely, IL-1β secretion depended on the signalling of both TRIF and MyD88 pathways 
(Figure 4-3b). A similar reduction of IL-1β levels was observed in both single and double KO 
cells for both C. jejuni and LPS stimulation. ~50% reduction in IL-12 levels was observed in 
TRIF-/- and MyD88-/- BMDCs, the cytokine was undetectable in DKO BMDCs (Figure 4-3c). IL-
23 levels were below the detection threshold for both C. jejuni stimulated single and 
double KO BMDCs (Figure 4-3d). Interestingly, C. jejuni-mediated IL-10 levels were not 
significantly reduced in the TRIF-/- BMDCs, whereas it was completely abolished in the 
MyD88-/- and DKO cells (Figure 4-3e). In contrast LPS-mediated IL-10 secretion was affected 
by both TRIF and MyD88 signalling pathways. These observations suggested a cumulative 
effect of MyD88 and TRIF signalling in IL-12 release by C. jejuni in contrast, IL-10 secretion 
was solely MyD88-dependent. 
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Figure 4-2: TLR signalling is essential for C. jejuni-mediated induction of BMDC maturation 
markers 
1 x 106 BMDCs generated from WT (WT), TRIF-/-, MyD88-/-, and TRIF-/-MyD88-/- double 
knock-out (DKO) mice were co-cultured with C. jejuni 11168H MOI for 24h. CD40 and CD80 
expression levels were assessed by flow cytometry. (a) Representative histograms from 
three independent experiments are shown. Isotype control (dashed line), unstimulated 
cells (solid grey), and C. jejuni stimulated levels (back line).  (b) Fold increases in MFI from 
the unstimulated cells. Values are means ± SEM. Paired t-test statistical analysis performed 
to compare specific columns.  
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Figure 4-3: TLR signalling is essential for C. jejuni-mediated BMDC pro- and anti-
inflammatory cytokine responses 
1 x106 WT, TRIF-/-, MyD88-/-, and DKO BMDCs were co-cultured with C. jejuni 11168H at an 
MOI 100 for 24h. Cytokine analyses was performed by ELISA for IL-6 (b) IL-1β (c) IL-12 (d) IL-
23 (e) IL-10. Values are means ± SEM from a minimum of three independent experiments. 
One-way ANOVA statistical analysis performed with Tukey post-test. No stars = not 
significant; * <0.05; ** <0.01; ***<0.001. 
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As MAPK activation is important in the induction of certain cytokines by C. jejuni (Figure 
3-13), and is downstream of TLRs (Takeda, Kaisho, & Akira 2003), we next wished to 
establish the impact of the absence of TLR signalling on C. jejuni-mediated MAPK activation 
(Figure 4-4). Interestingly, early activation of ERK was unaffected in the KO cells, however 
strong ERK signalling at 2h post-infection was only observed in the WT and TRIF-/- BMDCs. 
The DKO and MyD88-/- cells showed a similar pattern of early weak activation to C. jejuni 
but a lack of subsequent strong ERK activation at 2h. JNK activation was observed at 1h 
post-infection, with strong signalling at 2h. JNK phosphorylation was completely abolished 
in the DKO cells highlighting the necessity of TLR signalling for JNK activation. In TRIF-/- 
BMDCs JNK activation followed the same kinetics as the WT cells, however in MyD88-/- cells 
JNK activation was delayed being only detectable at 2h post-infection. In WT cells p38 
phosphorylation was detectable at 1h and 2h post-infection. Similarly to JNK signalling, p38 
phosphorylation was completely abolished in the DKO cells. Mirroring JNK activation, in 
TRIF-/- BMDCs kinetics of p38 phosphorylation was similar to that seen in WT cells. In 
contrast, p38 activation was completely abrogated 2h post-infection in MyD88 KO DCs. It is 
worth noting that the MyD88-dependent signalling appeared to alter all three MAPK 
pathways to a greater extent than TRIF-dependent signalling, and correspondingly MyD88 
seemed to have a greater potential role in the induction of specific cytokines, in particular 
IL-6 and IL-10.  
Taken together our observations suggested that C. jejuni-mediated BMDC cytokine 
responses were TLR-dependant. This raised a conundrum as to how C. jejuni flagella 
mediates IL-10 production and is yet not recognised by TLR5 (Andersen-Nissen, Smith, 
Strobe, Barrett, Cookson, Logan, & Aderem 2005). There have been multiple examples of 
pathogens interacting with carbohydrate binding receptors that modulate TLR signalling, 
often for the pathogens advantage (Gringhuis et al. 2007; Gringhuis et al. 2009). We 
hypothesised that glycosylated moiety of C. jejuni flagella interacts with as yet unidentified 
host receptors leading to modulation of IL-10 responses. We therefore assessed the ability 
of C. jejuni glycosylated flagella to interact with carbohydrate receptors independent of 
TLRs. 
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Figure 4-4: TLR signalling is essential for C. jejuni-mediated MAPK activation  
1 x 106 WT, TRIF-/-, MyD88-/-, and DKO BMDCs were co-cultured with C. jejuni 11168H MOI 
100 for the indicated time-points. Lysates were subjected to SDS-PAGE followed by 
Western blot analysis for the phosphorylated forms of p38, ERK, and JNK. Blots were 
stripped and probed for total ERK as a loading control. Blots are representative of two 
independent experiments. 
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4.3 Siglec-10 binds derivatives of Pseudaminic acid, components of 
C. jejuni flagella    
In 2006 a report indicated that C. jejuni binds to Siglec-7 via α2,8- linked sialic acid residues 
found on C. jejuni LOS (Avril et al. 2006). The authors also found two C. jejuni strains were 
able to bind to Siglec 10-Fc chimeras. As the interaction was not sialidase-sensitive the 
authors speculated that the interaction between the C. jejuni strains and Siglec-10 was non-
specific and therefore did not investigate this phenomenon any further. Here, the possible 
role of Siglec-10 in the binding of derivative of pseudaminic acid (Pse) structures present on 
C. jejuni flagella was explored. Siglec-10 is the human ortholog of Siglec-G which is 
expressed on murine BMDCs (Chen et al. 2009; Ding et al. 2007). Siglec-10 and Siglec-G 
share high sequence identity and conserved protein structure (Angata et al. 2001).  
Before undertaking binding assays the expression of Siglec-10 on human monocyte-derived 
DCs was firstly confirmed by flow cytometry (Figure 4-5) (Li et al. 2001). To investigate 
potential C. jejuni-Siglec-10 interactions, CHO cells overexpressing Siglec receptors were 
utilised. Siglec-7 is known to bind to C. jejuni bearing α2,8-linked sialylated LOS. 99% of 
Siglec-7 overexpressing cells expressed the receptor (Figure 4-6a) and ~80% of Siglec-10 
CHO cells expressed Siglec-10 (Figure 4-6b). WT CHO cells expressed neither Siglec-7 nor 
Siglec-10. To perform binding assays, C. jejuni strains were labelled with fluorescein 
isothiocyanate (FITC) for 1h at 37oC. C. jejuni strains WT, ∆flaA and ∆Cj1316 were all 
labelled with FITC to the same extent (Figure 4-7). Sialidase treatment of Siglec 
overexpressing CHO cells is routinely performed in binding assays to eliminate cis-
interactions between Siglecs and sialic acid found on the cell surface as this interaction 
reduces binding of Siglecs to ligands in trans (Avril et al. 2006). Optimisation assays were 
initially performed with Siglec-7 overexpressing CHO cells with C. jejuni strains GB11 and 
GB19, strains known to express α2,3-linked  and α2,8-linked sialic acid on their LOS 
respectively. Siglec-7 CHO cells were pre-treated with 0.1U/mL C. perfringens sialidase for 
1h to remove sialic acid prior to exposure to C. jejuni GB11 and GB19 at an MOI 100 for 2h 
at 4oC.  Differential binding pattern to siglec-7 CHO cells was observed between the two 
strains (Figure 4-8). Incubation at 4oC prevents endocytosis and bacterial uptake, therefore 
the data depicted Siglec-ligand binding alone.  
WT 11168H C. jejuni bound specifically to sialidase-treated Siglec-10 CHO cells compared to 
WT CHO cells (Figure 4-9a). Bacterial binding index (BBI) is a value derived from multiplying 
the percentage of CHO cells bound with FITC labelled bacteria by the geometric mean  
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Figure 4-5: Siglec-10 is expressed on human monocyte-derived DCs 
A representative histogram of human monocyte-derived DCs were stained with primary 
mouse monoclonal antibody, 5G6, and PE-conjugated donkey anti-mouse secondary 
antibody (black line), or secondary antibody alone (solid grey line). Histograms are 
representative of three independent experiments. 
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Figure 4-6: Siglec-CHO overexpressing cells specifically express Siglec-10 and Siglec-7  
WT and Siglec-overexpressing CHO were stained for Siglec expression and analysed by flow 
cytometry (a) WT CHO cells stained with anti-siglec-10 (b) siglec-10 CHO cells stained with 
anti-siglec-10 (c) WT CHO cells stained with anti-siglec-7 (d) siglec-7 CHO cells stained with 
anti-siglec-7. Data are representative histograms from two independent experiments. 
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Figure 4-7: FITC labelling of C. jejuni  
3 x 109 CFU/mL [(a) WT (b) ∆flaA (c) ∆Cj1316] C. jejuni were mixed 1:1 with a saturated FITC 
solution for 1h  at 37oC. Labelling of bacteria was subsequently assessed by flow cytometry. 
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Figure 4-8: C. jejuni strain GB19 binds specifically to Siglec-7  
Potential Siglec-CHO cells and C. jejuni interactions. Optimisation studies; 3 x 105 sialidase-
treated WT or siglec-7 expressing CHO cells were incubated with FITC-labelled C. jejuni 
strains GB11 or GB19 at an MOI 100 for 2h at 4oC. Binding was analysed by flow cytometry. 
Histograms are representative of two individual experiments. 
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fluorescence intensity (MFI) of the positive population. BBI gives an indication of the level 
of bacterial binding to the CHO cells (Avril et al. 2006). The BBI used in this study is a slight 
revision from previous studies as it uses the geometric mean rather than the mean 
fluorescence intensity because the population was normally distributed on a logarithmic 
scale.   
Figure 4-9b shows a trend towards an increase in BBI value with sialidase treatment of the 
siglec-10 CHO cells. As only 80% of Siglec-10 CHO cells express the receptor this enabled a 
more detailed analysis of which cells specifically bound C. jejuni. Siglec-10 CHO cells were 
counter stained with Siglec-10 after a 2h co-culture. Figure 4-10 shows a doubling in the BBI 
value with the Siglec-10 positive cells over Siglec-10 negative cells. This value is less than 
the binding seen in Figure 4-9. One possible explanation is the additional wash steps in the 
counterstaining removes many of the bound bacteria. The binding of 11168H to Siglec-10 
CHO cells could be specifically inhibited with the addition of a polyclonal anti-siglec-10 
antibody (Figure 4-11), whereas the irrelevant polyclonal anti-Siglec-5 antibody made no 
impact on bacterial binding.  
C. jejuni strain 11168H contains only internal α2,3-linked sialic acid residues on its LOS, and 
is therefore not predicted to bind to any known Siglec. Binding assays were performed with 
various sialic-acid family mutants of C. jejuni 11168H to determine the critical moieties 
involved in interacting with Siglec-10. Figure 4-12a shows representative histograms of C. 
jejuni WT and isogenic mutant strain interactions with Siglec-10 CHO cells. The top four 
histograms show comparable binding of the WT and isogenic mutants to WT CHO cells. The 
lower four histograms show WT C. jejuni can bind to Siglec-10 cells as seen in Figure 4-9. In 
addition the ∆waaF mutant (which expresses a truncated LOS structure and therefore lacks 
the sialic acid residue on the LOS) bound to Siglec-10 CHO cells signifying that the LOS sialic 
acid is not critical for Siglec-10 engagement. Conversely both the flagella mutant, ∆flaA, 
and flagella Pse5Ac7Am mutant, ∆Cj1316, showed comparable binding to Siglec-10 and WT 
CHO cells. Differences in binding of the WT 11168H and Pse5Ac7Am mutant strain to 
Siglec-10 CHO cells was found to be statistically significant (p <0.01; Figure 0.12b). These 
observations suggest potential novel interaction(s) between the Pse5Ac7Am modifications 
(or derivatives of) on C. jejuni flagella and host Siglec-10 receptors.        
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Figure 4-9: C. jejuni 11168H binds to Siglec-10 overexpressing CHO cells  
3 x 105 sialidase-treated (S-treat) WT, un-treated siglec-10 overexpressing, or sialidase-
treated siglec-10 overexpressing CHO cells were mixed with FITC-labelled C. jejuni strain 
11168H MOI 100 for 2h  at 4oC. Binding was analysed by flow cytometry. (a) Both WT and 
Siglec-10 cells were sialidase treated. Histograms are representative of six independent 
experiments. (b) Bacterial binding index was calculated by the percentage of CHO cells 
bound with FITC labelled bacteria by the geometric MFI of this population. Values are 
means ± SEM from a minimum of three independent experiments. One-way ANOVA 
statistical analysis performed with Tukey post-test. No stars = not significant; * <0.05; ** 
<0.01; ***<0.001. 
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Figure 4-10: C. jejuni binds specifically to Siglec-10 overexpressing CHO cells 
3 x 105 sialidase-treated Siglec-10 overexpressing CHO cells were mixed with FITC-labelled 
C. jejuni strain 11168H MOI 100 for 2h at 4oC. Cells were counter-stained with monoclonal 
5G6 anti-siglec-10 primary antibody and PE-secondary antibody. Cells were analysed by 
flow cytometry. (a) Representative dot plot of four individual experiments. Values are 
percentages within the individual quadrants (b) Mean values ± SEM for the bacterial 
binding index of the siglec-10 negative and positive populations.    
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Figure 4-11: Polyclonal antibodies specifically inhibit C. jejuni binding to Siglec-10 cells  
3 x 105 sialidase-treated (a) WT CHO cells (b) sialidase-treated siglec-10 CHO cells (c) 
sialidase-treated siglec-10 CHO cells in the presence of 10µM polyclonal antibody anti-
Siglec 10 (Ab) (d) sialidase-treated siglec-10 CHO cells in the presence of 10µM irrelevant 
polyclonal anti-Siglec 5 Ab  mixed with FITC-labelled C. jejuni strain 11168H MOI 100 for 2h 
at 4oC. Binding was analysed by flow cytometry. Histograms are representative of two 
independent experiments. (e) Mean bacterial binding index values ± SEM from two 
independent experiments. 
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Figure 4-12: Pseudaminic acid structures on C. jejuni flagella mediate Siglec-10 binding 
3 x 105 sialidase-treated WT or Siglec-10 CHO cells with FITC-labelled WT C. jejuni strain 
11168H, or isogenic mutant strains ∆flaA, ∆Cj1316, ∆waaF MOI 100 for 2h at 4oC. Binding 
was analysed by flow cytometry. (a) Histograms are representative of three independent 
experiments. (b) Mean bacterial binding index values ± SEM from six independent 
experiments. One-way ANOVA statistical analysis performed with Tukey post-test. No stars 
= not significant; * <0.05; ** <0.01; ***<0.001. 
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4.4 C. jejuni-mediated inflammasome activation is IPAF-
independent 
The ∆flaA flagellin mutant of C. jejuni 11168H strain induces significantly less IL-1β 
secretion than the WT strain (Figure 3-6). IPAF (NLRC4) is an intracellular NLR that 
recognises the flagellin protein and the type III secretion apparatus of bacteria (e.g. 
Salmonella typhimurium), this interaction initiates a cascade culminating in caspase-1 
activation and secretion of bioactive IL-1β and IL-18 (Franchi et al. 2006; Miao et al. 2010b). 
Amino acid alignment revealed that the C. jejuni FlaA protein contains critical amino-acids 
required for the activation of IPAF (Figure 4-13a) (Miao et al. 2010b), we therefore tested 
the ability of C. jejuni to activate the inflammasome (caspase-1 cleavage) via IPAF and other 
NLR proteins.  
Activation of the inflammasome can also induce pyroptosis, an alternative form of cell 
death to apoptosis and necrosis (Miao et al. 2010a). Trypan blue exclusion revealed 
minimal cell death in BMDCs as a consequence of co-culture at an MOI 100 for 24h 
suggesting pyroptosis is unlikely being induced by C. jejuni (data not shown). To decipher 
the potential crosstalk between C. jejuni and the inflammasome machinery, infections were 
conducted in BMDCs lacking individual NLRs, this included IPAF, NALP3, and ASC KO 
BMDCs. Phagocytosis rates after a standard 2h co-culture revealed comparable levels of 
uptake between the inflammasome mutants and WT BMDCs (Figure 4-13a). The 
bactericidal activities of the different mutants were also comparable to the WT cells; all 
internalised bacteria were killed by 24h post-infection (Figure 4-13b). This data showed 
efficient killing of internalised C. jejuni was independent of IPAF-, NALP3- and ASC-
dependent inflammasome activation. 
The ability of C. jejuni to induce IL-1β secretion was almost completely abrogated in the 
NALP3- and ASC-deficient BMDCs (Figure 4-14). In IPAF-/- BMDCs IL-1β secretion levels were 
comparable to WT in response to both C. jejuni- or LPS-stimulation, suggesting that IPAF 
plays a minimal role in IL-1β responses during C. jejuni infection (Figure 4-14a). 
Interestingly, LPS stimulation alone induced ~50% of IL-1β levels as C. jejuni despite being 
an inflammasome-independent PAMP. Western blot analysis revealed the 31KDa pro-IL-1β 
was induced to comparable levels between the different inflammasome KO cells (Figure 
4-14b). A faint 17KDa band (corresponding to the bioactive cleaved IL-1β) was visible at 4h 
and 8h post-infection in WT and IPAF-/- but not in NALP3-/- and ASC-/- BMDCs, which  
(a) 
124 
 
532 RDVDFAAESANYSKANILAQSGSYAMAQANSVQQNVLRLLQ 572 
   . | . | : | . | . : | . | : | . | | . | : | : . . : | | | | . | . | | | | . | | :  
332 EDSDYATEVSNMSRAQILQQAGTSVLAQANQVPQNVLSLLR 372    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-13: ASC, NALP3, and IPAF do not alter bactericidal activity of BMDCs  
(a) Sequence alignment for C-terminal C. jejuni FlaA (top line) and S. typhimurium FliC 
(bottom line). Known critical residues for IPAF recognition are underlined (Miao et al. 
2010b) (b) 2 x10 5 WT (WT), ASC-/-, NALP3-/-, and IPAF-/- BMDCs were co-cultured with C. 
jejuni 11168H MOI 100 for 4h. Viable intracellular bacterial numbers were enumerated by 
the gentamicin protection assay. Values are means ± SEM. (c) 2 x10 5 WT (WT), ASC-/-, 
NALP3-/-, and IPAF-/- BMDCs were co-cultured with C. jejuni 11168H MOI 100 for 2h and 
incubated in media containing gentamicin for the indicated time-points. Viable intracellular 
bacterial numbers were enumerated by the gentamicin protection assay. Values are means 
± SEM. Survival values are given as a percentage of the bacterial numbers enumerated at 
the 0h time point. 
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Figure 4-14: ASC and NALP3 but not IPAF are essential for the IL-1β secretion in response 
to C. jejuni 
1 x106 WT, ASC-/-, IPAF-/-, and NALP3-/- BMDCs were co-cultured with C. jejuni 11168H at an 
MOI 100. (a) IL-1β secretion was analysed by ELISA 24h post-infection. Values are means ± 
SEM from four independent experiments. (b) Lysates were subjected to SDS-PAGE followed 
by Western blot analysis using an antibody that recognizes both the pro- and cleaved- form 
of IL-1β. Western blots are representative of three independent experiments. One-way 
ANOVA statistical analysis performed with Tukey post-test. No stars = not significant; * 
<0.05; ** <0.01; ***<0.001. 
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confirmed the ELISA data (Figure 4-14). As a control, the supernatants from stimulated 
inflammasome KO cells were analysed for the secretion of IL-10. Figure 4-15 shows that the 
inflammasome KO cells were capable of secreting IL-10 in response to C. jejuni to 
comparable levels as those seen with WT BMDCs. Collectively this data indicated that C. 
jejuni flagella did not engage with IPAF in mediating inflammasome activation. In contrast, 
a dependence on NALP3 and ASC was documented.  
4.5 C. jejuni activated BMDCs promote Th1 mediated immunity  
We and others have previously shown that C. jejuni promotes Th1 and Th17 responses in 
human and mouse DC/T cell co-culture systems (Edwards et al. 2010; Rathinam, Hoag, & 
Mansfield 2008). In this study the role and contribution of the flagella in the activation of T 
cell responses was elucidated (Figure 4-16). BMDCs were infected for 24h with WT, ∆flaA, 
or 100ng/mL C. jejuni LOS. After gentamicin treatment the BMDCs were co-cultured for 4 
days with freshly isolated naïve CD4+ T-cells from the spleen in the presence of activating 
anti-CD3 beads. Supernatants were subsequently analysed for the presence for the Th1 
cytokine, IFNγ, the Th2 cytokine, IL-4, and the Th-17 cytokine, IL-17A. In control 
experiments neither BMDCs nor T cells alone secreted significant levels of these cytokines 
(data not shown). Naïve T cells cultured with uninfected BMDCs secreted detectable levels 
of IFNγ, IL-4, and IL-17A (Figure 4-16). Interestingly, WT C. jejuni induced higher levels of 
IFNγ above the unstimulated control although this was not statistically significant. The 
flagella mutant ∆flaA induced similar levels of IFNγ as the WT strain, showing the induction 
of Th1 responses was independent of the flagella. This was largely expected as the levels of 
the Th1 polarising cytokine, IL-12 was similar between the WT and mutant strain (Figure 
3-6) although minor differences in the level of the maturation marker CD40 had been 
observed. Both WT and ∆flaA strains failed to induce IL-4 and IL-17A levels above the levels 
of the unstimulated control. IL-17A in the unstimulated control were high (>1000pg/mL) 
which may explain why the bacterium failed to induce IL-17A unlike the reported induction 
in the human co-culture system (Edwards et al. 2010). This data showed a propensity of C. 
jejuni-stimulated BMDCs to induce Th1 polarisation independent of the flagella.         
4.6 Discussion 
At the start of this study little was known as to how Campylobacter jejuni triggers TLRs to 
drive inflammatory responses in innate immune cells. It was interesting to find a complete 
dependence in BMDCs on TLR signalling for the induction of maturation markers and 
cytokine secretion in response to C. jejuni (Figure 4-3, Figure 4-2). The importance of TLR4  
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Figure 4-15: IPAF plays no role in the induction of IL-10 by C. jejuni flagella 
1 x106 WT, ASC-/-, and IPAF-/- BMDCs were co-cultured with C. jejuni 11168H at an MOI 100 
or LPS (1µg/mL) for 24h. IL-10 levels were assessed by ELISA. Values are means ± SEM from 
three independent experiments. One-way ANOVA statistical analysis performed with Tukey 
post-test. No stars = not significant.   
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Figure 4-16: C. jejuni drives Th1 responses independent of the flagella  
CD4+ naïve T-cells were co-cultured for 4 days with BMDCs pre-stimulated with WT C. 
jejuni, ∆flaA, or C. jejuni LOS (100ng/mL). (a) IFNγ (b) IL-4 (c) IL-17A levels were analysed by 
ELISA. Values are means ± SEM from four independent experiments.  One-way ANOVA 
statistical analysis performed with Tukey post-test. No stars = not significant. 
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(MyD88- and TRIF-dependent) and TLR2 (MyD88-dependent) in the recognition of C. jejuni 
by BMDCs has since been reported (Rathinam et al. 2009). A dependency for both TLR4 and 
TLR2 signalling was required for the induction of both maturation markers and pro-
inflammatory cytokines, although TLR4 signalling was shown to have a greater impact than 
TLR2 in these pro-inflammatory responses. Interestingly, live C .jejuni is a poor stimulator of 
TLRs whereas as lysed bacteria are potent stimulators of TLR4 and TLR1/2/6 (de Zoete et al. 
2010). Differential dependency for either MyD88- or TRIF- signalling was observed for the 
secretion of various cytokines (Figure 4-3). The necessity of TLR signalling for the induction 
of IL-10 was previously unknown, and it was interesting to find a complete dependence on 
MyD88 signalling for its induction (Figure 4-3e). The ability of TLR4 to trigger both MyD88 
and TRIF signalling whereas other potential TLRs in the recognition of C. jejuni trigger only 
MyD88 signalling suggested that IL-10 induction is most likely TLR4-independent or solely 
driven by the TLR4-MyD88 axis. TLR2 signalling is known to be important for IL-10 secretion 
triggered by other pathogens or microbial stimuli (Manicassamy et al. 2009; Sing et al. 
2002). C. jejuni CPS has been implicated in the secretion of IL-6 by IECs via TLR2, although 
the purity of the CPS maybe questionable as complete removal of other microbial products 
such as LOS and lipoproteins during CPS purification remains challenging (Friis, Keelan, & 
Taylor 2009). The CPS isogenic mutant ∆kpsM did not influence IL-10 secretion negating a 
role for this bacterial structure in its regulation (Figure 3-4). The surface lipoprotein, JlpA, 
binds to IECs and triggers pro-inflammatory cytokine induction (Jin et al. 2003), and has 
been proposed to be the ligand for TLR2 recognition of C. jejuni (Rathinam et al. 2009).The 
shared dependency on TRIF- and MyD88-signalling for the induction of maturation markers 
and IL-12 family cytokines suggests TLR4 signalling may be important for their induction 
(Figure 4-2, Figure 4-3). This is supported by previous reports that TLR4-/- BMDCs have 
marked reduction in IL-12 secretion in response to C. jejuni and that the purified LOS drives 
IL-12 secretion from human monocyte-derived DCs (Hu et al. 2006; Rathinam et al. 2009). 
The use of BMDCs from specific TLR KO mice would elucidate specifically which TLR(s) are 
critical in the induction of IL-10 and whether they differ for IL-12 induction. It is interesting 
to hypothesise that C. jejuni has evolved to induce high IL-10 levels through the triggering 
of MyD88-dependent TLR signalling to dampen the immune system. Similar mechanisms 
are at play during Yesinia sp. and Helicobacter pylori/DC interactions (Hu et al. 2006;Sing et 
al. 2002; Wang et al. 2010). Although the acute inflammation seen in the majority of people 
infected with high doses of C. jejuni suggests this anti-inflammatory mechanism can be 
over-ridden by other pro-inflammatory stimuli (Hu et al. 2006; Tribble et al. 2010).   
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The ability of early (within 10mins post-infection) ERK signalling to occur in the absence of 
TLR-signals suggests alternative PRRs may be triggered in response to C. jejuni (Figure 4-4). 
However, this early ERK response varied between experiments and was not always 
observed (Figure 3-10). The strong activation of all three MAPK pathways between 1-2h 
post-infection was completely dependent on TLR signalling (Figure 4-4). The kinetics of 
activation suggested that the bacteria may need to be phagocytosed prior to initiation of 
TLR signals. This is supported by reports showing the inhibition of C. jejuni phagocytosis by 
chemical inhibitors blocks the secretion of pro-inflammatory cytokines (Rathinam et al. 
2008). Additionally, TLR4 and TLR2 are expressed in the endosomal compartments of 
human DCs and not on the cell surface (Uronen-Hansson et al. 2004).  MyD88-dependent 
signalling appears to have a greater role in MAPK activation than TRIF-dependent signalling 
(Figure 4-4). For IL-10 induction there is an interesting correlation between the necessities 
of MyD88 signalling, MAPK signalling, and the ability of MyD88-dependent events to drive 
MAPK activation (Figure 3-13, Figure 4-3, Figure 4-4). Conversely, IL-12 induction is not 
influenced by MAPK inhibition, is both TRIF- and MyD88-dependent, and TRIF signalling 
does not influence MAPK activation. It is possible that a particular TLR, independent of 
TRIF, triggers MAPK activation and subsequently IL-10; whereas as TLR4 activation triggers 
NF-κB activation and subsequent production of IL-12 related cytokines.  Interestingly, TLR2 
and TLR4 mediated MyD88-dependent signalling requires the adaptor molecule Mal, which 
via p38 activates the transcription factor CREB leading to transcription and subsequent 
expression of IL-10 (Mellett et al. 2011).  
The finding that the modification of C. jejuni flagellin protein, FlaA, with a derivative of Pse 
is important for the induction of high levels of IL-10 suggested a possible role of 
carbohydrate recognition receptors in C. jejuni-BMDC interactions (Figure 3-17). In this 
study we found the ability of WT C. jejuni strain 11168H to bind to Siglec-10 to be specific, 
which was not previously thought (Avril et al. 2006). Siglec-10 bound to C. jejuni flagella 
Pse5Ac7Am structures in a manner independent of the sialic acid structures on the LOS 
(Figure 4-12). It is tempting to hypothesise that the interaction between Pse5Ac7Am 
structures on the flagella is a pathogen driven strategy to manipulate host antimicrobial 
responses, including effects on anti-inflammatory cytokines such as IL-10. This interaction 
allows novel means to target and modulate TLR signalling, a signalling pathway critical for 
IL-10 expression (Figure 4-3). Previous reports have implicated Siglecs in host IL-10 
immunity. Overexpression of Siglec-9 and Siglec-5 in the macrophage cell-lines, RAW264 
and THP-1, followed by TLR stimulation results in increased  IL-10  production with a 
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parallel decrease in TNF-α (Ando et al. 2008). Tyrosine residues in the intracellular domain 
of Siglec-9 are critical for the recruitment of downstream signalling molecules SHP-1 and 
SHP-2, events involved in immune modulation.  Siglecs are largely immunomodulatory and 
have been hypothesised to be important in distinguishing “danger-associated” versus 
“pathogen-associated” signals (Chen et al. 2009). The ability of pathogens to express sialic 
acid and engage Siglecs to dampen immune responses via molecular mimicry can be 
considered an evolutionary advantage, as demonstrated by the ability of group B 
streptococcus to engage Siglec-9 on neutrophils and reduce their oxidative burst 
capabilities (Carlin et al.  2009b). It has been hypothesised, to counterbalance the ability of 
particular pathogens to engage Siglecs and dampen immune responses, paired receptors 
have evolved which are composed of the same extracellular domain but have altered the 
intracellular domain and are therefore able to activate signalling pathways (Cao and 
Crocker 2011a).  
As yet there are no reports investigating the influence of Siglec engagement on MAPK 
activation, therefore whether the altered activation of p38 by the flagella mutant was 
caused by its inability to bind to Siglec-10 requires clarification. There is however 
precedence in the literature as ligation of the C-type lectin receptor, Dendritic-cell-
associated C-type lectin-2 (DCAL2; which contains an ITIM) modulates MAPK activation and 
IL-10 production (Chen et al. 2006). Analysis of MAPK activation in either specific Siglec KO 
BMDCs or Siglec overexpressing DCs would aid in determining whether Siglec engagement 
can alter these signalling pathways. The ability of Siglec-E to dampen TLR-induced pro-
inflammatory cytokine induction in antibody cross-linking experiments occurs via 
dampening of NF-κB (Boyd et al. 2009). In addition, engagement of CD24 and Siglec-
G/siglec-10 to the DAMP high mobility group box 1 (HMGB1) leads to a decrease in pro-
inflammatory responses, again via NF-κB regulation (Chen et al. 2009). How Siglec and 
other carbohydrate receptors intercept NF-κB and MAPKs in fine tuning host immunity is 
an emerging area of host-pathogen research.  
In addition to the binding of sialic acid in the sialic acid binding pocket, Siglecs are able to 
bind other ligands on different parts of the receptor (Carlin et al. 2009a; Kivi et al. 2009). In 
the present study we did not undertake experiments to define if the Pse5Ac7Am structure 
of C. jejuni flagella binds directly to the sialic acid binding site of Siglec-10. The first partial 
crystal structure of a Siglec-family member, the N-terminal domain Sialoadhesin, revealed 
critical interactions in the carbohydrate binding domain with its ligand, 3-sialylactose (May 
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et al. 1998). Hydrogen bonds are predicted to form between the hydroxyl groups on the 8th 
and 9th carbon as well as the 4th carbon of the pyranose ring and amide group of the N-
acetyl group. The carboxylate group is also predicted to form salt bridges. The structure of 
pseudaminic acid is very similar to N-acetyl neuraminic acid (sialic acid) (Figure 1-4). The 
carboxylate group, hydroxyl groups on the 4th and 8th carbon, and amide group on the 5th 
carbon are all conserved. Siglecs have varying specificities for sialic acid structures, with 
linkage conformation and underlying carbohydrate backbone structure playing critical roles 
in their ligand specificity. As yet, the structure of Siglec-G and Siglec-10 is unknown; 
therefore the potential binding of Pse5Ac7Am to these receptors are a matter for future 
research.  
In the monocyte/macrophage cell line, THP-1, C. jejuni is able to induce high levels of IL-1β 
in the range of 2000pg/mL 24h post-infection (Siegesmund et al. 2004). In contrast, levels 
of IL-1β induced by BMDCs in responses to C. jejuni 24h post-infection were far lower, in 
the range of 200-400pg/mL (Figure 4-14a). The disparity between the levels of IL-1β in the 
different cell types may be due to differential regulation of caspase-1. Monocytes have 
been shown to constitutively activate capase-1 and therefore only require a TLR-stimulus 
to induce high levels of IL-1β (Netea et al. 2009). Conversely, macrophages and DCs do not 
express constitutively active caspase-1, therefore in addition to a TLR-stimulus which drives 
the production of pro-IL-1β, a second signal such as adenosine triphosphate (ATP) or 
muramyl dipeptide (MDP) is required to activate the inflammasome which results in 
caspase-1 cleavage and the eventual processing of IL-1β (Mariathasan et al. 2006). The low 
level of IL-1β in C. jejuni stimulated BMDCs despite the use of high MOIs suggests that C. 
jejuni is a poor inducer of inflammasome function. LPS stimulation reportedly does not 
induce IL-1β secretion in DCs due to a lack of constitutively activated caspase-1, therefore it 
is interesting to find LPS stimulation induces 50% of the levels of IL-1β that C. jejuni induces 
(Netea et al. 2009). One explanation is the possible contamination of the LPS with other 
microbial products that could act as the second signal for caspase-1 cleavage, such as MDP 
which activates NALP3. Alternatively, there may be minimal constitutive activation of 
capase-1 creating a “leaky system” that allows the activation of TLRs alone to drive 
secretion of minimal levels of mature IL-1β. Interestingly, both NALP3 and the more 
broadly used adaptor protein ASC were necessary for the induction of IL-1β from both the 
C. jejuni- and LPS-stimulated BMDCs. The necessity of this receptor and adaptor molecule 
has already been reported in the constitutive activation of caspase-1 in monocytes, 
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therefore neither of the possible explanation for the induction of IL-1β by LPS can be 
eliminated (Netea et al. 2009).  
Despite the flagellin protein, FlaA, sharing many “critical” amino acids that have been 
identified in the activation of IPAF, C. jejuni did not require IPAF in the induction of IL-1β 
(Figure 4-14a and b). The activation of IPAF by the flagellin proteins of other pathogens 
requires the translocation of the flagellin monomers directly into the cytosol, which is 
achieved via a type III secretion apparatus or artificially in vitro by transfection of the 
monomers (Sun et al. 2007). As IPAF is dispensable for the secretion of IL-1β by C. jejuni it is 
likely that the bacterium does not actively secrete flagellin monomers into the BMDC 
cytosol. There are two possible explanations for the reduced levels of IL-1β seen with the 
flagellin mutant, ∆flaA. Firstly, differential induction of pro-IL-1β between the WT and 
flagellin mutant may occur. Alternatively, the ability of the motility-deficient bacterium to 
enter the cytosol triggering ASC- and NALP3-dependent inflammasome activation may be 
altered; although there is currently no evidence which proves C. jejuni is able to enter the 
cytosol in DCs.  
C. jejuni-stimulated BMDCs were able to induce a strong IFNγ responses in T-cells (Edwards 
et al. 2010;Rathinam, Hoag, & Mansfield 2008), independent of the flagella (Figure 4-16a), 
but did not induce significant levels of IL-4. Strong IFNγ responses that are specific to C. 
jejuni antigens correlate with protection against re-infection, which suggests Th1 responses 
are critical in the clearance of the pathogen and in limiting infection to an acute disease 
(Tribble et al. 2010). Interestingly, the ability of H. pylori-stimulated DCs to induce 
regulatory T cells (Treg) skewing is via its ability to induce high levels of IL-10 and TGF-β 
(Kao et al. 2010), therefore it would be interesting to analyse the ability of C. jejuni to 
induce Tregs in the future.  
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Chapter 5.  
Structural Analyses of C. jejuni 
Lipooligosaccharide from Different 
Phylogenetic Clades 
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5.1 Background 
There are multiple reservoirs of C. jejuni that include not only livestock but also 
environmental or non-livestock sources such as contaminated water supplies and crops 
(Gardner et al. 2011; Kemp et al. 2005). Despite the microaerophillic nature favoured by C. 
jejuni, the bacteria can survive and grow in water in laboratory tests which suggests that C. 
jejuni may be able to adapt to ecological niches outside a mammalian or avian host 
(Tatchou-Nyamsi-Konig et al. 2007). The genetic adaptation to specific ecological niches by 
C. jejuni is beginning to be appreciated. Wren and colleagues investigated the phylogenetic 
relationship of 111 different C. jejuni strains isolated from either asymptomatic human 
carriers, human clinical isolates, livestock (chicken, bovine, and ovine) and environmental 
sources and the authors found a phylogenetic divide between livestock and environmental 
sources (Champion et al. 2005). Interestingly, the human clinical isolates are spread across 
the two phylogenetic clades suggesting that different genetic necessities promote livestock 
colonisation versus those that cause enteritis in humans. A key genetic locus that 
distinguishes the two phylogenetic clades includes the genes involved in the legionaminic 
acid (Leg) biosynthesis pathway.  The deletion of this genetic cluster leads to a reduction in 
C. jejuni colonisation in chickens (Howard et al. 2009). However, certain chicken isolates 
lack this genetic cluster suggesting that multiple genetic loci are likely to be important in 
livestock colonisation.  
The LOS structure varies widely amongst C. jejuni strains. The major variation lies in the 
outer core region of the oligosaccharide (OS) (Figure 1-2) (Dorrell et al. 2001), although 
diversity in the phosphorylation and number of amide linkages of the lipid A also exist 
(Figure 5-1) (Szymanski et al. 2003). Further, the level of phosphorylation and the 
abundance of amide linkages can vary between growths of the same C. jejuni strain 
suggesting that LOS structure may actively respond to the bacteria’s immediate 
environment (e.g. laboratory culture broth versus host nutritional status plus additional 
impact of the host microbial composition); such dynamic changes may promote virulence. 
In addition to environment-driven LOS modification(s), genetic variation in the C. jejuni LOS 
locus is also documented. In the present study we wished to test the hypothesis that 
structural variation in the LOS not only lends to differential cross-talk with the host innate 
immune system but this moiety may also contribute to defining the phylogenetic 
separation of C. jejuni strains.  
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Figure 5-1 C. jejuni Lipid A structure  
Hexacylated lipid A bearing (a) two phosphate and two phosphoethanolamine residues. 
Acyl chains are linked by either (b) ester (R = O) or amide (R = N) bonds.   
5.2      Isolation of the lipooligosaccharide (LOS) moiety from C. 
jejuni strains 
To assess whether the LOS structure is important in the distinction of the two phylogenetic 
clades, the LOS moiety from 15 C. jejuni strains (7 and 8 strains from livestock (including 
reference strain 11168H) and non-livestock (environmental) clades respectively) were 
purified (Table 5-1). Of the 7 livestock-associated strains, 3 were human clinical isolates 
(patients presenting with diarrhoea or bloody diarrhoea), 2 were from asymptomatic 
carriers, and 2 were from colonised livestock. Of the 8 environment-associated strains 4 
were human clinical isolates (patients presenting with diarrhoea or bloody diarrhoea) and 4 
were from asymptomatic carriers.  
To perform LOS structure and functional analyses, 1L broth cultures were grown for each 
strain under micro-aerophillic conditions for 24-48h. LOS was isolated using the hot-phenol 
method of extraction (Chapter 2.9.1). Yields of between 2-15mg were achieved and were 
quantified on a microbalance. Purity was assessed by SDS-PAGE and subsequent silver 
staining (Figure 5-2). High purity was achieved as no other bands were detected. The size of 
the LOS differed between the various preparations, suggesting that structural differences 
may occur between the strains. To assess these possible differences, Matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) analysis was 
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performed. The high purity suggested that the extracted LOS could be used directly without 
any further purification for structure (this chapter) and functional studies (Chapter 6). 
5.3 MALDI-TOF analysis of O-Deacylated LOS  
MALDI-TOF MS analysis allowed structural determination of the 15 LOSs’ isolated. MALDI-
TOF MS was performed on O-deacylated LOS samples to analyse lipid A amide linkages and 
determine the OS composition (described here). MALDI-TOF MS was also performed on the 
intact LOS to analyse lipid A phosphorylation status (Chapter 5.5).   Sample preparation and 
~80% of the MALDI-TOF spectra acquisitions’ were conducted by or under the direct 
guidance of Dr. C.  John (UCSF, USA). The remaining data was obtained by Dr. John.  
Removal of the O-linked acyl chains (O-deacylation) of the lipid A backbone aided MALDI-
TOF analysis, in particular for the acquisition of detailed spectra for the full length species 
(lipid A + OS). C. jejuni is known to have varying numbers of amide and ester bonds linking 
the acyl chains to the lipid A backbone (Figure 5-1) (Van Mourik et al. 2010). The sugar 
components of the disaccharide lipid A backbone are either 2,3-diamino-2,3-dideoxy-D-
glucose  (GlcN3N; 2 amide linkages) or D-glucosamine (GlcN; 1 amide linkage). Varying 
amounts of GlcN3N-GlcN3N, GlcN-GlcN3N, and GlcN-GlcN lipid A backbones have been 
observed amongst C. jejuni strains, although a comparison of abundance of these linkages 
from different strains has not been performed (Szymanski et al. 2003). As the O-deacylation 
treatment removes only the acyl chains that are linked via ester bonds (not amide bonds), 
it was possible to quantify the relative abundance of each disaccharide composition 
(GlcN3N-GlcN3N, GlcN-GlcN3N, and GlcN-GlcN). However, O-deacylation treatment also 
removed all O-linked amino acids and O-linked acyl modifications of the OS in addition to 
removing PEA residues on the lipid A core; therefore MALDI-TOF analysis of the native LOS 
was also performed. 
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Table 5-1: C. jejuni strains used in this study 
Strain numbers, phylogenetic clade, and clinical presentation for each strain 
 
Strain  Phylogenetic Clade  
Environmental (E) or Livestock (L) 
Clinical Presentation 
43205 E Bloody Diarrhoea 
32787 E Asymptomatic 
31481 E Asymptomatic 
56519 E Bloody Diarrhoea 
64555 E Bloody Diarrhoea 
33106 E Asymptomatic 
33084 E Asymptomatic 
40917 E Bloody Diarrhoea 
31485 L Asymptomatic 
11168H L Diarrhoea 
45557 L Bloody Diarrhoea 
KJShpSm4 
 
 
L Colonised Livestock 
56282 L Diarrhoea 
32799 L Asymptomatic 
KJCattle8 L Colonised Livestock 
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Figure 5-2: Silver stain of purified LOS from 15 different Campylobacter jejuni strains 
1µg of purified LOS was separated by SDS-PAGE and subsequently silver-stained using silver 
nitrate.   
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To O-deacylate the LOS, ~300µg of purified LOS was treated with anhydrous hydrazine. 
Prior to addition to the matrix, O-deacylated LOS were desalted and added to a 2, 5-
dihydroxybenzoic acid (DHB) matrix and subsequently analysed by MALDI-TOF in the 
negative ion mode (Chapter 2.9.3). Figure 5-3 and Figure 5-4 show a representative spectra 
for the O-deacylated LOS from each strain of the environmental and livestock clade 
respectively. Table 5-2 shows the calculated masses for the different lipid A species 
observed. The presence of GlcN3N-GlcN3N (four amide linkages; m/z 1402.6 Da) and 
GlcN3N-GlcN (three amide linkages; m/z 1177.2 Da) lipid A backbone containing two 
phosphate groups is seen for all of the LOSs’ analysed. The presence of lipid A containing 
only two amide linkages GlcN-GlcN (m/z 951.8 Da) was detected in LOS from environmental 
strains 64555 and 40917 (Figure 5-3f and h) and  livestock strain KJcattle8  (Figure 5-4f) and 
at far lower abundance (Table 5-3). Despite increasing the length of incubation of the LOS 
with anhydrous hydrazine from 20mins to 2h not all of the O-linked fatty acid chains were 
removed (under O-deacylated; m/z 1641.0 and 1415.6 Da of the GlcN3N-GlcN3N and 
GlcN3N-GlcN species respectively). Peaks were detected for masses corresponding to the 
loss of a phosphate group and one water molecule (-98Da; m/z 1304.6 and 1079.2; under 
O-deacylated m/z 1543.0 and 1317.6). The loss of the water in conjunction with the 
phosphate, and the lack of peaks showing loss of water alone, suggested these species 
were generated by hydrolysis of a phosphate group during the MALDI-TOF analysis and did 
not correspond to the presence of a monophosphorylated lipid A backbone. The lack of 
observable peaks for monophosphorylated species (m/z 1322.6, 1097.2, and 871.8 Da) 
agreed with this hypothesis. Peaks at m/z 1374.5 and 1149.2 Da corresponded to GlcN3N-
GlcN3N and GlcN3N-GlcN backbones containing a 14 carbon (C14) instead of a 16 carbon 
(C16) acyl chain respectively (under O-deacylated m/z 1612.9, 1387.6, and 1162.2).   
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Figure 5-3: MALDI-TOF analysis of O-deacylated environmental phylogenetic clade LOS 
Representative spectra from at least two independently acquired spectra for O-deacylated 
LOS from environmental strains (a) 43205 (b) 32787 (c) 31481 (d) 56519  
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Figure 5-3: MALDI-TOF analysis of O-deacylated environmental phylogenetic clade LOS 
Representative spectra from at least two independently acquired spectra for O-deacylated 
LOS from environmental strains (e) 33106 (f) 64555 (g) 33084 (h) 40917.  
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Figure 5-4: MALDI-TOF analysis of O-deacylated livestock phylogenetic clade LOS 
Representative spectra from at least two independently acquired spectra for O-deacylated 
LOS from livestock strains (a) 31485 (b) 45557 (c) KJShpSm4 (d) 56282 (e) 32799 (f) 
KJcattle8 (g) 11168H  
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Figure 5-4: MALDI-TOF analysis of O-deacylated livestock phylogenetic clade LOS 
Representative spectra from at least two independently acquired spectra for O-deacylated 
LOS from livestock strains (e) 32799 (f) KJcattle8 (g) 11168H  
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O-Deacylated lipid A Structure Calculated mass (M-H)- 
(Da) 
GlcN3N-GlcN3N-2P 1402.6 
GlcN-GlcN3N-2P 1177.2 
GlcN-GlcN-2P 951.8 
GlcN3N-GlcN3N-2P (C14) 1374.5 
GlcN-GlcN3N-2P (C14) 1149.2 
GlcN-GlcN-2P (C14) 923.8 
GlcN3N-GlcN3N-2P (minus P) 1304.6 
GlcN-GlcN3N-2P (minus P) 1079.2 
GlcN-GlcN-2P (minus P) 853.8 
GlcN3N-GlcN3N-2P (under O-deacylated) 1641.0 
GlcN-GlcN3N-2P (under O-deacylated) 1415.6 
GlcN-GlcN-2P (under O-deacylated) 1191.2 
 
 
 
Table 5-2: MALDI-TOF lipid A species for O-deacylated C. jejuni LOS  
Calculated mass for the described O-deacylated structures. Lipid A composed of two 2,3-
diamino-2,3-dideoxy-D-glucose sugars  (GlcN3N-GlcN3N; 4 amide linkages), two D-
glucosamine sugars (GlcN-GlcN; 2 amide linkage); or a combination of one D-glucosamine  
and one 2,3-diamino-2,3-dideoxy-D-glucose sugar (GlcN-GlcN3N; 3 amide linkages). P = 
phosphate group; C14 = 14 carbon long acyl chain instead of one 16 carbon long acyl chain. 
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The proportion of the GlcN3N-GlcN3N, GlcN3N-GlcN, and GlcN-GlcN backbone in the LOS 
for each species was calculated by combining the relative abundance of all the peaks 
relating to number of amide linkages from two independent spectra (Table 5-3).  For the 
majority of the strains analysed, GlcN3N-GlcN was the most abundant disaccharide 
backbone observed. Although there was a wide variation in the abundance of four amide 
linkages (GlcN3N-GlcN3N; range 26.1 – 73.7%, mean 33.5%, standard deviation 14.7%), this 
did not correlate with the phylogenetic clade or clinical presentation of each strain (Figure 
5-5). This data highlighted that variation in the relative abundance of amide and ester 
linkages of the acyl chains in the lipid A backbone of C. jejuni LOS was independent of the 
ecological niche of the corresponding strain. Additionally, the relative abundance of amide 
linkages in the lipid A backbone did not account for asymptomatic carriage of C. jejuni.  
In addition to the acyl linkage analysis, the composition of the OS for each strain was 
calculated from the O-deacylated spectra as the resolution for the larger masses was higher 
than for the intact spectra (compare Figure 5-3 and Figure 5-4 to Figure 5-10 and Figure 
5-11). The spectra for environmental strain, 31481, showed a peak at m/z 1679.9 Da which 
is consistent with an OS composed of KDO2PEAHep2Hex2HexNAc2; peaks at 1633.3 and 
1475.5 corresponded to the loss of CO2 (-44Da) and KDO (-220Da) from the OS respectively 
(Figure 5-3c). Full length species at m/z 2855.9Da and 3081.6Da corresponded to the OS 
plus the GlcN3N-GlcN and GlcN3N-GlcN3N backbone respectively. Strain 64555 had a peak 
at m/z 2159.7 Da corresponding to an OS structure of KDO2Hep2Hex7HexNAc1 (Figure 5-3f). 
Strain 33106 had a peak at m/z 1725.3 Da corresponding to an OS structure of 
KDO2PEAHep2Hex3; an additional peak at 1927.9 corresponded to an additional HexNAc1 
residue on the OS (Figure 5-3e). Peaks at m/z 2903.6, 3141.8 and 3368.9 Da corresponded 
to the KDO2PEAHep2Hex3 OS with the addition of GlcN3N-GlcN, under O-deacylated 
GlcN3N-GlcN, and under O-deacylated GlcN3N-GlcN3N lipid A backbone respectively. No 
peaks for the OS alone were observed for strain 33084 (Figure 5-3g). Peaks at m/z 3195.9 
Da corresponded to a GlcN3N-GlcN lipid A backbone with the addition of a 
KDO2PEAHep2Hex6NeuAc2 OS. Peaks at m/z 2903.8 and 2610.4 Da corresponded to the loss 
of one and two sialic acid residues respectively. The OS peak for strain 40917 is m/z 2485.2 
Da corresponding to KDO2PEAHep2Hex5HexNAc2NeuAc1, and loss of KDO at m/z 2265.7 Da 
Figure 5-3h). Full length peaks at m/z 3438.0, 3663.2, 3889.5, and 3902.0 Da corresponded 
to the OS plus GlcN-GlcN, GlcN3N-GlcN, GlcN3N-GlcN3N, and under O-deacylated GlcN3N-
GlcN lipid A backbone respectively. The peaks observed in the OS and full-length range for 
strains 43205, 32787, and 56519 did not correspond to any predicted carbohydrate  
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Table 5-3: Relative abundance of disaccharide backbone composition (amide linkages) for 
each strain 
The relative abundance of GlcN3N-GlcN3N, GlcN3N-GlcN, and GlcN-GlcN lipid A backbone 
was calculated from two individual spectra for each strain based on the area under the 
peaks of the masses from Table 0-2. E = environmental strain; L = livestock strain; BD = 
bloody diarrhoea; D = diarrhoea; A = asymptomatic; CL = colonised livestock.  
  
Strain Phylogenetic 
clade 
Clinical 
Presentation 
GlcN3N-GlcN3N 
(%) 
GlcN3N-GlcN 
(%) 
GlcN-GlcN 
%) 43205 E BD 19.6 77.8 2.7 
32787 E A 35.0 65.0 0.0 
31481 E A 39.5 60.5 0.0 
56519 E BD 48.4 51.6 0.0 
64555 E BD 27.8 70.8 1.5 
33106 E A 38.7 61.3 0.0 
33084 E A 26.2 72.6 1.2 
40917 E BD 13.7 77.1 9.2 
31485 L A 39.6 60.4 0.0 
11168H L D 73.7 26.3 0.0 
45557 L BD 32.8 67.2 0.0 
KJShpSm4 L CL 37.7 58.7 3.5 
56282 L D 31.3 68.2 0.5 
32799 L A 20.3 79.2 0.5 
KJCattle8 L CL 18.3 74.5 7.2 
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Figure 5-5: No correlation between the phylogenetic clade or clinical presentation of C. 
jejuni strains and the abundance of four amide linkages on the LOS 
The relative abundance of GlcN3N-GlcN3N (four amide linkages) lipid A backbone was 
calculated from two individual spectra for each strain based on the area under the peaks of 
the masses from Table 0-2. The relative abundances were plotted against (a) the 
phylogenetic clade of each strain (b) the clinical presentation of each strain. 
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composition, therefore higher resolution MALDI-TOF analysis was performed by Dr C. John 
at UCSF on intact LOS to obtain OS structural details and are described in Section 5.5.  
Livestock strain, 31485, had a peak at m/z 2415.4 correlating with an OS composed of 
KDO2PEAHep2Hex6HexNAc1NeuAc1 (Figure 5-4a). Peaks at m/z 3592.1, 3818.5, and 3828.8 
corresponded to the OS joined to a lipid A backbone GlcN3N-GlcN, GlcN3N-GlcN3N, and 
under O-deacylated GlcN3N-GlcN respectively. Strains 45557 and 11168H had the same OS 
composition as 31485, with peaks observed at m/z 2414.3 and 2414.8 Da respectively 
(Figure 5-4b and g). Peaks at m/z 3593.6 and 3819.0 Da for strain 45557, and m/z 3594.6 
and 3818.2 Da for strain 11168H, corresponded to the full length O-deacylated structures 
with a GlcN3N-GlcN and GlcN3N-GlcN3N respectively. The OS peak for strain KJShpSm4 was 
m/z 2252.0 Da, which matched KDO2PEAHep2Hex5HexNAc1NeuAc1 (Figure 5-4c), with 
corresponding full length peaks at m/z 3429.6 and 3654.7 Da for the OS plus a lipid A 
backbone composed of GlcN3N-GlcN and GlcN3N-GlcN3N respectively. Both strains 56282 
and 32799 have an OS composed of KDO2PEAHep2Hex4HexNAc1NeuAc2 shown at peaks m/z 
2382.8 and 2382.7 Da respectively (Figure 5-4d and e). Full length structures composing the 
OS with GlcN3N-GlcN lipid A backbone were seen at peaks m/z 3561.0 Da for strain 56282 
and 3559.3 Da for strain 32799, with loss of one sialic residues at m/z 3269.0 Da and 3268.0 
Da respectively. In addition, strain 32799 had peaks at m/z 2977.0 and 3785.0 Da 
corresponding to the loss of two sialic acid residues and the full length OS with a GlcN3N-
GlcN3N backbone respectively. Strain, KJCattle8 had an OS composed of 
KDO2PEAHep2Hex2HexNAc2NeuAc1 observed m/z 1968.3 Da, and full length m/z 3145.0 Da 
with GlcN3N-GlcN lipid A backbone (Figure 5-4f). 
MALDI-TOF analysis highlighted a wide variation in the OS structure of the 15 different 
strains (Table 5-4). Most strains were predicted to contain the inner core OS KDO2Hep2PEA. 
All strains bar 33084, 32787, 56519 contained a HexNAc residue. The OS structure of all 15 
strains was predicted to contain between 2 and 6 hexose residues. The presence of sialic 
acid in the OS was predicted for 10 out of the 15 strains based on the MS data. Comparison 
of the LOS MALDI-TOF data highlighted the presence of sialic acid as a possible 
distinguishing feature between the clades as at least one sialic acid residue was present in 
all 7 livestock strains tested; in contrast only 3 out 8 environmental strains were sialic acid 
positive.  We next confirmed the presence of sialic acid synthesis genes (sialic acid synthase 
(neuB1), sialic acid transferase (cst) and sialic-acid O-acetyl transferase (SOAT) genes).  
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Table 5-4: C. jejuni LOS OS structures predicted from O-deacylated spectra  
Calculated and observed average masses for the subsequent predicted structures for the 
OS portions of the 15 strains, based on peaks in the OS and full length section of a 
minimum of two individual O-deacylated spectra for each strain. Hex = hexose; PEA = 
phosphoethanolamine; Hep = heptose; KDO = 3-Deoxy-D-manno-oct-2-ulosonic acid ; 
HexNAc = N-acetyl hexosamine ; NeuAc = N-acetyl neuraminic acid (sialic acid). * denotes 
exact masses (performed by high resolution MALDI-TOF on intact species 
  
 
Strain 
 
Clade 
 
Predicted carbohydrate structure 
Predicted 
mass (M-H)- 
(Da) 
Observed 
mass (M-H)- 
(Da) 
11168H L KDO2 PEA Hep2 Hex6 HexNAc1NeuAc1 2414.1 2414.8 
45557 L KDO2 PEA Hep2 Hex6 HexNAc1NeuAc1 2414.1 2414.3 
31485 L KDO2 PEA Hep2 Hex6 HexNAc1NeuAc1 2414.1 2414.6 
32799 L KDO2 PEA Hep2 Hex4 HexNAc1NeuAc2 2381.0 2382.5 
KJShpsm4 L KDO2 PEA Hep2 Hex5 HexNAc1NeuAc1 2251.9 2252.0 
KJCattle8 L KDO2 PEA Hep2 Hex2 HexNAc2NeuAc1 1968.7 1968.3 
56282 L KDO2 PEA Hep2 Hex4 HexNAc1NeuAc2 2381.0 2382.8 
33106 E KDO2 PEA Hep2 Hex3 HexNAc1NeuAc1 1926.9 1927.9 
33084 E KDO2 PEA Hep2 Hex6 NeuAc2 2015.7 2017.5 
40917 E KDO2 PEA Hep2 Hex5 HexNAc2NeuAc1 2485.1 2485.5 
31481 E KDO2 PEA Hep2 Hex2 HexNAc2 1677.4 1676.9 
56519 E KDO2 PEA Hep2 Hex7 P2 OAc 2282.6* 2282.1* 
32787 E KDO2 PEA Hep2 Hex7 P2 OAc 2282.6* 2282.8* 
64555 E KDO2 Hep2 Hex7 HexNAc1 2161.9 2159.7 
43205 E KDO2 P Hep2 Hex8 HexNAc1 2402.7* 2402.7* 
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5.4 Genetic analysis of sialic acid-synthesis genes 
The sequence of the sialic acid synthase gene in the LOS locus, neuB1, varies widely 
between LOS classes A and B compared to C (Parker et al. 2005). The identity between 
11168H neuB1 (class C) and 81-176 (class B) is 76.7% (EMBOSS Needle: Pairwise Sequence 
Alignment Software). A previous microarray study utilised primers based on the genomic 
sequence of strain 11168H, therefore the lack of identity between the difference LOS 
classes most likely accounts for why only 4 of the 15 strains were reported to be positive 
for the neuB1 gene (Champion et al. 2005) (Dr O Gundogdu, LSHTM, personal 
communication). Using primers designed to anneal to the homologous regions shared 
between the neuB1 genes from the various LOS classes, PCR analysis was performed on 
whole genomic DNA extracted from C. jejuni strains.  10 strains predicted to have sialic acid 
in the LOS by MS were also found to be positive for the presence of the neuB1 gene (Figure 
5-6, top band). In addition, primers designed by Parker and colleagues (Parker et al. 2005) 
were also used to distinguish strains on the basis of the presence of the neuB1 and sialic 
acid transferase (cst) genes from classes A and B from class C (Figure 5-6). Out of the 10 
strains positive for the neuB1 gene, 5 were positive for both class A & B neuB1 and cst 
genes, and the others were positive for class C neuB1 and cst genes. The four strains that 
were positive according to Champion et al. all belonged to class C, confirming that the 
observed low degree of identity in the neuB1 gene may be responsible for the false 
negative data for sialic acid synthase genes in some of the strains. Interestingly, the 5 
strains that were negative for sialic synthesis genes (for all sets of primers utilised) were 
from the environmental clade (5/8). Primers annealing to a gene present in the LOS locus of 
all C. jejuni strains, htrB, was used as a positive control.  Taken together, gene analysis and 
the MS data indicated that compared to the environmental strains, a higher proportion of 
the livestock strains LOS contained the sialic acid moiety.  
To add greater weight to the observations noted above, the presence of sialic acid 
synthesis genes was sought in a further 12 strains from the environmental clade and 14 
strains from the livestock clade. Of the 12 environmental strains analysed, 6 were positive 
for the neuB1 gene (Figure 5-7). Of the 14 livestock strains analysed all 14 were positive for 
the neuB1 gene (Figure 5-8). Therefore, overall 45% (9/20) of all environmental-associated 
clade strains contained the neuB1 gene, compared to 100% (21/21) for the livestock-
associated clade. Of the sialic acid positive strains, 78% for the environmental strains 
belonged to class A or B compared to 43% for the livestock clade. All strains analysed from 
the environmental clade were human isolates. 10 of the 21 livestock strains were human  
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Figure 5-6: Detection of sialic acid synthesis genes in Campylobacter jejuni environmental 
and livestock strains 
Sialic acid synthesis genes were amplified by PCR and visualised by agarose gel 
electrophoresis with gel-red staining. Primers utilised are described in the text. 30 PCR 
cycles were performed at an annealing temperature of 52oC for orf 7ab (neuB1 ab), orf 7c 
(neuB1c), orf 8ab (cst ab), and orf 8c (cst c); neuB1 and htrB at 55oC.  
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Figure 5-7: Detection of Sialic acid synthesis genes in environmental Campylobacter jejuni 
strains 
Sialic acid synthesis genes were amplified by PCR and visualised by agarose gel 
electrophoresis with gel-red staining. 30 PCR cycles were performed at an annealing 
temperature of 52oC for orf 7ab (neuB1 ab), orf 7c (neuB1c), orf 8ab (cst ab), and orf 8c (cst 
c); neuB1 and htrB at 55oC. 
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Figure 5-8: Detection of sialic acid synthesis genes in livestock Campylobacter jejuni 
strains 
Sialic acid synthesis genes were amplified by PCR and visualised by agarose gel 
electrophoresis with gel-red staining. 30 PCR cycles were performed at an annealing 
temperature of 52oC for orf 7ab (neuB1 ab), orf 7c (neuB1c), orf 8ab (cst ab), and orf 8c (cst 
c); neuB1 and htrB at 55oC. 
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isolates, for which 40% were classes A or B; the other 11 were from colonised livestock for 
which 45% were classes A or B. Of the 6 strains isolated from asymptomatic carriers 33% 
did not contain sialic-acid synthesis genes, 50% were positive for class A or B, and 17% 
were positive for class C. No correlation between the asymptomatic strains and the 
presence/absence of sialic acid synthesis genes was found. The expanded PCR analysis 
confirmed the presence of sialic acid synthesis genes in the LOS locus as a distinguishing 
feature between the two phylogenetic clades, but not for asymptomatic carriage of C. 
jejuni.        
Champion and colleagues suggested a possible correlation between strains that contain the 
sialic acid synthesis genes and the presence of the two-domain containing Cj1135 (lgtF), a 
gene predicted to function in the addition of two glucose residues to the two heptose 
residues in the core OS (Champion et al. 2005; Parker et al. 2005). Strains that lack the two-
domain lgtF carry an lgtF gene that encodes a one-domain protein which is predicted to 
only add one glucose residue to the heptose residue proximal to the KDO residue. To 
confirm the correlation between strains containing sialic acid synthesis genes and the 
presence of the two-domain lgtF gene PCR analysis was performed. PCR analysis using the 
same forward primer (lgtF fwd 1) and a reverse primer that binds to a region in the first 
domain (lgtF rev 1) or a reverse primer that binds to a region in the second domain (lgtF 
rev 2) was used to distinguish the one-domain and two-domain genes (top two lanes Figure 
5-9). 11 of the 15 strains contained the two-domain lgtF gene. Two of the strains yielded a 
PCR product that corresponded to the one-domain lgtF, with no product indicative for the 
presence of a second domain. Similar to the neuB1 gene, sequence variation between 
strains occurs for lgtF. A third set of primers for lgtF were designed on the basis of the 
sequence of the one-domain lgtF gene from C. jejuni strain 81116 which has low sequence 
homology to 11168H lgtF (lgtF fwd2 and lgtF rev3). The genome sequence for strain 81116 
is known and the strain lacks sialic acid synthesis genes in its LOS locus. The two strains that 
were negative for the primers based on 11168H lgtF were positive for the one-domain 
81116 based lgtF primers. Only strain 64555 from the environmental clade was negative for 
the sialic acid synthesis genes but positive for the two domain lgtF. The other 4 strains that 
lacked sialic acid synthesis genes contained only a one-domain lgtF gene.  This data 
suggested a strong correlation between the presence of the two-domain lgtF gene and the 
presence of sialic-acid synthesis genes.        
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Figure 5-9: Detection of the Cj1135 gene in environmental and livestock Campylobacter 
jejuni strains 
Cj1135 gene was amplified by PCR and visualised by agarose gel electrophoresis with gel-
red staining. 30 PCR cycles were performed at an annealing temperature of 55oC for all 
primers sets. 
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5.5 MALDI-TOF analysis of native LOS  
Phosphorylation of the lipid A moiety can modulate the degree of TLR4 activation. As the 
LOS phosphorylation status can vary between strains of the same species it was of interest 
to correlate phosphorylation levels and the biological activity of the LOSs’ under 
investigation (Liu et al. 2010). As the O-deacylation of LOS removes PEA residues from the 
lipid A backbone MALDI-TOF analysis was performed on the native LOS to quantify the 
relative abundance of phosphorylation of the lipid A backbone (Figure 5-10 and Figure 
5-11). Native LOS was first desalted before being loaded onto a thin layer of 2,4,6-
trihydroxyacetophenone/nitrocellulose matrix (Chapter 2.9.4.1) MALDI-TOF analysis was 
performed in the negative ion mode. 
Figure 5-10 and Figure 5-11 show representative spectra for native LOS of the 8 
environment- and 7 livestock-associated strains respectively. Table 5-5 shows the predicted 
lipid A masses for native C. jejuni LOS. The masses are calculated for lipid A backbones 
containing 2 amide and 2 ester linkages (GlcN-GlcN) for the fatty acid chains. A decrease of 
2Da and 4Da from these values would be observed for GlcN3N-GlcN and GlcN3N-GlcN3N 
respectively. In general, the peaks were broader than those seen for the O-deacylated data 
which is likely a reflection of the composition of the linkages in the backbone differing 
within the same species, resulting in a wider mass range. The most abundant peaks 
observed for the majority of the species corresponded to the addition of two phosphates 
(P) and one phosphoethanolamine (PEA) residues on the lipid A backbone (m/z 2004.4 Da) 
and the corresponding peak for the hydrolysis of a phosphate group during the MALDI-TOF 
analysis (loss of -98Da; m/z 1906.4 Da). For other strains the most abundant peak was for 
2P modified lipid A backbone (m/z 1881.4; corresponding loss of phosphate m/z 1783.4 
Da). In addition minor peaks were seen for 2P2PEA modified lipid A, m/z 2127.5 Da (loss of 
phosphate, m/z 2029.5 Da), 2P3PEA m/z 2250.5 (loss of phosphate, m/z 2152.5Da). Only 
strain 45557 showed a peak correlating to the presence of lipid A modified with one 
phosphate only (m/z 1801.4; Figure 5-11b). Peaks were also observed for masses 
corresponding to one acyl chain being 14 carbons long instead of 16; masses for these 
peaks are detailed in Table 5-2. Peaks at m/z 1878.0 corresponded to 2PPEA (C14) with loss 
of one phosphate; due to the similarity in mass between this peak and m/z 1881.4 Da 2P 
caution was taken when assigning the peaks of around this mass to either lipid A structure. 
Calculations were done to assess whether peaks were likely to correspond to the 1906.4 Da 
peak (loss of 28.1Da; C14 instead of C16) or 1783.4 Da peak (mass difference 98Da; 1783.4 
corresponds to the loss of phosphate for 2P modified lipid A).   
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Figure 5-10: MALDI-TOF analysis of intact environmental phylogenetic clade LOSs 
Representative spectra from at least two independently acquired spectra for the intact LOS 
from environmental strains (a) 43205 (b) 32787 (c) 31481 (d) 56519  
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Figure 5-10: MALDI-TOF analysis of intact environmental phylogenetic clade LOSs 
Representative spectra from at least two independently acquired spectra for the intact LOS 
from environmental strains (e) 33106 (f) 64555 (g) 33084 (h) 40917.  
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Figure 5-11: MALDI-TOF analysis of intact livestock phylogenetic clade LOSs 
Representative spectra from at least two independently acquired spectra for the intact LOS 
from livestock strains (a) 31485 (b) 45557 (c) KJShpSm4 (d) 56282  
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Figure 5-11: MALDI-TOF analysis of intact livestock phylogenetic clade LOSs 
Representative spectra from at least two independently acquired spectra for the intact LOS 
from livestock strains (e) 32799 (f) KJcattle8 (g) 11168H  
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Native Lipid A Structure    Calculated mass (M-H)- 
(Da) 
GlcN-GlcN-P 1801.4 
GlcN-GlcN-2P 1881.4 
GlcN-GlcN-PPEA 1924.5 
GlcN-GlcN-2PPEA 2004.4 
GlcN-GlcN-2P2PEA 2127.5 
GlcN-GlcN-2P3PEA 2250.5 
GlcN-GlcN-P (C14) 1769.0 
GlcN-GlcN-2P (C14) 1853.0 
GlcN-GlcN-PPEA (C14) 1892.0 
GlcN-GlcN-2PPEA (C14) 1976.0 
GlcN-GlcN-2P2PEA (C14) 2099.0 
GlcN-GlcN-2P3PEA (C14) 2223.0 
GlcN-GlcN-P (minus P) 1703.4 
GlcN-GlcN-2P (minus P) 1783.4 
GlcN-GlcN-PPEA (minus P) 1826.5 
GlcN-GlcN-2PPEA (minus P) 1906.4 
GlcN-GlcN-2P2PEA (minus P) 2029.5 
GlcN-GlcN-2P3PEA (minus P) 2152.5 
 
 
 
Table 5-5 : Native LOS lipid A masses from MALDI-TOF 
Calculated masses for the described intact lipid A species. Lipid A composed of two D-
glucosamine sugars (GlcN-GlcN; 2 amide linkage) is used for the calculations. P = phosphate 
group; PEA = phosphoethanolamine; C14 = 14 carbon long acyl chain instead of one 16 
carbon long acyl chain. 
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To compare the level of phosphorylation between the different strains, the relative 
abundance of the tri- (2PPEA) or tetra-phosphorylated (2P2PEA) lipid A was compared to 
the relative abundance of the un- mono- (P) or di-phosphorylated (2P or PPEA) lipid A. 
There was a wide diversity between the strains in the level of phosphorylation. The range 
for the percentage of the tri- or tetra-phosphorylated lipid A was 26.3-87.5% (mean 65.4%, 
standard deviation 19.03%). Despite this diversity no one particular clade had a statistically 
higher level of phosphorylation than the other (Figure 5-12a). Similarly, the clinical 
outcome of each strain did not correlate with the level of phosphorylation (Figure 5-12b). 
There also was no correlation between the relative abundance of amide linkages and the 
relative abundance of tri- and tetra-phosphorylation of the lipid A (Figure 5-13). This data 
suggested the regulation of phosphorylation did not contribute to phylogenetic division 
and also did not account for the clinical presentation of each C. jejuni strain. 
The resolution of the full length intact LOS species was far lower than that observed for the 
O-deacylated spectra, however conformation of some of the OS structures predicted from 
the O-deacylated data was possible. Peaks at m/z 3680.4, 3583.6, and 3804.5 Da for strain 
31481 corresponded to the OS, KDO2PEAHep2Hex2HexNAc1, with lipid A modified with 
2PPEA, 2PPEA with loss of one phosphate, and 2P2PEA respectively (Figure 5-10c). The 
peak at m/z 4489.4 Da for strain 40917 corresponded to the OS, 
KDO2PEAHep2Hex5HexNAc2NeuAc1, with 2PPEA lipid A (Figure 5-10h). Livestock strain, 
31485, had a peak at m/z 4418.4 Da, corresponding to the OS, 
KDO2PEAHep2Hex6HexNAc1NeuAc1, with 2PPEA lipid A (Figure 5-11a). However, for strain 
11168H predicted to have the same OS composition as 31485, a peak at m/z 4256.0 Da 
corresponding to a lipid A modified with only 2P was observed (Figure 5-11g). For strain 
KJShpSm4, a peak at m/z 4256.0 Da corresponded to KDO2PEAHep2Hex5HexNAc1NeuAc1 OS 
plus a 2PPEA lipid A (Figure 5-11c). Strains 56282 and 32799 showed peaks corresponding 
to the KDO2PEAHep2Hex4HexNAc1NeuAc2 OS at m/z 2379.5 and 2379.7 Da respectively 
(Figure 5-11d and e). The peak seen at m/z 3874.0 Da for KJcattle8 corresponded to the 
KDO2PEAHep2Hex2HexNAc2NeuAc1 OS plus a lipid A modified with 2PPEA (with loss of one 
phosphate) (Figure 5-11f).   
To obtain structural composition of environmental strains 43205, 32787, and 56519 high 
resolution MALDI-TOF analyses were performed on the native LOS structures. These 
analyses revealed peaks that corresponded to exact masses of structures opposed to the 
average masses seen with lower resolution MALDI-TOF. Strains 32787 and 56519 yielded  
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Figure 5-12: No correlation between the phylogenetic clade of C. jejuni strains and the 
presence of LOS phosphate groups  
The relative abundance of lipid A species modified with either 3 or 4 phosphoryl groups 
(phosphate or phosphoethanolamine) was calculated from two individual spectra for each 
strain based on the area under the peaks of the masses from Table 0-5. The relative 
abundances were plotted against (a) the phylogenetic clade of each strain (b) the clinical 
presentation of each strain. 
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Figure 5-13: No correlation between the percentage of amide linkages and the 
phosphorylation status of the lipid A 
The relative abundance of GlcN3N-GlcN3N lipid A backbone was plotted against the 
relative abundance of lipid A backbone modified with 3 or 4 phosphoryl groups for each 
strain.  
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peaks at m/z 2282.1 and 2282.8 respectively corresponding to an OS composed of 
KDO2PEAHep2Hex7P2Ac. Strain 43205 had an OS peak at m/z 2345.7 of unknown 
composition. Currently these are provisional structures for these strains and await further 
confirmation by MS.  
The sialic acid residues of C. jejuni LOS from particular strains can be modified with the 
addition of O-linked acetyl groups (Dzieciatkowska et al. 2007). The gene responsible 
encodes an O-acetyl transferase; SOAT (sialylate O-acetyltransferase). Using primers for the 
SOAT gene which has high identity between strains, only 5 of the 15 strains under 
investigation were found to encode this gene (Figure 5-14). Of these 5 positive strains all 
encoded sialic acid synthesis genes from LOS class A or B, two were from the 
environmental clade and 3 were from the livestock clade. The addition of acetyl groups 
could be seen in the spectra for two strains, 56282 and 32799 (Figure 5-11d and e). Peaks 
at m/z 2423.9 and 2423.3 Da corresponded to the addition of an acetyl group to the OS of 
56282 and 32799 respectively. In addition peaks at m/z 2439.1 and 2437.6, and 2479.3 and 
2480.6 Da correlated with the addition of a glycine residue and both glycine and an acetyl 
group on the 56282 and 32799 OS respectively.  
5.6 Discussion 
Mass spectroscopy combined with gene analysis revealed differences in three structural 
components of C. jejuni LOS, these included variation in the number of amide versus ester 
linkages, lipid A phosphorylation and the carbohydrate moiety.  These observations confirm 
previous reports on the diversity of C. jejuni LOS (Moran et al. 1991; Szymanski et al. 
2003).It was found that only the OS structure variations correlated with the phylogenetic 
clade, this was a novel finding (Table 5-4, Figure 5-6, Figure 5-7, Figure 5-8, Figure 5-9). The 
level of phosphorylation and abundance of amide linkages was not distinguished by clade 
(Figure 5-5, Figure 5-12). The level of phosphorylation and abundance of amide linkages has 
previously been reported to vary between growths of one particular strain of C. jejuni as 
well as between strains, whereas the expression of the OS does not vary (unless OS genes 
are under phase variable regulation (Szymanski et al. 2003)). This may explain the lack of 
correlation, despite the wide range in the expression of these modifications between 
strains. The variability of these modification in the lipid A backbone has been suggested as 
a potential virulence factor, as both the chemical linkages of the acyl groups and lipid A 
phosphorylation status have been shown to modulate the immune response to C. jejuni 
and other pathogens (Liu, John, & Jarvis 2010; Van Mourik et al. 2010). The ability of the 
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Figure 5-14: Detection of SOAT genes in Campylobacter jejuni 
SOAT gene was amplified by PCR in 15 strains under investigation and visualised by agarose 
gel electrophoresis followed with gel-red staining. 30 PCR cycles were performed at an 
annealing temperature of 55oC for SOAT and htrB primers.  
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LOS isolated from these different strains to activate innate immune cells is explored further 
in Chapter 6.  
Interestingly, no correlation between the C. jejuni strains isolated from either humans 
presenting with clinical symptoms of disease or asymptomatic carriers was observed for 
the abundance of amide linkages, the phosphorylation of the lipid A, or the OS structure. 
This is in keeping with previous findings showing no phylogenetic link between C. jejuni 
strains with similar clinical outcomes (Champion et al. 2005). This data suggests that that 
the host rather than bacterial factors may play a greater role in defining asymptomatic 
carriage of C. jejuni.   
A range in the relative abundance of the GlcN-GlcN, GlcN3N-GlcN, and GlcN3N-GlcN3N was 
observed, although for the majority of the strains the GlcN3N-GlcN backbone was the 
dominant species (Figure 5-3, Figure 5-4, Figure 5-5). GlcN-GlcN lipid A structures were 
seen at a low abundance in a few strains. Recently, the genes responsible for the 
production of the GlcN3N precursor, UDP-GlcNAc3N, have been identified as gnnA and 
gnnB (Van Mourik et al. 2010). These genes are present in the genomes of all strains of C. 
jejuni studied to date. Mutation of either of the genes results in the production of only 
GlcN-GlcN disaccharide lipid A backbone, suggesting that there is an evolutionary 
advantage for C. jejuni in the production of GlcN3N. Indeed, the mutation of these genes 
increased the ability of the C. jejuni LOS to activate a TLR4-reporter cell line, and increased 
the susceptibility of the bacterium to the antimicrobial peptides, polymixin B, colistin, and 
cathelicidin-1 (Van Mourik et al. 2010). This may explain the relative lack of GlcN-GlcN lipid 
A structures for the strains. 
Wide variation in the level of lipid A phosphorylation (addition of phosphate or PEA groups) 
was observed in the intact LOS structures (Figure 5-10, Figure 5-11, Figure 5-12). A diverse 
mix of lipid A structures modified by one or two phosphate groups and one or two PEA 
groups were observed. The spread of the strains in abundance of 3 or 4 phosphoryl 
modifications was greater than seen for the abundance of 4 amide linkages. The 
modification of C. jejuni lipid A with PEA has recently been attributed to the gene, Cj0256 
(Cullen & Trent 2010). Interestingly, mutation of this gene also abolishes modification of 
the flagellar rod protein, FlgG, with PEA residues. An increase of 20-fold in susceptibility to 
polymixin B was observed for the Cj0256 mutant. The modification of Salmonella enterica 
lipid A with PEA groups has also been shown to decrease their susceptibility to polymixin B 
(Lee et al. 2004).  The effects of this Cj0256 mutation on TLR4 activation are unknown. The 
169 
 
abundance of phosphoryl-modification of the lipid A for Neisseria menigitidis is critical for 
TLR4 activation which suggests phosphorylation of C. jejuni may also alter TLR signalling 
(Liu, John, & Jarvis 2010). The effects of C. jejuni phosphorylation on TLR4 activation is 
described in Chapter 6.   
The OS portion is the most variable region of C. jejuni LOS, and has been studied 
extensively; this is due to its association with the onset of GBS (Table 5-4 ; (Godschalk et al. 
2004)). The number of genetic classes of the LOS locus has increased to 19 in recent years 
(Parker et al. 2008). The genes that distinguish these classes largely encode proteins that 
modify the outer core OS. In the present study, use of MALDI-TOF MS has allowed 
prediction of the OS composition for 15 strains of C. jejuni, only one of which was 
previously known. The inner core OS, composed of two heptose residues linked by a KDO 
residue to the lipid A is predicted for all of the strains studied (Table 5-4). Additional 
modification of the inner core with another KDO residue and PEA is also predicted for most 
of the strains. The modification of the two heptose residue in the inner core is performed 
by the lgtF gene product. 11 of the 15 strains encode a two-domain lgtF protein that is 
predicted to add a glucose residue to both heptose residues in the inner core (Figure 5-9; 
(Naito et al. 2010)). The other four strains contained a one-domain lgtF gene that is 
predicted to add only one glucose residue to the heptose residue proximal to the KDO 
linking the OS to the lipid A. Interestingly, the four strains that encoded the one-domain 
lgtF gene were all from the environmental-clade. This correlation is more likely to be a 
reflection of the correlation between the two-domain protein and LOS classes containing 
sialic acid synthesis genes although the possibility of the second glucose being important in 
the colonisation of livestock cannot be ruled out as all ABC LOS classes contain the two 
domain protein (Parker et al. 2008). The outer core OS structure is known to vary widely 
between strains, and it is this portion that contains the antigenic determinants responsible 
for development of auto-reactive antibodies and GBS. Only one study to date has analysed 
the OS structure of non-ABC C. jejuni strains and therefore the present study greatly 
expands on our current understanding of non-ABC OS structures (Houliston et al. 2011).  
The SOAT gene was present in 5 strains containing LOS classes A or B (Figure 5-14), and yet 
MS masses corresponding to O-linked acetyl groups were only found in two strains. The 
acetylation of C. jejuni sialic acid is known to require an α2,8-linked sialic acid, which only 
arises when it is attached to an proximal sialic acid residue (Dzieciatkowska et al. 2007). 
Therefore strains that contain only one sialic acid residue, or strains that contain only α2,3-
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linked sialic acid cannot be modified by the addition of an acetyl group. Only 3 of the 5 
strains from LOS classes A or B contained two sialic acid residues, and two of these strains 
indeed showed peaks by MS for acetyl modification. A most likely explanation for the 
observed data suggested that the third strain with two sialic acid residues may contain only 
α2,3-linked sialic acid or alternatively may have the SOAT gene under phase-variable 
genetic control.  
The flagellin glycosylation Cj1321-26 island is an important genetic marker for the 
distinction of the two C. jejuni phylogenetic clades (Champion et al. 2005). However, even if 
these genes were removed from the analysis the strains still divide into the two distinct 
clades, suggesting a distinct evolutionary separation irrespective of this genetic island. 
Here, all 21/21 strains from the livestock-clade were positive for genes encoding sialic 
synthesis genes; in comparison only 9/20 environment-associated strains were positive. 
The PCR data confirmed MALDI-TOF MS data for all 15 strains. This genetic distinction was 
not noticed during the original microarray study, this is most likely due to a lack of identity 
between the sialic acid synthesis gene, neuB1, amongst strains. Of the 15 strains, 11 were 
also positive for the Cj1324 legionaminic acid synthesis gene, a gene identified as critical in 
distinguishing the phylogenetic clades in the 2005 study (data not shown). Similar to the 
sialic acid synthesis genes, all of the livestock strains tested were positive for Cj1324.  
Multi-locus sequence typing (MLST) is used to group different C. jejuni strains based on 
specific sequences within particular house-keeping genes. In agreement with our findings, a 
separate study showed a greater propensity for C. jejuni poultry and bovine/lamb sources 
to contain sialic acid on the LOS (Hotter et al. 2010). However, another study of 335 C. 
jejuni strains, sampling multiple STs, found ~85% of C. jejuni strains from bovine sources 
contained LOS sialic-acid; this value dropped to ~40% from poultry sources (Revez and 
Hanninen 2012). The smaller sample population of our study (n = 41) may mean that 
sampling bias may have resulted in a greater skew towards sialic acid positive strains from 
the livestock strains. The LOS classes of C. jejuni strains have recently been reported to 
correlate strongly with the ST type of each strain (Revez & Hanninen 2012). As the ST types 
of the strains used in our study are unknown, potentially a sampling bias towards one 
particular ST type may have introduced LOS class bias into the study. However, our data 
agrees with previous reports suggesting an increased association between livestock strains 
and the presence of sialic-acid synthesis genes, even if they do not show as strong a 
correlation as seen in our study.  
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It is interesting to hypothesise that similar to legionaminic acid on the flagellin, sialic acid 
expression on the LOS is required for the long term colonisation of livestock, potentially 
due to the binding to specific receptors. Potentially redundancy between these structurally 
related carbohydrates may account for why not all livestock-associated strains contain both 
sialic-acid and legionaminic acid. In contrast, C. jejuni strains that both lack sialic acid or 
contain it are both able to cause acute disease in humans. Similarly, in the aforementioned 
study only ~45% of human clinical isolates contained sialic acid biosynthesis genes (Revez & 
Hanninen 2012). This data highlights sialic acid as a critical determinant involved in C. jejuni 
interactions with a particular host i.e. livestock versus human.  
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Chapter 6.  
Phosphorylation and Sialylation of C. 
jejuni Lipooligosaccharide Alters Pro-
inflammatory Cytokine Response(s) 
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6.1 Background 
The detection of LPS/LOS moiety of Gram-negative bacteria by the host is essential for the 
elimination and resolution of infection. This has been best demonstrated by the ability of 
the causative agent of plague, Yersinia pestis, to produce tetra-acylated lipid A which is a 
potent antagonist of human TLR4 when grown at 37oC (Montminy et al. 2006). The failure 
of TLR4 to detect Y. pestis LPS allows the rapid systemic dissemination of the bacterium 
often resulting in fatality before an effective immune response can be mounted. Murine 
mouse models also show that removal of MD2, a critical component of the TLR4 
recognition complex, results in increased susceptibility to S. typhimurium infection (Nagai 
et al. 2002). Conversely to the protective role of TLR4 signalling in host defense, 
overactivation of TLR4 can in itself have pathological consequences. For example, LPS/LOS 
is the cause of endotoxic shock during infections; this is mainly due to the induction of high 
levels of pro-inflammatory cytokines and acute-phase proteins (Poltorak et al. 1998). 
Individuals with polymorphisms in TLR4 that render them hypo-responsive to inhaled LPS 
have increased likelihood of suffering from endotoxic shock (Lorenz et al. 2002b). This 
suggests that a muted TLR4 response can also lead to endotoxic shock as a consequence of 
increased bacterial load.  
The recognition of LPS/LOS by TLR4 involves a multiple protein complex. First, the serum 
protein LPS-binding-protein (LBP) extracts LPS/LOS from the bacterial outer membrane, 
LPS/LOS bound LBP is then recognised by CD14 (which can be present in soluble or 
membranous form (Wright et al. 1990). CD14 serves to increase affinity of LPS/LOS for the 
TLR4 complex. Two LPS/LOS moieties are subsequently recognised by the tetrameric TLR4 
complex, composed of two TLR4 and two MD2 molecules (Poltorak et al. 1999; Park et al. 
2009). Engagement of TLR4 leads to the activation of both MyD88-dependant and –
independent (TRIF-dependant) signalling cascades which results in the transcriptional 
activation of a plethora of inflammatory genes (Figure 1-5) 
Structural variation in LPS/LOS between bacterial species results in variable activation of 
human TLR4. Typically, hexacylated lipid A, as seen in Escherichia coli and also C. jejuni, is a 
potent activator of TLR4. Both tetra-acylated lipid A, such as lipid IVa (an intermediary in E. 
coli lipid A biosynthesis) or from Y. pestis, and penta-acylated lipid A, from Rhodobacter 
sphaeroides, are antagonists of human TLR4 (Lien et al. 2000; Lohmann et al. 2003; 
Montminy et al. 2006). Additionally phosphate modifications of the lipid A backbone from 
S. enterica and Neisseria meningitidis induce higher levels of TLR4 activation (Liu, John, & 
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Jarvis 2010; Mata-Haro et al. 2007). In the case of C. jejuni LOS, the amide linkage of the 
acyl chains reduces to human TLR4 activation when compared to the presence of an ester 
linkage (Van Mourik et al. 2010). At present, the contribution of the phosphorylation status 
of the lipid A moiety to TLR4 activation is unknown. An added complication to dissecting 
these interactions is that the same strain can vary many of these modifications as described 
in Chapter 5.   
The elucidation of the three-dimensional structure of hexacylated E. coli LPS in complex 
with TLR4/MD2 has greatly aided in our current understanding of TLR4 activation (Park et 
al. 2009). The accommodation of hexacylated lipid A into the hydrophobic β-sheet folds of 
MD-2 leaves one acyl chain partially exposed creating the dimerisation interface for TLR4. 
Alteration in the lipid A conformation upon dimerisation allows interaction between 
phosphate groups on the lipid A backbone and positively charged residues in TLR4 and 
MD2 which aids formation of the complex. TLR4 undergoes a conformational change upon 
dimerisation; a conformation that allows the docking of adaptor molecules to the 
intracellular TIR domain resulting in the activation of downstream signalling.  
Interestingly, human TLR4 is far less promiscuous than murine TLR4. Tetra-acylated lipid A 
is an agonist of murine TLR4 whilst an antagonist of human TLR4. It has been suggested 
that the differences in affinity for LPS structures may account for the variations in disease 
outcomes between mice and humans (Miller et al. 2005). The differences between human 
and mice TLR4 highlight the necessity to use human cells during studies assessing LPS/LOS 
activation.   
6.2 Sialic acid on C. jejuni LOS impacts on TNF-α production from 
THP-1 cells 
In chapter 5, interesting distinctions in the LOS structure from C. jejuni strains of the 
different phylogenetic clades were described. We next wished to investigate if these 
structural differences translated into differential TLR4-mediated immune response(s). For 
this purpose, the release of TNF-α in response to C. jejuni LOSs’ was investigated. The 
monocytic cell-line THP-1 was employed for these studies. Prior to stimulation, THP-1 cells 
were treated overnight with phorbol 12-myristate 13-acetate (PMA) to induce 
differentiation of pro-monocytic cells to cells with phenotypic similarities to 
monocytes/macrophages (Daigneault et al. 2010). Cells were stimulated with either 10ng 
or 100ng of isolated LOS and TNF-α protein levels were quantified 20h post stimulation. At 
10ng concentration, LOS from the livestock strains induced approximately twice the 
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amount of TNF-α than that observed in response to LOS from the environmental strains, 
interestingly this difference rose to 50% at 100ng concentration (Figure 6-1). These 
observations suggested that structural differences found in the LOS from the two 
phylogenetic clades may indeed impact on TLR4 function as noted by variation in TNF-α 
levels.  
We next wished to know if the whole live bacteria from the different clades showed a 
similar pattern of TLR4 activation as noted in the presence of their respective purified LOS. 
For this series of experiments optimisation assays to assess bacterial growth rates were 
first performed (Figure 6-2). This was necessary as differential growth rates may of C. jejuni 
strains may alter cytokine induction. The CFU counts at an OD of 1 (equivalent to 3 x 
109/mL CFU of strain 11168H) were comparable between the strains; with the exception of 
the environmental strain, 40917 (Figure 6-2 white bars). The CFU counts after 24h in 
culture media (RPMI containing 10% FCS, 5% CO2, ,37
oC without shaking) increased ~10-fold 
with the exception of environmental strains 43205 and 31481 which remained similar to 
the initial inoculum (Figure 6-2 black bars). The strain with the lower initial CFU count, 
40917, had similar final CFU counts to the other strains. This data suggested that C. jejuni 
strains under investigation contained similar CFU counts in the initial inoculum and also no 
significant difference was noted in the growth rates of the various strains.  
To assess the ability of live bacteria to induce TNF-α, co-cultures studies utilising C. jejuni at 
an MOI of 10 or 100 were conducted (Figure 6-3). There was a statistically significant 
increase in TNF-α production by the livestock-associated strains over the environmental 
strains upon stimulation with live bacteria (Figure 6-3; p = 0.04). At an MOI 100, the mean 
secretion of TNF-α induced by the livestock strains was approximately 50% higher than the 
environmental strains, however the spread of the data was far larger and the difference 
was no longer statistically significant. Similarity between the live infection and the 
corresponding purified LOS effects on TNF-α production suggested that the distinctions in 
the LOS structures are most likely to impact on the immunity and maybe a critical 
determinant defining disease outcome.  
LOS sialylation is known to contribute to higher levels of pro-inflammatory cytokines during   
C. jejuni–mediated DC activation (Kuijf et al. 2010). As only 45% of the environmental clade-
associated strains contained sialic acid versus 100% for the livestock clade-associated 
strains the correlation between LOS sialylation and TNF-α production was assessed. Figure 
6-4 shows the data presented in Figure 6-1 but in this instance the data was re-derived to  
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Figure 6-1: Differential TNF-α production in response to stimulation with LOS moieties 
from C. jejuni strains belonging to the livestock and environmental phylogenetic clades.  
1x 105 PMA-matured THP-1 cells were stimulated with either 10ng or 100ng of LOS isolated 
from 8 environment-clade associated strains or 7 livestock-clade associated strains for 20h. 
TNF-α levels were analysed by ELISA. Data are plotted against the phylogenetic clade of 
each strain. Each dot represents average TNF-α levels induced by LOS isolated from an 
individual strain from four independent experiments. Mann-Whitney statistical test 
performed.   
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Figure 6-2: Bacteria CFU counts and survival data 
CFU counts were performed for individual strains at an OD 0.03 (white bars; calculated to 
be 1 x108 CFU/mL for strain 11168H from previous experiments). Bacteria were left in 
culture media for 20h at 37oC under aerobic condition without shaking to mimic infection 
conditions and CFU counts were subsequently performed (black bars).   
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Figure 6-3: Live bacteria from the livestock phylogenetic clade induce higher levels of 
TNF-alpha from THP-1 cells 
1x 105 PMA-matured THP-1 cells were stimulated with the 8 environment and 6 livestock-
clade associated C. jejuni strains at an MOI 10 or 100 for 20h. TNF-α levels were analysed 
by ELISA. Data are plotted against the phylogenetic clade of each strain. Each dot 
represents average TNF-α levels induced by live bacteria of an individual strain from four 
independent experiments. Mann-Whitney statistical test performed.  
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Figure 6-4: Presence of sialic acid on C. jejuni LOS increases TNF-α levels in THP-1 cells  
1x 105 PMA-matured THP-1 cells were stimulated with either (a) 10ng or (b) 100ng of LOS 
isolated from 8 environment-clade associated strains or 7 livestock-clade associated strains 
for 20h. TNF-α levels were analysed by ELISA. Data are plotted against the number of sialic 
acid residues in the LOS of each strain. Each dot represents average TNF-α levels induced 
by LOS isolated from an individual strain from four independent experiments. One-way 
ANOVA statistical analysis performed with Tukey post-test. No stars = not significant; * 
<0.05; ** <0.01; ***<0.001. 
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separate the strains into groups based on their expression of 0, 1, or 2 sialic acid residues. 
There was a progressive increase in the levels of TNF-α induced with increasing numbers of 
sialic acid at 10ng LOS (Figure 6-4a). This increase was statistically significant between no 
sialic acid containing and 2 sialic-acid containing LOS structures (p < 0.01). At 100ng the 
increase induced by LOS from strains that contain 1 and 2 sialic acid residue was similar 
(Figure 6-4a). These differences were also observed when THP-1 cells were exposed to live 
bacteria (Figure 6-5). At an MOI 10 a significant increase in TNF-α production was observed 
by strains containing 1 sialic acid residue over sialic-acid negative strains (Figure 6-5a). At 
an MOI 100 there was a progressive increase in TNF-α induction with increasing numbers of 
sialic acid residues, however due to the spread of the data the difference was only 
statistically significant between strains that contain 0 and 2 sialic acid residues (Figure 6-5b; 
p < 0.05). Collectively, this data suggested a correlation between the level of LOS sialylation 
and TNF-α production, in response to both purified LOS and live bacteria; sialylation may 
therefore account for the observed increase in TNF-α levels noted in response to infection 
with livestock strains.     
6.3 C. jejuni lipid A phosphorylation impacts on TNF-α production  
The experiments described above were performed during a 3 month visit to Professor Gary 
Jarvis’s laboratory (University of California, San Francisco (UCSF)). Similar experiments were 
performed on returning to ICH and surprisingly the impact of increasing LOS sialylation had 
less impact on experiments performed in the UK, although there was still a statistically 
significant correlation (Figure 6-6; p < 0.05). The preparations of the LOS were the same in 
both sets of experiments; however the THP-1 cells were different. Interestingly, the 
magnitude of TNF-α induced was also different between the UK and US THP-1 cells. TNF-α 
levels induced in the US THP-1 cells ranged between 200-1000pg/mL 20h post-infection, 
compared to 3000-4000pg/mL in the UK THP-1 cells. This data suggested that potential 
biological differences between US and UK THP-1 cells may impact on responsiveness to C. 
jejuni LOS stimulation. 
A previous report indicated that the amide linkage between the acyl chain and the lipid A 
backbone generates a C. jejuni LOS that is less potent in activating TLR4 when compared to 
an LOS with ester linkages (Van Mourik et al. 2010). Data in Chapter 5 highlighted the 
potential of different strains to express varying levels of amide and ester linkages, although 
this did not correlate with the phylogenetic clade of the strain. The potential correlation 
between amide linkage abundance and the induction of TNF-α was assessed by plotting  
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Figure 6-5: Presence of sialic acid on C. jejuni LOS increases TNF-α levels in THP-1 cells in 
response to live bacteria  
1x 105 PMA-matured THP-1 cells were stimulated with either (a) an MOI 10 or (b) an MOI 
100 of 8 environment-clade associated strains or 6 livestock-clade associated C. jejuni 
strains for 20h. TNF-α levels were analysed by ELISA. Data are plotted against the number 
of sialic acid residues in the LOS of each strain. Each dot represents average TNF-α levels 
induced by live bacteria from an individual strain from four independent experiments. One-
way ANOVA statistical analysis performed with Tukey post-test. No stars = not significant; * 
<0.05; ** <0.01; ***<0.001. 
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Figure 6-6: Sialic acid on LOS has less impact on TNF-α secretion from UK THP-1 cells 
1x 105 PMA-matured THP-1 cells were stimulated with either (a) 10ng or (b) 100ng of LOS 
isolated from 8 environment-clade associated strains or 7 livestock-clade associated strains 
for 20h. TNF-α levels were analysed by ELISA. Data are plotted against the number of sialic 
acid residues in the LOS of each strain. Each dot represents average TNF-α levels induced 
by LOS isolated from an individual strain from five independent experiments. One-way 
ANOVA statistical analysis performed with Tukey post-test. No stars = not significant; * 
<0.05; ** <0.01; ***<0.001.  
0 1 2
0
500
1000
1500
2000
2500
3000
3500
4000
4500 *
No. of sialic acids
T
N
F
- 
 (
p
g
/m
L
)
0 1 2
0
500
1000
1500
2000
2500
3000
3500
4000
4500
No. of sialic acids
T
N
F
- 
 (
p
g
/m
L
)
(a)
(b)
183 
 
cytokine levels against the percentage of lipid A from each strain that contained 4 amide 
linkages (Figure 6-7). Only strains containing sialic acid were analysed to eliminate 
confounding the data. Although there was a trend towards reduced TNF-α production with 
increasing abundance of the 4 amide linkages in the lipid A backbone this was not 
statistically significant when data from the US THP-1 cells was analysed (Figure 6-7). 
However, there was a statistically significant correlation between the abundance of amide 
linkages and decreasing TNF-α production  from the UK THP-1 cells stimulated with 10ng 
but not 100ng LOS (r2 = 0.66; Figure 6-7c and d). This data suggested a correlation between 
the abundance of amide linkages and a reduction in pro-inflammatory responses may 
occur. 
Lipid A phosphorylation status can affect pro-inflammatory responses via an increase in 
TLR4 stimulation from other bacterial species (Liu, John, & Jarvis 2010). In chapter 5 it was 
established that the relative abundance lipid A modified with 3 or 4 phosphate compared 
to 0, 1, or 2 varied between the 15 strains of C. jejuni studied, although similar to the amide 
linkage data this did not correlate with the phylogenetic clades. The effect of lipid A 
phosphorylation status on TNF-α levels was analysed by plotting TNF-α levels against 
abundance of lipid A modified with 3 or 4 phosphate groups. Figure 6-8a and b shows a lack 
of correlation between the relative abundance of 3 or 4 phosphate groups and TNF-α from 
the US THP-1 cells at 10ng and 100ng concentration respectively. In contrast, a clear 
correlation between the level of phosphorylation and the induction of TNF-α was observed 
at the 10ng LOS concentration for the UK THP-1 cells (r2 =0.81, p = 0.0003), and 100ng 
concentration (r2 = 0.41, p = 0.045) (Figure 6-8c and d). This data suggested a strong 
correlation between the level of phosphorylation of the lipid A and the induction of pro-
inflammatory responses, however this was only observed in the UK THP-1 cells. 
In chapter 5, no correlation between the levels of phosphorylation and the number of 
amide linkages was found, however the strain with the highest abundance for amide 
linkages also expressed the lowest levels of phosphate groups on the lipid A (strain 
11168H). These two factors were both predicted to reduce levels of TNF-α therefore it was 
important to re-analyse the data without this one strain. Removing 11168H from the amide 
linkage correlation graph (Figure 6-7) meant the correlation was no longer statistically 
significant, therefore this correlation relied heavily on this one data point. For the 
phosphorylation correlation, the removal of the one point decreased the r2 value from 0.83 
(p = 0.0003) to 0.73 (p = 0.003) for 10ng and from 0.41 (p = 0.045) to 0.38 for 100ng (p =  
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Figure 6-7: Amide linkages in C. jejuni LOS influence TNF-α secretion in UK THP-1 cells 
1x 105 PMA-matured THP-1 cells were stimulated with either (a) and (c) 10ng or (b) and (d) 
100ng of LOS isolated from 10 sialic-acid containing C. jejuni strains for 20h. TNF-α levels 
were analysed by ELISA. Data are plotted against percentage abundance of lipid A 
containing four amide linkages. (a) and (b) data from US THP-1 cells. (c) and (d) data from 
UK THP-1 cells. Each dot represents average TNF-α levels induced by LOS isolated from an 
individual strain from at least four independent experiments. Linear regression statistical 
analysis performed. 
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Figure 6-8: Phosphate groups on the lipid A on C. jejuni LOS increase TNF-α production 
1x 105 PMA-matured THP-1 cells were stimulated with either (a) and (c) 10ng or (b) and (d) 
100ng of LOS isolated from 10 sialic-acid containing C. jejuni strains for 20h. TNF-α levels 
were analysed by ELISA. Data are plotted against percentage abundance of lipid A modified 
with either 3 or 4 phosphate groups. (a) and (b) data from US THP-1 cells. (c) and (d) data 
from UK THP-1 cells. Each dot represents average TNF-α levels induced by LOS isolated 
from an individual strain from at least four independent experiments. Linear regression 
statistical analysis performed. 
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0.08). This showed that the correlation between the phosphorylation and induction of TNF-
α did not rely heavily on this one strain. This data suggested the presence of the 11168H 
data point in the amide linkage correlation may confound the analysis as it has low levels of 
phosphorylation in addition to high amide linkage abundance.   
6.4 Potential role of LOS sialic acid and phosphorylation in 
modulating primary human monocyte response(s) 
We next wished to investigate the impact of LOS modifications on human peripheral blood 
monocytes. Interestingly, of 6 donors studied 3 showed a progressive increase in TNF-α 
induction with increasing numbers of sialic acid residues on the LOS (Figure 6-9a; p < 0.01). 
5 of the 6 donors showed a correlation between the degree of lipid A phosphorylation and 
TNF-α protein levels (Figure 6-9b; r2 = 0.61 p = 0.01). This data confirmed our previous 
observations obtained in the THP-1 cell line. The data also highlighted that differences in 
responsiveness to different structural elements of the LOS was donor- dependent.  
As induction of pro- and anti-inflammatory cytokines can be differentially regulated, it was 
imperative to investigate the impact of C. jejuni LOS modifications on IL-10 production. The 
same donors that induced increased levels of TNF-α in response to LOS sialylation also 
showed increased levels of IL-10.  Figure 6-10a shows IL-10 data from these three donors. 
In contrast, none of the donors showed a correlation between the induction of IL-10 and 
the phosphorylation of the lipid A (Figure 6-10b). This data suggested LOS sialylation 
impacts both on pro- and anti-inflammatory TNF-α and IL-10 responses, in contrast lipid A 
phosphorylation only influenced TNF-α responses. 
In Chapter 5, a correlation between the presence of the one-domain lgtF gene and a lack of 
sialic acid synthesis genes in the C. jejuni LOS locus was observed. To confirm that the 
cytokine responses observed in response to purified LOS was influenced by sialic acid 
residues and not the glucose modifications of the inner core OS (encoded by lgtF) biological 
assays were repeated using sialidase treated-LOS. LOS was treated with sialidase from 
Athrobacter ureafaciens, which is the only known sialidase to remove internally branched 
sialic acid residues (Uchida et al. 1979). Removal of the sialic acid from the LOS reduced the 
mean level of TNF-α in THP-1 cells; this decrease was observed only in the LOS that 
contained sialic acid (Figure 6-11). Comparable levels of TNF-α secretion were observed 
between the strains that lacked sialic acid and the sialidase-treated LOSs’. In addition, the 
sialidase treated LOS also caused less potent TNF-α production in monocytes from 2 donors 
(Figure 6-11b). Although the present study was relatively small, the data suggested that  
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Figure 6-9: Sialic acid residues and phosphorylation on the lipid A influence TNF-α 
production from primary human monocytes 
1 x 105 human peripheral blood monocytes were stimulated with either 10ng of LOS 
isolated from (a) 8 environment-clade associated strains and 7 livestock-clade associated 
strains (b) 9 sialic-acid containing C. jejuni strains for 20h. TNF-α levels were analysed by 
ELISA. Data were plotted against (a) number of sialic acid residues (b) percentage 
abundance of lipid A modified with either 3 or 4 phosphate groups. Each dot represents 
average TNF-α levels induced by LOS isolated from an individual strain from at least four 
independent experiments. (a) One-way ANOVA statistical analysis performed with Tukey 
post-test. No stars = not significant; * <0.05; ** <0.01; ***<0.001. (b) Linear regression 
statistical analysis performed. 
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Figure 6-10: Sialic acid but not phosphorylation on C. jejuni LOS influences IL-10 
production by primary human monocytes 
1x 105 human peripheral blood monocytes were stimulated with either 10ng of LOS 
isolated from (a) 8 environment-clade associated strains and 7 livestock-clade associated 
strains (b) 10 sialic-acid containing C. jejuni strains for 20h. IL-10 levels were analysed by 
ELISA. Data were plotted against (a) number of sialic acid residues (b) percentage 
abundance of lipid A modified with either 3 or 4 phosphate groups. Each dot represents 
average IL-10 levels induced by LOS isolated from an individual strain from at least four 
independent experiments. (a) One-way ANOVA statistical analysis performed with Tukey 
post-test. No stars = not significant; * <0.05; ** <0.01; ***<0.001. (b) Linear regression 
statistical analysis performed. 
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Figure 6-11: Sialidase treatment of sialic-acid containing LOS reduces TNF-α production in 
primary monocytes 
1 x 105 (a) UK THP-1 cells (b) human monocytes were stimulated with 10ng LOS either 
treated with 0.8U/mL sialidase from Arthrobacter ureafaciens (N-treated) or untreated for 
20h. TNF-α levels were analysed by ELISA. Each dot represents average TNF-α levels 
induced by LOS isolated from an individual strain from (a) five independent experiments (b) 
two individual donors. (a) Mann-Whitney statistical analysis performed (b) One-way 
ANOVA statistical analysis performed with Tukey post-test. No stars = not significant; * 
<0.05; ** <0.01; ***<0.001. 
U
nt
re
at
ed
 0
 
N
-t
re
at
ed
 0
 
U
nt
re
at
ed
 1
 o
r 
2 
N
-t
re
at
ed
 1
 o
r 
2 
0
1000
2000
3000
4000
5000
p = 0.02
ns
No. of sialic acids
T
N
F
-
 (
p
g
/m
L
)
U
nt
re
at
ed
 0
 
N
-t
re
at
ed
 0
 
U
nt
re
at
ed
 1
 o
r 
2 
N
-t
re
at
ed
 1
 o
r 
2 
0
1000
2000
3000
4000
5000 *
ns
T
N
F
-
 (
p
g
/m
L
)
(a)
(b)
190 
 
LOS sialic acid residue mediated an increase in TNF-α, and different structural feature on 
the LOS such as the glucose residues on the inner core OS were less critical. 
Lipid IVa, an antagonist of human TLR4, was used to assess the importance of TLR4 on the 
induction of TNF-α levels (Lien et al. 2000). THP-1 cells were pre-treated with either 50 or 
500ng/mL Lipid IVa for 1h prior to stimulation with 10ng/mL LOS in the presence of the 
inhibitor for a further 20h. In the presence of 50ng/mL of the inhibitor there was  a marked 
reduction in TNF-α levels in response to both sialylated and non-sialylated LOS; this 
reduction was even more prominent (>90% reduction) at the 500ng/mL concentration 
(Figure 6-12). No statistical difference in TNF-α levels were observed between sialylated 
and non-sialylated LOS at both 50ng/mL and 500ng/mL which suggested that sialylation 
mediated its pro-inflammatory effects via TLR4. The almost complete inhibition in the LOS-
stimulated TNF-α levels in the presence of the inhibitor also indicated that the LOS 
preparations utilised were of high purity with minimal lipoprotein contamination (TLR2 
agonists) which is a common problem with LOS/LPS preparations. For control experiments, 
peptidoglycan (PGN), a known TLR2 agonist, was used to stimulate THP-1 cells in the 
presence of Lipid IVa. 1µg/mL PGN stimulation is the absence of lipid IVa induced and 
average of ~1700pg/mL TNF-α after 20h, compared to ~1500pg/mL in the presence of 
500ng/mL lipid IVa  showing that there was non-specific effect of treating the cells with the 
Lipid IVa inhibitor. 
A TLR4 reporter cell-line was utilised to assess the effects of structural differences in C. 
jejuni LOS specifically during TLR4 engagement. Human embryonic kidney (HEK) cells 
express no or minimal basal levels of TLRs which therefore makes it a good reporter cell-
line to genetically over-express and analyse TLR function. HEK293 cells stably transfected 
with human TLR4, CD14, and MD-2 co-receptors and in addition a secreted embryonic 
alkaline phosphatase (SEAP) reporter gene were employed (Invivogen). The SEAP gene was 
under the control of a minimal IL-12p40 promoter with additional transcription binding 
sites for NF-κB and AP-1 which render the SEAP responsive upon TLR4 engagement. The 
level of SEAP activity was assessed by the addition of a substrate which underwent colour 
change in the presence of alkaline phosphatase. An increasing trend towards higher TLR4 
activity with increasing LOS sialylation was observed (Figure 6-13a). There was a large 
spread of the data from LOS that contained one sialic acid but statistical significance was  
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Figure 6-12: TLR4 signalling is essential for C. jejuni LOS-mediated TNF-α induction in THP-
1 cells 
1x 105 PMA-treated UK THP-1 cells were pre-treated for 1h with Lipid IVa at 50ng/mL or 
500ng/mL, or left untreated. 10ng LOS isolated from 8 environment-clade associated 
strains or 7 livestock-clade associated strains were used to stimulate the cells for 20h. TNF-
α levels were analysed by ELISA. Each dot represents average TNF-α levels induced by LOS 
isolated from an individual strain from three independent experiments. One-way ANOVA 
statistical analysis performed with Tukey post-test. ns = not significant; * <0.05; ** <0.01; 
***<0.001. 
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Figure 6-13: Sialic acid on the LOS influences TLR4 activation in a TLR4-reporter cell line 
HEK/TLR4 SEAP reporter cells were stimulated with 1ng/mL purified LOS from (a) 8 
environment-clade associated strains and 7 livestock-clade associated strains (b) & (c) 10 
sialic-acid containing C. jejuni strains for 20h. SEAP activity was measured with the addition 
of an alkaline phosphatase sensitive substrate that turned blue/purple upon phosphatase 
activity. Data are from three independent experiments and are plotted against (a) the 
number of sialic acid residues in the LOS of each strain (b) the percentage abundance of 
four amide linkages in the lipid A backbone (c) percentage abundance of 3 or 4 phosphate 
groups on the lipid A. (a) Mann-Whitney statistical analysis performed on specific columns.  
(b) and (c) Linear regression statistical analysis performed.   
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noted between the non-sialylated versus LOS containing 2 sialic acid residues (p < 0.05). 
There was no statistically significant correlation between TLR4 function and the level of LOS 
phosphorylation nor with the extent of amide linkage (Figure 6-13b and c). This data clearly 
suggested that LOS sialylation directly impacted on TLR4 engagement.  
6.5 Discussion 
The present study highlighted a significant difference in monocytic/macrophage derived 
TNF-α production in response to C. jejuni LOS from the two different phylogenetic clades 
(Figure 6-1). LOS sialylation was found to be the main structural feature contributing to this 
biological response. In Chapter 5, 7/7 of the livestock strains were found to contain sialic 
acid compared to only 3/5 of the environmental strains. Comparing cytokine response(s) 
with the expression of sialic acid clearly showed that THP-1 cell-derived TNF-α levels were 
dependent upon the presence of LOS sialic acid; in primary human monocytes both TNF-α 
and IL-10 production showed this dependence (Figure 6-4; Figure 6-9; Figure 6-10). 
Evidence for these findings were obtained by exposing cells to sialidase-treated LOS. Co-
cultures in the presence of treated LOS led to reduced TNF-α levels confirming the 
importance of sialylation (Figure 6-11). A previous study reported the importance of sialic 
acid on C. jejuni LOS in modulating human monocyte-derived DC cytokine responses (Kuijf 
et al. 2010). The induction of cytokines was significantly reduced in DCs stimulated with 
either sialidase-treated LOS or LOS isolated from the sialic acid transferase mutant, ∆cstII. 
By analysing the effects of natural variants of C. jejuni LOS sialylation, the current study 
extends our current knowledge of C. jejuni LOS sialylation function. 
The effects of LOS sialylation were found to be TLR4 dependent. The inhibition of TLR4 
using the antagonist, lipid IVa caused marked reduction (~90%)  in  TNF-α levels and this 
effect abolished the observed differences between the sialylated and non-sialylated strains 
(Figure 6-12). In addition, the level of sialylation impacted on the degree of TLR4 activation 
(Figure 6-13). The ability of C. jejuni LOS sialylation to alter TLR4 responses has previously 
been reported (Kuijf et al. 2010). LOS isolated from a ∆cstII mutant induced <50% activity 
when compared to its WT counterpart. The sialic-acid modification of C. jejuni LOS has 
been identified as important in binding to two receptors: Sialoadhesin and Siglec-7 (Avril et 
al. 2006; Heikema et al. 2010). Siglec-7 is able to bind to terminal α2,8-linked sialic acid, 
whereas Sialoadhesin binds terminal linked α2,3-linked sialic acid. Interestingly, DC-
mediated cytokine responses and downstream polarisation of naïve T cells differs 
depending on linkage conformation of the sialic-acid on the LOS (Bax et al. 2011). In the 
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current study the potential differences in sialic acid linkage between various LOS species 
was not investigated and at present remains unknown. As differences in sialylation 
impacted on TLR4 signalling in a reporter cell line that lacks expression of Siglecs, the 
potential importance of Siglecs or other co-receptors in the differential responses between 
non-sialylated and sialylated LOS requires further investigation. . The ability of most Siglecs 
to signal via intracellular inhibitory ITIM motifs to dampen inflammation also raises 
mechanistic concerns over the ability of Siglecs to modulate pro-inflammatory responses 
(Cao and Crocker 2011b).  A more plausible mechanism for the differential responses is a 
direct impact of sialylation on the recognition LOS by the TLR4-MD2 complex. However, no 
known structural studies have elucidated how sialylation may impact on TLR4 recognition 
and engagement; to date only the inner core OS residues have been shown to interact with 
the TLR4-MD2 complex and any potential interactions between the outer core of the OS 
and the host TLR complex remain ill-defined (Park et al. 2009).  
The effects of LOS sialylation on DC TNF-α production were reproducible in cells stimulated 
by whole live bacteria, signifying the importance of structural modification of C. jejuni LOS 
in the recognition of the whole bacterium by the innate immune system (Figure 6-3). 
Interestingly, LOS sialylation of C. jejuni human clinical isolates is associated with severity of 
gastro-enteritis (Mortensen et al. 2009). Patients infected with C. jejuni bearing sialic-acid 
on the LOS are more likely to suffer from bloody diarrhoea and have longer duration of 
symptoms. Sialylation of C. jejuni LOS has also been shown to increase C. jejuni invasion of 
IECs (Louwen et al. 2008). It is possible that both the increased invasion of IECs and 
elevated pro-inflammatory responses contributes to the severity of gastro-enteritis. In 
patients, elevated antibody responses are also associated with sialylated C. jejuni strains 
(Mortensen et al. 2009). In vitro studies indicate that sialylated C. jejuni strain-mediated DC 
activation lead to enhanced B-cell responses (Kuijf et al. 2010). In summary, sialylation of C. 
jejuni LOS affects many aspects of the host-pathogen crosstalk; this spectrum ranges from 
initial epithelial/innate immune response to later adaptive immune outcome.  
Pathogenic bacteria have adapted sialylation as a successful immune evasion strategy. This 
moiety can be employed via a number of different mechanisms. Sialic acid on Neisseria 
menigitidis LOS inhibits DC phagocytosis and it impairs complement activation for Neisseria 
gonorrhoea (Ngampasutadol et al. 2008; Unkmeir et al. 2002). Interestingly, the sialylation 
of Neisseria mengitidis LOS has no impact on cytokine induction, suggesting that the 
influence of LOS structural modifications is pathogen specific (Pridmore et al. 2003). 
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Sialylation of Group B Streptococcus capsular polysaccharide engages the inhibitory 
receptor, Siglec-9, which reduces neutrophil oxidative burst (Carlin et al. 2009b). Complex 
interactions have evolved between pathogens and the host; sialic acid on microbes clearly 
interacts with the host innate immune system; in the case of C. jejuni our data suggested 
that sialic acid can elevate pro-inflammatory responses via increased activation of PRRs. It 
is interesting to speculate that the nature of these interactions may be critical for the 
outcome of C. jejuni depending on the host. As 100% of all livestock strains analysed 
contain genes required to sialylate the LOS, this may be critical for a potential receptor 
interaction or immune evasion strategy that allows long-term colonisation of livestock. 
Conversely, LOS sialylation is not essential for acute pathogenic infection of the human 
host, although it increases disease severity. This suggests that the interaction between the 
sialylated LOS and the human immune system is very different to that seen in livestock.  
Phosphate modification (addition of phosphate or phosphoethanolamine groups) of lipid A 
in other pathogens is known to be critical in increasing cytokine induction in innate 
immune cells (Liu, John, & Jarvis 2010). Variation in the level of lipid A phosphorylation 
between C. jejuni strains has previously been observed but not quantified (Szymanski et al. 
2003). Here, the level of phosphorylation of different C. jejuni strains was found to strongly 
correlate with the induction of TNF-α from UK THP-1 cells and human primary monocytes 
(Figure 6-8; Figure 6-9). The recently elucidated crystal structure of the TLR4-MD2 complex 
with hexacylated Escherichia coli LPS highlighted the critical importance of lipid A 
phosphorylation in the formation of the TLR4-MD2 complex (Park et al. 2009). The two 
phosphate groups form interactions with a cluster of positively charged residues on both 
MD-2 and TLR4, and a hydrogen bond forms with a residue in MD-2, aiding the formation 
of the heterodimer. It is interesting to speculate that additional phosphate groups on C. 
jejuni LOS may form additional interactions in the TLR4-MD2 complex increasing the 
signalling capacity of the receptor complex and therefore increasing downstream cytokine 
induction. Disappointingly, phosphorylation levels did not alter the induction of TLR4 in the 
HEK/TLR4 reporter cell line (Figure 6-13). This may have been a problem with saturation of 
TLR4 activation, lower concentrations of LOS were needed to activate the HEK/TLR4 cells in 
comparison to THP-1 cells. Interestingly, the level of phosphorylation varies between 
growths of the same C. jejuni strain (Szymanski et al. 2003), and although this is a potential 
virulence factor nothing is known about the regulation of the genes involved in controlling 
phosphorylation levels in vivo.  
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Alteration of C. jejuni lipid A from ester to amide bonds linking the acyl chains to the 
backbone has been reported to reduce TLR4 activation (Van Mourik et al. 2010). Although 
the correlation between the abundance of four amide linkages and a reduction in TNF-α 
production from UK THP-1 cells was statistically significant, the correlation relied heavily on 
data from one strain that coincidently had both high levels of amide linkages and low levels 
of phosphorylation, both factors predicted to induce low TNF-α levels (Figure 6-7). It was 
therefore not possible to conclude whether the natural variation in the abundance of 
amide linkages influenced the levels of TNF-α secretion.  
Interestingly, different THP-1 cells appeared to have differing sensitivity to structural 
modifications of C. jejuni LOS. US THP-1 cells were responsive to sialylation but not 
phosphorylation of the LOS (Figure 6-4; Figure 6-8). Conversely, sialylation has less impact 
on UK THP-1 cells but phosphorylation greatly increased the induction of TNF-α (Figure 6-6; 
Figure 6-8). It is interesting to speculate that point mutations may have occurred in TLR4 or 
MD2 during the continual passage of the THP-1 cells, resulting in diverging specificities for 
LOS structural features. Interestingly, monocytes from different donors also showed 
differing responsiveness to LOS modifications (Figure 6-9). Only 3/6 donors showed a 
correlation between sialylation and TNF-α production. 5/6 donors showed a trend towards 
a correlation between phosphorylation and TNF-α production, which only became 
statistically significant when the data from the donors was combined. Polymorphisms in 
the human TLR4 are well characterised and alter susceptibility to a range of diseases such 
as septic shock, ulcerative colitis, and pre-term labour (Lorenz et al. 2002a; Lorenz et al. 
2002b; Torok et al. 2004). TLR4 polymorphisms with reduced responsiveness to LPS 
conversely increased susceptibility of the host to septic shock due to increased burdens of 
Gram negative infection (Lorenz et al. 2002b). It would be interesting to assess the impact 
of TLR4 polymorphisms on human C. jejuni infection as it remains unknown whether TLR4 
signalling protects the host by reducing bacterial load or exacerbates disease by inducing 
pro-inflammatory responses.     
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   Discussion 
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The immune system has evolved in parallel with the microbes that it encounters. This has 
allowed the evolution of interactions between host Pattern Recognition Receptors (PRRs) 
and conserved Pathogen- or Microbe-Associated Molecular Patterns (PAMPs/MAMPs). The 
detection of invading pathogens by PRRs provides a robust immediate immune response 
that limits pathogen spread before a specific adaptive immune response can be generated. 
The ability to detect MAMPs is most likely an absolute requirement for species survival. 
Although TLRs were first discovered in Drosophila, it is now appreciated that plants also 
express transmembrane receptor kinases bearing LRR domains that are involved in 
microbial recognition (Gomez-Gomez and Boller 2000; Song et al. 1995). The plant PRR for 
flagellin, FLS2, recognises a conserved domain in flagellin which is distinct from the domain 
involved in TLR5 interactions, suggesting that plants and animals have evolved MAMP 
recognition convergently which highlights its importance in host defense (Gomez-Gomez & 
Boller 2000). The idea that these PRRs can also detect host-related components when out 
of their usual context (DAMPs) suggests that PRRs also function to detect deviations from 
normal homeostatic conditions. During homeostasis it is likely that a large proportion of 
the gut microbiota do not interact directly with the GI mucosa due to the thick mucus layer 
covering the epithelium. However, it is also likely that many “commensal” bacteria are able 
to survive within the mucus layer and interact with cells of the mucosa via MAMPs/PRR 
interactions, generating a tolerogenic immune response with the overall effect of allowing 
commensalism and/or symbiosis to flourish. One method for generating tolerogenic 
immunological status is the regulation of TLR expression and signalling within the lamina 
propria (LP) . For example, TLR4 is expressed in lower levels on intestinal immune cells and 
TLR signalling pathways are dampened in intestinal macrophages (Smythies et al. 2010). 
The invasive properties of enteric pathogens however overcome the dampened intestinal 
immune status by engaging PRRs in an overt manner promoting an inflammatory status.  
In vitro studies show C. jejuni is able to invade intestinal epithelial cells (IECs) and disrupt 
tight barrier junctions, this is likely to aid passage into the LP whereupon C. jejuni will 
encounter innate immune cells (Bras & Ketley 1999; Wine, Chan, & Sherman 2008). ~1.6% 
of LP cells are CD11c+ DCs (in mice) which function both in intestinal homeostasis and 
present antigen during infection (Denning et al. 2007). In the present study we investigated 
C. jejuni-mediated effects on BMDC and human monocyte derived DCs. C. jejuni induced DC 
maturation resulting in the secretion of a wide-range of inflammatory cytokines and 
infection also led to the upregulation of co-stimulatory molecules and MHC class II (Figure 
3-3 and Figure 3-4). 
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The pro-inflammatory cytokines IL-6 and TNF--α were induced in high levels by C. jejuni in 
BMDCs (Figure 3-4). The induction of the cytokines upon DC/C. jejuni interaction may aid 
understanding of C. jejuni-mediated pathology in the intestine. IL-6 and TNF--α both induce 
the acute phase response causing infiltration and activation of neutrophils and other 
leukocytes into the LP (Andus et al. 1988). Collectively the induction of high levels of pro-
inflammatory cytokines likely aids in the clearance of C. jejuni but at the cost of inducing 
pathology. Regulation of IL-1β however presented a more complex scenario. C. jejuni 
induced fairly low levels of IL-1β from BMDCs (Figure 3-4).The physiological relevance of 
this IL-1β induction during early C. jejuni infection is debateable as few reports suggest high 
levels of IL-1β during C. jejuni infection in in vitro DC- or ex vivo biopsy-co-culture studies 
(Edwards et al. 2010; Hu et al. 2006). Parallel studies in our laboratory investigating other 
enteric pathogens found IL-1β levels of >2000 pg/mL in response to EPEC, C. difficile, and S. 
typhimurium at low MOI of between 1 and 10, compared to ~300pg/mL by C. jejuni at an 
MOI 100. We have previously reported low levels of IL-1β induction (<20pg/mL) in  human 
intestinal biopsies co-cultured with C. jejuni 8h post-infection in an ex-vivo model of 
infection (Edwards et al. 2010). In contrast, C. difficile induces levels of ~500pg/ml in a 
similar ex-vivo model (Jafari N, unpublished data).  Although this may be a result of the 
conditions of our in vitro assays not inducing expression of specific virulence factors in C. 
jejuni that may induce the inflammasome.  No reports so far have shown the activation of 
the inflammasome by ε-proteobacteria, a factor that may aid long-term colonisation with 
the host. The lower activation levels of IL-1β by C. jejuni may explain why other enteric 
pathogens have shorter incubation periods before inducing overt intestinal inflammation.  
Interestingly, C. jejuni induced higher levels of IL-12 compared to IL-23 from BMDCs (Figure 
3-4). This correlated with induction of IFNγ but not IL-17A in naive T-cells stimulated with C. 
jejuni-activated DCs and is in agreement with other studies highlighting Th1 skewing by C. 
jejuni (Figure 4-16) (Edwards et al. 2010;Rathinam, Hoag, & Mansfield 2008). The driving of 
Th1 in the mucosa is linked to the activation of innate immune cells, including PMNs which 
is likely to contribute to the inflammatory pathology associated with campylobacteriosis. 
However, in humans with prior exposure to infection C. jejuni-antigen dependent induction 
of IFNγ is associated with protection from pathology but has limited impact on colonisation 
(Tribble et al. 2010). This suggests that the production of IL-12 in DCs in responses to C. 
jejuni is beneficial to the host via the induction of protective Th1 responses which may limit 
invasion of C. jejuni into the mucosa and minimise the onset of inflammatory diarrhoea. 
However, C. jejuni may still be able to inhabit the mucus layer as Th1 responses afford 
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minimal protection from colonisation. This highlights a potential dual role of Th1 responses 
in driving pathology in immune naïve individuals whilst affording protection in humans with 
prior exposure by limiting C. jejuni contact with LP immune cells.  
A recent review of the literature suggested that as less than 1/100 human exposures to C. 
jejuni results in pathology (Havelaar et al. 2009). It is also known that repeated exposure to 
C. jejuni limits pathology but not colonisation upon re-infection. It is interesting to 
speculate that C. jejuni may manipulate the adaptive immune response in order to favour 
colonisation in the human intestine. Despite symptomatic disease lasting on average less 
than week the mean carriage of C. jejuni after infection is 37 days (Kapperud et al. 1992). 
This suggests that the bacterium is able to persist within the mucosa without causing 
further pathology and adds weight to the hypothesis of bacterial-mediated immune 
manipulation. The ability of the murine pathobiont Helicobacter hepaticus and human 
pathogen Helicobacter pylori to drive Treg induction in in vivo and in vitro highlights the 
notion that bacteria other than “true” commensals do manipulate the adaptive immune 
system as an immune evasion strategy (Kao et al. 2010; Kullberg et al. 2002).  
 It was interesting to observe the high levels of IL-10 induction by C. jejuni in BMDCs (Figure 
3-4). Other enteric pathogens such as EPEC, C. difficile, and S.typhimurium show markedly 
lower IL-10 induction when compared to C. jejuni (data not shown). IL-10 plays a critical 
role in intestinal immune regulation which is highlighted by the spontaneous development 
of colitis in IL-10 KO mice (Kuhn et al. 1993). The induction of IL-10 by C. jejuni may be 
advantageous to the bacterium as it would limit inflammation and potentially reduce 
clearance by the immune system. It is interesting to note that only IL-10-/- mice develop 
pathology to C. jejuni despite similar levels of colonisation to wild-type mice (Mansfield et 
al. 2007). This suggests colonisation can occur without pathology, and only the 
dysregulation of the immune system generates pathology. High IL-10 induction is important 
for Treg skewing by H. pylori, and is implicated in the establishment of long-term infection 
as IL-10 KO mice show markedly lower colonisation rates than WT mice (Kao et al. 2010; 
Panthel, Faller, & Haas 2003). Differential induction of cytokines such as IL-10 by C. jejuni in 
humans may explain the multiple outcomes observed upon infection. 
Engagement of PRRs by microbes tailors the innate immune response which dictates the 
overall immune outcome to infection. PRRs detect specific MAMPs because they are largely 
conserved on microbes which suggest they are structurally necessary for cell viability; 
mutations that may aid in reduced PRR detection may also not support survival raising a 
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conundrum for microbial fitness. Some bacteria have however evolved to manipulate these 
interactions by altering surface structures; exemplified by the ability of α- and ε-
proteobacteria to evade TLR5 recognition via specific mutation in the flagellin protein 
monomers (Andersen-Nissen et al. 2005). Due to the absolute requirement of MyD88- and 
TRIF-dependent TLR signalling for C. jejuni-mediated cytokine production (Figure 4-3) and 
the lack of interaction between C. jejuni FlaA and TLR5, it was interesting to observe a 
marked reduction in IL-10 and IL-1β production with the ΔflaA mutant (Figure 3-6) These 
observations led to the hypothesis that C. jejuni flagellin may modulate immune responses 
via TLR5-independent mechanism(s). The identity of these interactions was further sought 
(Chapter 4).  
In recent years, questions have arisen as to whether Janeway’s original paradigm of 
microbial detection by engagement of PAMPs/PRRs is sufficient to explain the differential 
immune response seen between the gut microbota during homeostasis and/or during 
infection. This has led researchers to favour Matzinger’s danger theory, whereby the host 
does not elicit an overt inflammatory immune response unless “danger” is sensed 
(Matzinger 2001). This is exemplified by the detection of intracellular bacteria by the 
inflammasome. C. jejuni induces IL-1β secretion from BMDCs (Figure 3-6) which is reduced 
when the FlaA protein is mutated. Interestingly, C. jejuni-dependent IL-1β secretion was 
independent of the intracellular flagellin receptor, IPAF but dependent on NLRP3 and ASC 
(Figure 4-14). This suggests an as yet unknown ligand of C. jejuni induces the inflammasome 
and IL-1β in BMDCs. There are two possible hypothesises for the lower induction of IL-1β 
by the ∆flaA isogenic mutant. Firstly, the loss of motility may alter subcellular localisation of 
the bacterium once phagocytosed. It is possible that low numbers of C. jejuni may escape 
the phagosome resulting in NALP3- and ASC-dependent activation of the inflammasome, 
and this may be altered with the mutation of the flagella. Secondly, glycosylation moieties 
on the flagellin may directly interact with other lectin-receptors that may activate the non-
canonical inflammasome pathways as was recently reported for dectin-1 (Gringhuis et al. 
2012).  
 Signalling via the Pse5Ac7Am structural modification (or derivatives of) of C. jejuni flagellin 
accounted for ~a third of C. jejuni-induced IL-10 production (Figure 3-17). In contrast, the 
carbohydrate moiety of the flagella did not significantly alter the induction pro-
inflammatory cytokines. This suggested that particular carbohydrate modifications of C. 
jejuni surface structures may be beneficial to the bacterium by manipulating the host 
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innate immune response. Interestingly, many of the surface structures of C. jejuni are 
glycosylated. Many of these structural modifications vary between different C. jejuni strains 
including the LOS, capsule, and flagella. Glycosylation can be a means of immune evasion as 
it allows masking of antigenic surface proteins from immune recognition. In addition, it is 
becoming increasing clear that these carbohydrate structures themselves are important for 
interaction with the host via PRR engagement. Genes encoding the Pse (pseudaminic acid) 
pathway have been found in most C. jejuni strains studied to date whereas a significant 
proportion of strains lack the Ptm (legionaminic acid) pathway (Champion et al. 2005). The 
Pse pathway is also found in H. pylori (Schirm et al. 2003). However, the flagella of H. pylori 
are coated in a sheath which protects it from immune detection; this corresponds to a lack 
of diversity in the pseudaminic structures found between H. pylori compared to the 
diversity observed between strains of C. jejuni.  
The ability of C. jejuni to bind Siglec-10 via the glycosylated flagella was elucidated in this 
study (Figure 4-9). We are currently undertaking experiments to decipher whether direct 
engagement of Siglec-10 by C. jejuni induces IL-10. The engagement of Siglec-9 leads to the 
specific induction of IL-10 suggesting the engagement of Siglec-10 by C. jejuni could induce 
IL-10 (Ando et al. 2008). Although Siglec-10 is known to be expressed in the small intestine, 
the specific cellular expression is unknown (Li et al. 2001). It is interesting to speculate that 
the expression of modulating immune receptors such as Siglecs may vary between humans 
and chickens and may in part account for the difference in disease outcomes between the 
two hosts. Indeed, one report has highlighted a link between the underexpression of 
Siglecs and the over-reactivity of human B- and T-cells compared to chimpanzee cells to a 
number of different stimuli (Soto et al. 2010). The engagement of the CLR, SIGNR1, on LP 
DCs has also been shown to specifically induce IL-10 promoting the generation of 
regulatory T cells and inducing oral tolerance (Zhou et al. 2010). This suggests engagement 
of inhibitory receptors on DCs in the mucosa could be a target for enteric pathogens. 
Potentially, differential expression of inhibitory receptors between individuals may also 
account for why only a small percentage of people who are exposed to C. jejuni develop 
pathology (Havelaar et al. 2009). Interestingly, chickens do not express a functional 
homolog of Siglec-10 which could lead to differential immune interactions between C. 
jejuni with the mucosal immune cells of the chicken and human intestine.      
In Chapters 3 and 4 we observed that C. jejuni activated MAPK signalling in a TLR-
dependent manner. IL-10 in particular was suppressed during pharmalogical inhibition of 
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the MAPK signalling cascades (Figure 3-13). Additionally, the ∆flaA isogenic mutant showed 
reduced activation of p38 (Figure 3-10). Analysing the ability for Siglec-10 engagement to 
modulate MAPK signalling is critical to taking the current observations further. The 
presence of a grb2-binding domain on the intracellular portion of Siglec-10/G suggests 
receptor engagement could potentially link to the activation of MAPK signalling (Zhang et 
al. 2003). This however would be the first report of Siglec-mediated MAPK activation.  
We studied C. jejuni LOS-mediated innate immune interactions in addition to responses to 
the flagella (Chapter 6). Mutation of genes involved in C. jejuni lipid A biosynthesis, the 
ligand for TLR4, is lethal suggesting that the LOS is critical for membrane integrity 
(Phongsisay, Perera, & Fry 2007). Although the lipid A acyl chains form the major structural 
mass in the dimerisation of the TLR4 complex, phosphorylation of the lipid A disaccharide 
backbone is also involved in charge interactions with the TLR4 complex (Park et al. 2009). 
Different strains of C. jejuni contained varying levels of phosphorylation on the lipid A 
backbone (Chapter 5). Further, abundance of phosphorylation correlated with TNF--α levels 
in monocytes and THP-1 cells; a process that was TLR4-dependent (Chapter 6). Mutation of 
C. jejuni lipid A PEA modifications causes a 20-fold increase in susceptibility to cationic 
AMPs suggesting that the phosphorylation of lipid A is beneficial to the bacterium despite 
inducing higher levels of TNF--α (Cullen & Trent 2010). Variation in the abundance of amide 
versus ester linkage of the acyl chains to the lipid A backbone between different C. jejuni 
strains was also noted (Chapter 5). The alteration of ester linkages to amide linkages has 
previously been reported to both reduce TLR4 activation and also decrease susceptibility to 
AMPs (Van Mourik et al. 2010). We observed a trend towards this correlation between the 
strains under investigation, however due to lack of spread of the strains the data did not 
prove this statistically. Collectively the data indicated that different C. jejuni strains possess 
various chemical modifications on their lipid A, which can alter TLR4 engagement and the 
induction of pro-inflammatory cytokines.  
C. jejuni strains from the “livestock” clade all contained genes involved in the biosynthesis 
of LOS sialic acid, whereas less than 50% of strains from the “environmental” clade 
contained these genes (Chapter 5). This data suggested that LOS sialylation is similar to the 
modification of C. jejuni flagella with legionaminic acid and its derivatives, with a greater 
propensity for livestock strains to contain these modifications. The glycosylation of many C. 
jejuni surface structures is hypervariable therefore it was interesting to find a critical 
component of C. jejuni in the colonisation of livestock.  
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There are many reasons why bacteria sialylate their surface. These include enhancing 
factor H binding which limits complement deposition (Ram et al. 1998); molecular mimicry 
of host glycoconjugates which reduces bacteria-specific antibody responses (Vimr and 
Lichtensteiger 2002); to reduce neutrophil oxidative burst by binding the inhibitory 
receptor Siglec-9 (Carlin et al. 2009b); and to aid binding to epithelial cells (Louwen et al. 
2008). Any of these cellular events may explain the greater propensity for the presence of 
sialic acid biosynthesis genes in livestock C. jejuni strains. Interestingly, in our study human 
clinical isolates did not show as strong a correlation with sialic acid biosynthesis genes as 
livestock strains. Potentially, overlapping function between the sialic acid on the LOS and 
sialic acid-like structures on the flagella in the human intestine could account for why fewer 
human clinical isolates contain sialylated LOS.  
Contrary to its role in immune evasion, increasing levels of sialylation correlated with an 
increase in TNF-α from monocytes (Chapter 6). This correlation was abolished upon 
sialidase treatment. Additionally, inhibition of TLR4 with the agonist lipid IVa inhibited TNF-
α secretion which implicated TLR4 signalling. This data agreed with a previous report which 
showed a sialic acid-deficient isogenic mutant of C. jejuni causes reduced activation of TLR4 
compared to the WT strain (Kuijf et al. 2010). The crystal structure of TLR4 bound to E. coli 
hexacylated LPS does not show a definitive position of the OS moiety in the receptor 
complex (Park et al. 2009). However this does not negate potential contribution of OS in 
receptor ligation. Interestingly, the KDO residue which links the OS to the lipid A is found in 
most bacterial LPS/LOS moieties. The KDO is similar to sialic acid in that it is negatively 
charged due to the presence of a carboxyl group on the 5-carbon ring structure. Potentially 
this negative charge could aid in a similar manner as suggested for the lipid A phosphate in 
TLR4 complex formation. The charge on sialic acid could potentially modify the strength of 
receptor ligation. Interestingly, the sialic acid on LOS from other bacterial species, such as 
Histophilis somni, has been shown to reduce TLR4 signalling in murine macrophages 
(Howard et al. 2011). This suggests that the impact of LPS/LOS sialylation may be 
dependent on the host species, which raises interesting questions as to the possible 
differences between TLR4 signalling between chickens and humans. The increased 
activation of human TLR4 by sialylated LOS may have evolved to counter the other immune 
evasion benefits of sialylation. It is interesting that other surface structures of C. jejuni 
contain sialic acid-like structures, which potentially confer similar advantages of immune 
evasion seen with sialic-acid whilst not increasing activation of TLRs.      
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A recent phylogenomic study showed that ~20% of microbial genomes examined contained 
genes encoding sialic acid biosynthesis pathways (Lewis et al. 2009). Interestingly, sialic-
acid biosynthesis pathways are most commonly found in ε-proteobacteria, a class of 
bacteria that often associate with animals. Until recently it was believed that de novo sialic 
acid-synthesis was limited only to bacterial strains that associate with animals and that this 
genetic information was inherited by horizontal gene transfer from animal cells. It is now 
appreciated that the genetic loci for sialic acid biosynthesis is more ancient and that 
bacteria may have evolved this capability from mutation of the Leg biosynthesis pathway.  
Other bacterial carbohydrate structures have been shown to be important in manipulating 
intestinal immune responses. In germ-free mice H. hepaticus drives colitis due to impaired 
development of CD4+ T cells. These mice are protected from colitis if treated with B. fragilis 
polysaccharide A (PSA) due to the inhibition of Th17 cells and expansion of Tregs 
(Mazmanian et al. 2008). Interestingly, the PSA does not alter numbers of H. hepaticus in 
the intestine. Protection from H. hepaticus—mediated colitis by PSA is dependent on the 
production of IL-10 from CD4+ T cells. This suggests that manipulation of IL-10 signalling can 
alter intestinal pathology generated by particular bacteria.   
In conclusion, this study has shown how the carbohydrate moieties of two critical C. jejuni 
surface structures, the flagella and LOS, modulate host innate immune responses. Firstly, 
the modification of the flagella with derivatives of pseudaminic acid drives high IL-10 
responses by the manipulation of the TLR-activated MAPK pathway. This potentially is a 
down-stream effect of Siglec-10 engagement however a direct connection between 
receptor ligation and IL-10 remains to be proven. Secondly, sialylation of the LOS drives 
higher pro-inflammatory cytokine responses and is dependent on the phylogenetic source 
of the C. jejuni. This may be an evolutionary feature of human TLR4 to counter the immune 
dampening effects of bacterial sialylation. Many more questions remain as to how the 
carbohydrate surface structure of C. jejuni modulates immune responses. 
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